<?xml version="1.0" encoding="UTF-8"?><!-- generator="podbean/5.5" -->
<rss version="2.0"
     xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:wfw="http://wellformedweb.org/CommentAPI/"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:atom="http://www.w3.org/2005/Atom"
     xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
     xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0"
     xmlns:spotify="http://www.spotify.com/ns/rss"
     xmlns:podcast="https://podcastindex.org/namespace/1.0"
    xmlns:media="http://search.yahoo.com/mrss/">

<channel>
    <title>HistoTalks: NSH Podcasts</title>
    <atom:link href="https://feed.podbean.com/nshpodcasts/feed.xml" rel="self" type="application/rss+xml"/>
    <link>https://nshpodcasts.podbean.com</link>
    <description>Histology related podcasts brought to you by the National Society for Histotechnology</description>
    <pubDate>Fri, 06 Mar 2026 09:56:04 -0500</pubDate>
    <generator>https://podbean.com/?v=5.5</generator>
    <language>en</language>
        <copyright>Copyright 2016  . All rights reserved.</copyright>
    <category>Science</category>
    <ttl>1440</ttl>
    <itunes:type>episodic</itunes:type>
          <itunes:summary>Histology related podcasts brought to you by the National Society for Histotechnology</itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
<itunes:category text="Science" />
    <itunes:owner>
        <itunes:name>National Society for Histotechnology</itunes:name>
            </itunes:owner>
    	<itunes:block>No</itunes:block>
	<itunes:explicit>false</itunes:explicit>
    <itunes:image href="https://pbcdn1.podbean.com/imglogo/image-logo/1355248/Podcast_2020.png" />
    <image>
        <url>https://pbcdn1.podbean.com/imglogo/image-logo/1355248/Podcast_2020.png</url>
        <title>HistoTalks: NSH Podcasts</title>
        <link>https://nshpodcasts.podbean.com</link>
        <width>144</width>
        <height>144</height>
    </image>
    <item>
        <title>Fixation on Histology: Understanding the Tools of Embedding</title>
        <itunes:title>Fixation on Histology: Understanding the Tools of Embedding</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/fixation-on-histology-understanding-the-tools-of-embedding/</link>
                    <comments>https://nshpodcasts.podbean.com/e/fixation-on-histology-understanding-the-tools-of-embedding/#comments</comments>        <pubDate>Fri, 06 Mar 2026 09:56:04 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/bf5f02fa-388b-31ee-a19a-85cfff44d84e</guid>
                                    <description><![CDATA[<p>Fixation on Histology: Understanding the Tools of Embedding</p>
<p>Written based on the NSH Webinar: <a href='https://elearn.nsh.org/products/embedding-basics-and-troubleshooting'>Embedding Basics &amp; Troubleshooting</a></p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2026/03/06/understanding-the-tools-of-embedding?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>To read the full blog, click here</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Fixation on Histology: Understanding the Tools of Embedding</p>
<p>Written based on the NSH Webinar: <a href='https://elearn.nsh.org/products/embedding-basics-and-troubleshooting'>Embedding Basics &amp; Troubleshooting</a></p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2026/03/06/understanding-the-tools-of-embedding?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>To read the full blog, click here</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/566ksrdkw4zxpm56/Embedding_2026.mp3" length="3107622" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fixation on Histology: Understanding the Tools of Embedding
Written based on the NSH Webinar: Embedding Basics &amp; Troubleshooting
To read the full blog, click here. ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>194</itunes:duration>
                <itunes:episode>203</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/fixationblogvideoimage.png" medium="image">
                            <media:title type="html">Fixation on Histology: Understanding the Tools of Embedding</media:title></media:content>    </item>
    <item>
        <title>Fixation on Histology: The High Cost of Johne’s Disease</title>
        <itunes:title>Fixation on Histology: The High Cost of Johne’s Disease</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/fixation-on-histology-the-high-cost-of-johne-s-disease/</link>
                    <comments>https://nshpodcasts.podbean.com/e/fixation-on-histology-the-high-cost-of-johne-s-disease/#comments</comments>        <pubDate>Fri, 20 Feb 2026 10:32:15 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/6530fce0-414f-3699-8f9c-bd93ed369eee</guid>
                                    <description><![CDATA[<p>Fixation on Histology: The High Cost of Johne’s Disease</p>
<p>Written based on the NSH Webinar <a href='https://elearn.nsh.org/products/jonesing-for-johnes-afb-control-tissue'>Jonesing For Johne’s - AFB Control Tissue</a></p>
<p><a href='https://elearn.nsh.org/products/jonesing-for-johnes-afb-control-tissue'>To Read the Full Blog, Click Here</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Fixation on Histology: The High Cost of Johne’s Disease</p>
<p>Written based on the NSH Webinar <a href='https://elearn.nsh.org/products/jonesing-for-johnes-afb-control-tissue'>Jonesing For Johne’s - AFB Control Tissue</a></p>
<p><a href='https://elearn.nsh.org/products/jonesing-for-johnes-afb-control-tissue'>To Read the Full Blog, Click Here</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9hz5fdqsvvxvekex/Johne_s_Disease_2026busb0.mp3" length="3298211" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fixation on Histology: The High Cost of Johne’s Disease
Written based on the NSH Webinar Jonesing For Johne’s - AFB Control Tissue
To Read the Full Blog, Click Here]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>206</itunes:duration>
                <itunes:episode>202</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Fixation on Histology: Top 5 Traits of a Great Histotechnologist</title>
        <itunes:title>Fixation on Histology: Top 5 Traits of a Great Histotechnologist</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/fixation-on-histology-top-5-traits-of-a-great-histotechnologist/</link>
                    <comments>https://nshpodcasts.podbean.com/e/fixation-on-histology-top-5-traits-of-a-great-histotechnologist/#comments</comments>        <pubDate>Fri, 06 Feb 2026 14:04:38 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/16ab3883-bcf9-3ea5-9ab1-6678fc53eeb1</guid>
                                    <description><![CDATA[<p>Fixation on Histology: Top 5 Traits of a Great Histotechnologist</p>
<p>Written by: Connie Wildeman, Director of Education, NSH</p>
<p>To read the full blog, <a href='https://www.nsh.org/blogs/ashley-stewart/2026/02/06/top-5-traits-of-a-great-histotechnologist?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>click here</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Fixation on Histology: Top 5 Traits of a Great Histotechnologist</p>
<p>Written by: Connie Wildeman, Director of Education, NSH</p>
<p>To read the full blog, <a href='https://www.nsh.org/blogs/ashley-stewart/2026/02/06/top-5-traits-of-a-great-histotechnologist?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>click here</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nhwv5kzt2bcq9qpp/5_Traits_2026bgpp9.mp3" length="3378460" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fixation on Histology: Top 5 Traits of a Great Histotechnologist
Written by: Connie Wildeman, Director of Education, NSH
To read the full blog, click here. ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>211</itunes:duration>
                <itunes:episode>201</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/fixationblogvideoimage.png" medium="image">
                            <media:title type="html">Fixation on Histology: Top 5 Traits of a Great Histotechnologist</media:title></media:content>    </item>
    <item>
        <title>Career Advice: All Roads Lead to Success in Histology</title>
        <itunes:title>Career Advice: All Roads Lead to Success in Histology</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/career-advice-all-roads-lead-to-success-in-histology/</link>
                    <comments>https://nshpodcasts.podbean.com/e/career-advice-all-roads-lead-to-success-in-histology/#comments</comments>        <pubDate>Thu, 05 Feb 2026 16:45:07 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/97fd5506-39df-3d36-8038-0014e7aa57e6</guid>
                                    <description><![CDATA[<p>In this episode, NSH Director Education, Connie Wildeman, sat down with Olivia Hoppe and Olivia Mouch, both Application Support Specialists with Milestone Medical, to discuss their unique roads to histology.  The also discuss important traits of a histotech - no matter the background.  Whether you looking to hire a tech or trying to determine if you could be a good tech, this podcast provides great insights into your histology lab future! </p>
<p> </p>
<p>Special thanks to Milestone Medical for supporting this episode. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, NSH Director Education, Connie Wildeman, sat down with Olivia Hoppe and Olivia Mouch, both Application Support Specialists with Milestone Medical, to discuss their unique roads to histology.  The also discuss important traits of a histotech - no matter the background.  Whether you looking to hire a tech or trying to determine if you could be a good tech, this podcast provides great insights into your histology lab future! </p>
<p> </p>
<p>Special thanks to Milestone Medical for supporting this episode. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9grju4epify5ak3t/Career_Paths_and_Skills_Podcast60l1a.mp3" length="33851603" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, NSH Director Education, Connie Wildeman, sat down with Olivia Hoppe and Olivia Mouch, both Application Support Specialists with Milestone Medical, to discuss their unique roads to histology.  The also discuss important traits of a histotech - no matter the background.  Whether you looking to hire a tech or trying to determine if you could be a good tech, this podcast provides great insights into your histology lab future! 
 
Special thanks to Milestone Medical for supporting this episode. ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>846</itunes:duration>
                <itunes:episode>200</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Fixation on Histology: Are Multiple GMS-Stained Levels Needed? Not Necessarily, According to Study</title>
        <itunes:title>Fixation on Histology: Are Multiple GMS-Stained Levels Needed? Not Necessarily, According to Study</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/fixation-on-histology-are-multiple-gms-stained-levels-needed-not-necessarily-according-to-study/</link>
                    <comments>https://nshpodcasts.podbean.com/e/fixation-on-histology-are-multiple-gms-stained-levels-needed-not-necessarily-according-to-study/#comments</comments>        <pubDate>Fri, 09 Jan 2026 13:05:00 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/7dae4d00-e03d-3998-8e12-114f16442016</guid>
                                    <description><![CDATA[<p>Fixation on Histology: Are Multiple GMS-Stained Levels Needed? Not Necessarily, According to Study</p>
<p>Written based on the article "<a href='https://www.tandfonline.com/doi/full/10.1080/01478885.2024.2437587'>Multiple levels of Gomori methenamine silver (GMS) stains do not improve diagnostic yield in esophageal biopsies"</a> published in the Journal of Histotechnology</p>
<p>To read the blog, click <a href='https://www.nsh.org/blogs/ashley-stewart/2026/01/09/are-multiple-gms-stained-levels-needed'>here</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Fixation on Histology: Are Multiple GMS-Stained Levels Needed? Not Necessarily, According to Study</p>
<p>Written based on the article "<a href='https://www.tandfonline.com/doi/full/10.1080/01478885.2024.2437587'>Multiple levels of Gomori methenamine silver (GMS) stains do not improve diagnostic yield in esophageal biopsies"</a> published in the Journal of Histotechnology</p>
<p>To read the blog, click <a href='https://www.nsh.org/blogs/ashley-stewart/2026/01/09/are-multiple-gms-stained-levels-needed'>here</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/p99bb6fsizrzb4qt/GMS_Necessary_2026bp5ap.mp3" length="4196406" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fixation on Histology: Are Multiple GMS-Stained Levels Needed? Not Necessarily, According to Study
Written based on the article "Multiple levels of Gomori methenamine silver (GMS) stains do not improve diagnostic yield in esophageal biopsies" published in the Journal of Histotechnology
To read the blog, click here. ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>262</itunes:duration>
                <itunes:episode>199</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/fixationblogvideoimage.png" medium="image">
                            <media:title type="html">Fixation on Histology: Are Multiple GMS-Stained Levels Needed? Not Necessarily, According to Study</media:title></media:content>    </item>
    <item>
        <title>Fixation on Histology: NSH Was Doing Distance Learning Before It Was Cool — Here’s Why It Still Works</title>
        <itunes:title>Fixation on Histology: NSH Was Doing Distance Learning Before It Was Cool — Here’s Why It Still Works</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/fixation-on-histology-nsh-was-doing-distance-learning-before-it-was-cool-%e2%80%94-here-s-why-it-still-works/</link>
                    <comments>https://nshpodcasts.podbean.com/e/fixation-on-histology-nsh-was-doing-distance-learning-before-it-was-cool-%e2%80%94-here-s-why-it-still-works/#comments</comments>        <pubDate>Fri, 12 Dec 2025 10:13:37 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/36518fa9-ce1b-3c4d-9a48-7d45364503fa</guid>
                                    <description><![CDATA[<p>Fixation on Histology: NSH Was Doing Distance Learning Before It Was Cool — Here’s Why It Still Works</p>
<p>Written by: Connie Wildeman, MPA, Director of Education at NSH</p>
<p>To Read the Full Blog, Click <a href='https://www.nsh.org/blogs/ashley-stewart/2025/12/12/nsh-was-doing-distance-learning-before-it-was-cool'>Here</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Fixation on Histology: NSH Was Doing Distance Learning Before It Was Cool — Here’s Why It Still Works</p>
<p>Written by: Connie Wildeman, MPA, Director of Education at NSH</p>
<p>To Read the Full Blog, Click <a href='https://www.nsh.org/blogs/ashley-stewart/2025/12/12/nsh-was-doing-distance-learning-before-it-was-cool'>Here</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/exkki4fc4xd8c66g/Distance_Learning_2025bnbbr.mp3" length="5270143" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fixation on Histology: NSH Was Doing Distance Learning Before It Was Cool — Here’s Why It Still Works
Written by: Connie Wildeman, MPA, Director of Education at NSH
To Read the Full Blog, Click Here]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>329</itunes:duration>
                <itunes:episode>198</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/fixationblogvideoimage.png" medium="image">
                            <media:title type="html">Fixation on Histology: NSH Was Doing Distance Learning Before It Was Cool — Here’s Why It Still Works</media:title></media:content>    </item>
    <item>
        <title>NSH Poster Podcast (2025): Histological Whole Slide Scanning Reproducibility Study</title>
        <itunes:title>NSH Poster Podcast (2025): Histological Whole Slide Scanning Reproducibility Study</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-2025-histological-whole-slide-scanning-reproducibility-study/</link>
                    <comments>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-2025-histological-whole-slide-scanning-reproducibility-study/#comments</comments>        <pubDate>Tue, 09 Dec 2025 11:48:45 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/834d1b8d-8b21-3f99-a0d3-9ba31a0c8419</guid>
                                    <description><![CDATA[<p>Title: Histological Whole Slide Scanning Reproducibility Study  </p>
<p>Authors: Hannah Benton, BSa, Tomoe Shiomi, MS, HTL(ASCP)CM, CT(IAC)CM, Fatma Farooqi, BSc, HTL(ASCP), Elizabeth A. Chlipala, BS, HTL(ASCP)QIHC and Luis Chiriboga, PhD, HT(ASCP)QIHC</p>
<p>Abstract: Whole slide imaging (WSI) is an increasingly versatile method for capturing and sharing high-resolution digital images of stained histological slides. These images can be used for a variety of applications, including clinical diagnosis, pathology review, and image analysis. While many whole slide scanners exist with varying features tailored to different use cases, a critical factor across all platforms is the accuracy and reproducibility of the scanned images. To investigate scan consistency over time, a control slide was prepared using a tissue microarray stained with Hematoxylin and Eosin (H&amp;E). Ink dots were applied to the slide to define a consistent scanning region. The slide was scanned 77 times over six months using an Aperio AT2 whole slide scanner at 40x magnification.Image analysis was performed using HALO software by Indica Labs. Both the entire scan area and individual tissue punches were analyzed to assess total stained area and stain intensity, quantified by optical density (OD) for both hematoxylin and eosin.
A linear regression model was applied to data from all individual punches and the full scan region. Additionally, a two-way ANOVA was conducted to compare OD values of hematoxylin and eosin between the first 10 scans and the last 10 scans. Key findings were that hematoxylin showed a statistically significant decline in both stained areas and OD over time, while eosin demonstrated a statistically significant increase in stained area, but a decrease in OD. These results suggest potential degradation of staining quality or imaging consistency over time. Possible contributing factors include slide bleaching, light source variability, annotation region size, or other imaging conditions. These will be the focus of future investigations to better understand and control variability in longitudinal slide scanning studies.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Title: Histological Whole Slide Scanning Reproducibility Study  </p>
<p>Authors: Hannah Benton, BSa, Tomoe Shiomi, MS, HTL(ASCP)CM, CT(IAC)CM, Fatma Farooqi, BSc, HTL(ASCP), Elizabeth A. Chlipala, BS, HTL(ASCP)QIHC and Luis Chiriboga, PhD, HT(ASCP)QIHC</p>
<p>Abstract: Whole slide imaging (WSI) is an increasingly versatile method for capturing and sharing high-resolution digital images of stained histological slides. These images can be used for a variety of applications, including clinical diagnosis, pathology review, and image analysis. While many whole slide scanners exist with varying features tailored to different use cases, a critical factor across all platforms is the accuracy and reproducibility of the scanned images. To investigate scan consistency over time, a control slide was prepared using a tissue microarray stained with Hematoxylin and Eosin (H&amp;E). Ink dots were applied to the slide to define a consistent scanning region. The slide was scanned 77 times over six months using an Aperio AT2 whole slide scanner at 40x magnification.Image analysis was performed using HALO software by Indica Labs. Both the entire scan area and individual tissue punches were analyzed to assess total stained area and stain intensity, quantified by optical density (OD) for both hematoxylin and eosin.<br>
A linear regression model was applied to data from all individual punches and the full scan region. Additionally, a two-way ANOVA was conducted to compare OD values of hematoxylin and eosin between the first 10 scans and the last 10 scans. Key findings were that hematoxylin showed a statistically significant decline in both stained areas and OD over time, while eosin demonstrated a statistically significant increase in stained area, but a decrease in OD. These results suggest potential degradation of staining quality or imaging consistency over time. Possible contributing factors include slide bleaching, light source variability, annotation region size, or other imaging conditions. These will be the focus of future investigations to better understand and control variability in longitudinal slide scanning studies.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/c98aqaqgm7m7v9rh/E9_P6013.mp3" length="28178852" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Title: Histological Whole Slide Scanning Reproducibility Study  
Authors: Hannah Benton, BSa, Tomoe Shiomi, MS, HTL(ASCP)CM, CT(IAC)CM, Fatma Farooqi, BSc, HTL(ASCP), Elizabeth A. Chlipala, BS, HTL(ASCP)QIHC and Luis Chiriboga, PhD, HT(ASCP)QIHC
Abstract: Whole slide imaging (WSI) is an increasingly versatile method for capturing and sharing high-resolution digital images of stained histological slides. These images can be used for a variety of applications, including clinical diagnosis, pathology review, and image analysis. While many whole slide scanners exist with varying features tailored to different use cases, a critical factor across all platforms is the accuracy and reproducibility of the scanned images. To investigate scan consistency over time, a control slide was prepared using a tissue microarray stained with Hematoxylin and Eosin (H&amp;E). Ink dots were applied to the slide to define a consistent scanning region. The slide was scanned 77 times over six months using an Aperio AT2 whole slide scanner at 40x magnification.Image analysis was performed using HALO software by Indica Labs. Both the entire scan area and individual tissue punches were analyzed to assess total stained area and stain intensity, quantified by optical density (OD) for both hematoxylin and eosin.A linear regression model was applied to data from all individual punches and the full scan region. Additionally, a two-way ANOVA was conducted to compare OD values of hematoxylin and eosin between the first 10 scans and the last 10 scans. Key findings were that hematoxylin showed a statistically significant decline in both stained areas and OD over time, while eosin demonstrated a statistically significant increase in stained area, but a decrease in OD. These results suggest potential degradation of staining quality or imaging consistency over time. Possible contributing factors include slide bleaching, light source variability, annotation region size, or other imaging conditions. These will be the focus of future investigations to better understand and control variability in longitudinal slide scanning studies.]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>704</itunes:duration>
                <itunes:episode>197</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/ConventionLogoMaster2025_Circles_onlybfpi5.png" medium="image">
                            <media:title type="html">NSH Poster Podcast (2025): Histological Whole Slide Scanning Reproducibility Study</media:title></media:content>    </item>
    <item>
        <title>NSH Poster Podcast (2025): Employing Multi-Tissue Controls to Enhance Kidney Biopsy Protocol Education in a Program in Histotechnology Student Lab</title>
        <itunes:title>NSH Poster Podcast (2025): Employing Multi-Tissue Controls to Enhance Kidney Biopsy Protocol Education in a Program in Histotechnology Student Lab</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-2025-employing-multi-tissue-controls-to-enhance-kidney-biopsy-protocol-education-in-a-program-in-histotechnology-student-lab/</link>
                    <comments>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-2025-employing-multi-tissue-controls-to-enhance-kidney-biopsy-protocol-education-in-a-program-in-histotechnology-student-lab/#comments</comments>        <pubDate>Tue, 09 Dec 2025 11:47:28 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/bd17a5d4-8060-3bef-926b-2e483e102bfa</guid>
                                    <description><![CDATA[<p>Title: Employing Multi-Tissue Controls to Enhance Kidney Biopsy Protocol Education in a Program in Histotechnology Student Lab </p>
<p>Authors: Hyder Aljanabi, Damon Bendolph, Gabriella Casas, Yosan Embrafrash, Sara Hassan, Anastasja Kraft, Stephan Lloyd-Brown , Nida Mubeen, Minh Nguyen, Xena Orosco, Nicole Rivera, Moriam Sissoho, Tan Tang , Kaleena Ramirez, Toysha Mayer, Mark Bailey</p>
<p>Abstract: In a Program in Histotechnology student laboratory, establishing a representative and clinical teaching laboratory environment is essential for preparing students to manage the complexities of diagnostic tissue processing. The objective of the project was to simulate real-world clinical procedures by integrating multi-tissue controls into student education competencies for kidney biopsy staining protocols. Students participated in the investigation, each receiving four pieces of formalin-fixed, paraffin-embedded (FFPE) tissue: kidney, liver, gastrointestinal tract (GI), and tonsil. The tissues served as controls to validate staining techniques commonly used in renal pathology. Students prepared tissue sections using a rotary microtome, sectioning tissue at four microns. In total, forty slides were prepared, with eighteen slides manually stained using specific histochemical methods. Stains included hematoxylin and eosin (H&amp;E), periodic acid-Schiff (PAS), periodic acid methenamine silver (PAMS), and the Gomori Trichrome technique. The results yielded identifiable cellular and structural features critical for diagnostic interpretation. A slide review was conducted, and acceptable representative slides were selected for digital imaging. In addition, the results demonstrated the four tissue types which may be approved to use as controls, due to the consistency of demonstrating staining characteristics and features required for evaluating kidney biopsy protocols. Upon technical validation, the use of multi-tissue controls contributed to educational and operational outcomes. Students gained quality assurance experience, and the experience reinforced special stain and laboratory operations competencies, teaching students how to conserve reagent use, and to reduce time and expense. Furthermore, the protocol introduced the application of digital pathology and quality assurance in a real-world lab setting. Our investigation supports the integration of multi-tissue controls in histotechnology education as a valuable tool for enhancing both learning and laboratory efficiency. Future studies are recommended to include additional tissue types, stains, and immunohistochemical markers, to further advance and expand histotechnology educational competencies.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Title: Employing Multi-Tissue Controls to Enhance Kidney Biopsy Protocol Education in a Program in Histotechnology Student Lab </p>
<p>Authors: Hyder Aljanabi, Damon Bendolph, Gabriella Casas, Yosan Embrafrash, Sara Hassan, Anastasja Kraft, Stephan Lloyd-Brown , Nida Mubeen, Minh Nguyen, Xena Orosco, Nicole Rivera, Moriam Sissoho, Tan Tang , Kaleena Ramirez, Toysha Mayer, Mark Bailey</p>
<p>Abstract: In a Program in Histotechnology student laboratory, establishing a representative and clinical teaching laboratory environment is essential for preparing students to manage the complexities of diagnostic tissue processing. The objective of the project was to simulate real-world clinical procedures by integrating multi-tissue controls into student education competencies for kidney biopsy staining protocols. Students participated in the investigation, each receiving four pieces of formalin-fixed, paraffin-embedded (FFPE) tissue: kidney, liver, gastrointestinal tract (GI), and tonsil. The tissues served as controls to validate staining techniques commonly used in renal pathology. Students prepared tissue sections using a rotary microtome, sectioning tissue at four microns. In total, forty slides were prepared, with eighteen slides manually stained using specific histochemical methods. Stains included hematoxylin and eosin (H&amp;E), periodic acid-Schiff (PAS), periodic acid methenamine silver (PAMS), and the Gomori Trichrome technique. The results yielded identifiable cellular and structural features critical for diagnostic interpretation. A slide review was conducted, and acceptable representative slides were selected for digital imaging. In addition, the results demonstrated the four tissue types which may be approved to use as controls, due to the consistency of demonstrating staining characteristics and features required for evaluating kidney biopsy protocols. Upon technical validation, the use of multi-tissue controls contributed to educational and operational outcomes. Students gained quality assurance experience, and the experience reinforced special stain and laboratory operations competencies, teaching students how to conserve reagent use, and to reduce time and expense. Furthermore, the protocol introduced the application of digital pathology and quality assurance in a real-world lab setting. Our investigation supports the integration of multi-tissue controls in histotechnology education as a valuable tool for enhancing both learning and laboratory efficiency. Future studies are recommended to include additional tissue types, stains, and immunohistochemical markers, to further advance and expand histotechnology educational competencies.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kjhkzwvt8necdg46/E8_P6049.mp3" length="15153154" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Title: Employing Multi-Tissue Controls to Enhance Kidney Biopsy Protocol Education in a Program in Histotechnology Student Lab 
Authors: Hyder Aljanabi, Damon Bendolph, Gabriella Casas, Yosan Embrafrash, Sara Hassan, Anastasja Kraft, Stephan Lloyd-Brown , Nida Mubeen, Minh Nguyen, Xena Orosco, Nicole Rivera, Moriam Sissoho, Tan Tang , Kaleena Ramirez, Toysha Mayer, Mark Bailey
Abstract: In a Program in Histotechnology student laboratory, establishing a representative and clinical teaching laboratory environment is essential for preparing students to manage the complexities of diagnostic tissue processing. The objective of the project was to simulate real-world clinical procedures by integrating multi-tissue controls into student education competencies for kidney biopsy staining protocols. Students participated in the investigation, each receiving four pieces of formalin-fixed, paraffin-embedded (FFPE) tissue: kidney, liver, gastrointestinal tract (GI), and tonsil. The tissues served as controls to validate staining techniques commonly used in renal pathology. Students prepared tissue sections using a rotary microtome, sectioning tissue at four microns. In total, forty slides were prepared, with eighteen slides manually stained using specific histochemical methods. Stains included hematoxylin and eosin (H&amp;E), periodic acid-Schiff (PAS), periodic acid methenamine silver (PAMS), and the Gomori Trichrome technique. The results yielded identifiable cellular and structural features critical for diagnostic interpretation. A slide review was conducted, and acceptable representative slides were selected for digital imaging. In addition, the results demonstrated the four tissue types which may be approved to use as controls, due to the consistency of demonstrating staining characteristics and features required for evaluating kidney biopsy protocols. Upon technical validation, the use of multi-tissue controls contributed to educational and operational outcomes. Students gained quality assurance experience, and the experience reinforced special stain and laboratory operations competencies, teaching students how to conserve reagent use, and to reduce time and expense. Furthermore, the protocol introduced the application of digital pathology and quality assurance in a real-world lab setting. Our investigation supports the integration of multi-tissue controls in histotechnology education as a valuable tool for enhancing both learning and laboratory efficiency. Future studies are recommended to include additional tissue types, stains, and immunohistochemical markers, to further advance and expand histotechnology educational competencies.]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>378</itunes:duration>
                <itunes:episode>196</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/ConventionLogoMaster2025_Circles_onlybfpi5.png" medium="image">
                            <media:title type="html">NSH Poster Podcast (2025): Employing Multi-Tissue Controls to Enhance Kidney Biopsy Protocol Education in a Program in Histotechnology Student Lab</media:title></media:content>    </item>
    <item>
        <title>NSH Poster Podcast (2025): Comparative assessment of routine H&amp;E and Mason’s Trichrome Stain to Differentiate Normal from Infected Urinary Bladders in the Göttingen Minipig</title>
        <itunes:title>NSH Poster Podcast (2025): Comparative assessment of routine H&amp;E and Mason’s Trichrome Stain to Differentiate Normal from Infected Urinary Bladders in the Göttingen Minipig</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/nsh-posterpodcast2025comparative-assessmentof-routineheand-masons-trichrome-stain-todifferentiatenormal-from-infectedurinary-bladders-inthegottingen/</link>
                    <comments>https://nshpodcasts.podbean.com/e/nsh-posterpodcast2025comparative-assessmentof-routineheand-masons-trichrome-stain-todifferentiatenormal-from-infectedurinary-bladders-inthegottingen/#comments</comments>        <pubDate>Tue, 09 Dec 2025 11:46:01 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/6efc01af-97d6-360b-9a7a-2c1a290a9742</guid>
                                    <description><![CDATA[<p>Title: Comparative assessment of routine H&amp;E and Mason’s Trichrome Stain to Differentiate Normal from Infected Urinary Bladders in the Göttingen Minipig  </p>
<p>Authors: Stephanie D. Rivera, MS, HT(ASCP); Anthony Romanello, BS; Ronnie Chamanza, BVSc, MSc, FRC Path, MRCVS, FIATP, Preclinical Sciences &amp; Translational Safety, Johnson &amp; Johnson Innovative Medicine, Spring House, Pa</p>
<p>Abstract: The objective of this experiment was to evaluate the difference between normal and infected Göttingen minipig urinary bladder and determine the difficulty of microscopically evaluating infectious urinary bladder. The focus was on the histology of the tissue using routine Hematoxylin and Eosin(H&amp;E) staining and the Masson Trichrome (MT) special stain to demonstrate the morphology of normal and infectious urinary bladder. To improve on the translation between preclinical and clinical studies, the Göttingen minipig model is appropriate to use for research for diseased human bladder treatment because the minipig anatomy and organ system are similar to humans.
The procedure was designed to evaluate normal uninfected urinary bladder and bacteria infected (E. coli) urinary bladder by evaluating morphology/cellular changes associated with the resultant inflammatory response in the urinary bladder of the Ellegaard Gottingen Minipig. The H&amp;E-stained urinary bladder tissue section and a Masson Trichrome stained urinary bladder section were used to evaluate control ‘normal’ tissue vs infected tissue cellular differences.
Optimal microscopic evaluation requires that the urinary bladders are properly fixed and processed. By using proper fixation and diligent histologic practices, all components of the urinary bladder are captured for proper histologic evaluation.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Title: Comparative assessment of routine H&amp;E and Mason’s Trichrome Stain to Differentiate Normal from Infected Urinary Bladders in the Göttingen Minipig  </p>
<p>Authors: Stephanie D. Rivera, MS, HT(ASCP); Anthony Romanello, BS; Ronnie Chamanza, BVSc, MSc, FRC Path, MRCVS, FIATP, Preclinical Sciences &amp; Translational Safety, Johnson &amp; Johnson Innovative Medicine, Spring House, Pa</p>
<p>Abstract: The objective of this experiment was to evaluate the difference between normal and infected Göttingen minipig urinary bladder and determine the difficulty of microscopically evaluating infectious urinary bladder. The focus was on the histology of the tissue using routine Hematoxylin and Eosin(H&amp;E) staining and the Masson Trichrome (MT) special stain to demonstrate the morphology of normal and infectious urinary bladder. To improve on the translation between preclinical and clinical studies, the Göttingen minipig model is appropriate to use for research for diseased human bladder treatment because the minipig anatomy and organ system are similar to humans.<br>
The procedure was designed to evaluate normal uninfected urinary bladder and bacteria infected (E. coli) urinary bladder by evaluating morphology/cellular changes associated with the resultant inflammatory response in the urinary bladder of the Ellegaard Gottingen Minipig. The H&amp;E-stained urinary bladder tissue section and a Masson Trichrome stained urinary bladder section were used to evaluate control ‘normal’ tissue vs infected tissue cellular differences.<br>
Optimal microscopic evaluation requires that the urinary bladders are properly fixed and processed. By using proper fixation and diligent histologic practices, all components of the urinary bladder are captured for proper histologic evaluation.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rcgkznxr2fcfs8ys/E7_P6004.mp3" length="17309823" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Title: Comparative assessment of routine H&amp;E and Mason’s Trichrome Stain to Differentiate Normal from Infected Urinary Bladders in the Göttingen Minipig  
Authors: Stephanie D. Rivera, MS, HT(ASCP); Anthony Romanello, BS; Ronnie Chamanza, BVSc, MSc, FRC Path, MRCVS, FIATP, Preclinical Sciences &amp; Translational Safety, Johnson &amp; Johnson Innovative Medicine, Spring House, Pa
Abstract: The objective of this experiment was to evaluate the difference between normal and infected Göttingen minipig urinary bladder and determine the difficulty of microscopically evaluating infectious urinary bladder. The focus was on the histology of the tissue using routine Hematoxylin and Eosin(H&amp;E) staining and the Masson Trichrome (MT) special stain to demonstrate the morphology of normal and infectious urinary bladder. To improve on the translation between preclinical and clinical studies, the Göttingen minipig model is appropriate to use for research for diseased human bladder treatment because the minipig anatomy and organ system are similar to humans.The procedure was designed to evaluate normal uninfected urinary bladder and bacteria infected (E. coli) urinary bladder by evaluating morphology/cellular changes associated with the resultant inflammatory response in the urinary bladder of the Ellegaard Gottingen Minipig. The H&amp;E-stained urinary bladder tissue section and a Masson Trichrome stained urinary bladder section were used to evaluate control ‘normal’ tissue vs infected tissue cellular differences.Optimal microscopic evaluation requires that the urinary bladders are properly fixed and processed. By using proper fixation and diligent histologic practices, all components of the urinary bladder are captured for proper histologic evaluation.]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>432</itunes:duration>
                <itunes:episode>195</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/ConventionLogoMaster2025_Circles_onlybfpi5.png" medium="image">
                            <media:title type="html">NSH Poster Podcast (2025): Comparative assessment of routine H&amp;E and Mason’s Trichrome Stain to Differentiate Normal from Infected Urinary Bladders in the Göttingen Minipig</media:title></media:content>    </item>
    <item>
        <title>NSH Poster Podcast (2025): Evaluating the Reverse Slide Embedding Method vs. Heat Extractor Embedding in the Mohs Laboratory: A Comparative Quality Review of 100 Cases</title>
        <itunes:title>NSH Poster Podcast (2025): Evaluating the Reverse Slide Embedding Method vs. Heat Extractor Embedding in the Mohs Laboratory: A Comparative Quality Review of 100 Cases</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/nsh-posterpodcast2025evaluating-the-reverseslideembeddingmethod-vsheat-extractor-embedding-inthe-mohs-laboratorya-comparativequality-reviewof-100-cas/</link>
                    <comments>https://nshpodcasts.podbean.com/e/nsh-posterpodcast2025evaluating-the-reverseslideembeddingmethod-vsheat-extractor-embedding-inthe-mohs-laboratorya-comparativequality-reviewof-100-cas/#comments</comments>        <pubDate>Tue, 09 Dec 2025 11:43:56 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/4978b99f-0ae8-3258-8158-0c8b4192bf7c</guid>
                                    <description><![CDATA[<p>Title: Evaluating the Reverse Slide Embedding Method vs. Heat Extractor Embedding in the Mohs Laboratory: A Comparative Quality Review of 100 Cases</p>
<p>Authors: Tashsa Cromedy, Heather Frye, Ochsner MD Anderson Cancer Center, St. Tammany Cancer Center A Campus of Ochsner Medical Center</p>
<p>Abstract: </p>
<p>Overview</p>
<p>Accurate tissue embedding is critical in Mohs micrographic surgery for complete margin assessment. This study evaluates the efficacy of a reverse slide embedding method compared to the conventional heat extractor technique. The goal was to determine which method yields fewer artifacts or discrepancies that may compromise histologic interpretation and margin assessment.</p>
<p>Methods</p>
<p>A total of 100 Mohs cases were retrospectively reviewed in a controlled laboratory setting. Two embedding techniques were compared:
Reverse Slide Method: 50 cases were embedded by placing the tissue on a chilled slide before embedding, ensuring orientation preservation and minimizing heat exposure.
Heat Extractor Method: 50 cases were embedded using the traditional heat extractor to flatten and orient tissue in the embedding medium.
All slides were reviewed by a Mohs surgeon for processing artifacts, orientation challenges, and histologic discrepancies.</p>
<p>Validation</p>
<p>The Mohs surgeon identified a total of 17 artifact inconsistencies or discrepancies across all cases:
13 instances were associated with the heat extractor method.
4 instances occurred with the reverse slide method.
These findings suggest that the reverse slide method may reduce artifacts and improve embedding accuracy compared to the heat extractor, offering potential benefits for tissue integrity and diagnostic confidence in the Mohs laboratory.</p>
<p>Conclusion</p>
<p>The reverse slide embedding method demonstrated a significant reduction in embedding-related artifacts compared to the heat extractor technique. These findings support its use in the Mohs laboratory to enhance tissue quality, reduce the risk of diagnostic errors, and improve patient outcomes. Further studies with larger sample sizes and multi-lab validations are recommended to confirm these results.</p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Title: Evaluating the Reverse Slide Embedding Method vs. Heat Extractor Embedding in the Mohs Laboratory: A Comparative Quality Review of 100 Cases</p>
<p>Authors: Tashsa Cromedy, Heather Frye, Ochsner MD Anderson Cancer Center, St. Tammany Cancer Center A Campus of Ochsner Medical Center</p>
<p>Abstract: </p>
<p>Overview</p>
<p>Accurate tissue embedding is critical in Mohs micrographic surgery for complete margin assessment. This study evaluates the efficacy of a reverse slide embedding method compared to the conventional heat extractor technique. The goal was to determine which method yields fewer artifacts or discrepancies that may compromise histologic interpretation and margin assessment.</p>
<p>Methods</p>
<p>A total of 100 Mohs cases were retrospectively reviewed in a controlled laboratory setting. Two embedding techniques were compared:<br>
Reverse Slide Method: 50 cases were embedded by placing the tissue on a chilled slide before embedding, ensuring orientation preservation and minimizing heat exposure.<br>
Heat Extractor Method: 50 cases were embedded using the traditional heat extractor to flatten and orient tissue in the embedding medium.<br>
All slides were reviewed by a Mohs surgeon for processing artifacts, orientation challenges, and histologic discrepancies.</p>
<p>Validation</p>
<p>The Mohs surgeon identified a total of 17 artifact inconsistencies or discrepancies across all cases:<br>
13 instances were associated with the heat extractor method.<br>
4 instances occurred with the reverse slide method.<br>
These findings suggest that the reverse slide method may reduce artifacts and improve embedding accuracy compared to the heat extractor, offering potential benefits for tissue integrity and diagnostic confidence in the Mohs laboratory.</p>
<p>Conclusion</p>
<p>The reverse slide embedding method demonstrated a significant reduction in embedding-related artifacts compared to the heat extractor technique. These findings support its use in the Mohs laboratory to enhance tissue quality, reduce the risk of diagnostic errors, and improve patient outcomes. Further studies with larger sample sizes and multi-lab validations are recommended to confirm these results.</p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/m84c6fbximme7ugx/E6_P6025.mp3" length="14441578" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Title: Evaluating the Reverse Slide Embedding Method vs. Heat Extractor Embedding in the Mohs Laboratory: A Comparative Quality Review of 100 Cases
Authors: Tashsa Cromedy, Heather Frye, Ochsner MD Anderson Cancer Center, St. Tammany Cancer Center A Campus of Ochsner Medical Center
Abstract: 
Overview
Accurate tissue embedding is critical in Mohs micrographic surgery for complete margin assessment. This study evaluates the efficacy of a reverse slide embedding method compared to the conventional heat extractor technique. The goal was to determine which method yields fewer artifacts or discrepancies that may compromise histologic interpretation and margin assessment.
Methods
A total of 100 Mohs cases were retrospectively reviewed in a controlled laboratory setting. Two embedding techniques were compared:Reverse Slide Method: 50 cases were embedded by placing the tissue on a chilled slide before embedding, ensuring orientation preservation and minimizing heat exposure.Heat Extractor Method: 50 cases were embedded using the traditional heat extractor to flatten and orient tissue in the embedding medium.All slides were reviewed by a Mohs surgeon for processing artifacts, orientation challenges, and histologic discrepancies.
Validation
The Mohs surgeon identified a total of 17 artifact inconsistencies or discrepancies across all cases:13 instances were associated with the heat extractor method.4 instances occurred with the reverse slide method.These findings suggest that the reverse slide method may reduce artifacts and improve embedding accuracy compared to the heat extractor, offering potential benefits for tissue integrity and diagnostic confidence in the Mohs laboratory.
Conclusion
The reverse slide embedding method demonstrated a significant reduction in embedding-related artifacts compared to the heat extractor technique. These findings support its use in the Mohs laboratory to enhance tissue quality, reduce the risk of diagnostic errors, and improve patient outcomes. Further studies with larger sample sizes and multi-lab validations are recommended to confirm these results.
 ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>361</itunes:duration>
                <itunes:episode>194</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/ConventionLogoMaster2025_Circles_onlybfpi5.png" medium="image">
                            <media:title type="html">NSH Poster Podcast (2025): Evaluating the Reverse Slide Embedding Method vs. Heat Extractor Embedding in the Mohs Laboratory: A Comparative Quality Review of 100 Cases</media:title></media:content>    </item>
    <item>
        <title>NSH Poster Podcast (2025): High-resolution histological preparation of Araneomorphae and Mygalomorphae chelicerae using a modified petrographic technique</title>
        <itunes:title>NSH Poster Podcast (2025): High-resolution histological preparation of Araneomorphae and Mygalomorphae chelicerae using a modified petrographic technique</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-2025-high-resolution-histological-preparation-of-araneomorphae-and-mygalomorphae-chelicerae-using-a-modified-petrographic-technique/</link>
                    <comments>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-2025-high-resolution-histological-preparation-of-araneomorphae-and-mygalomorphae-chelicerae-using-a-modified-petrographic-technique/#comments</comments>        <pubDate>Tue, 09 Dec 2025 11:37:09 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/8ad80f12-138f-3b67-bcaf-933c134c102b</guid>
                                    <description><![CDATA[<p>Title: High-resolution histological preparation of Araneomorphae and Mygalomorphae chelicerae using a modified petrographic technique</p>
<p>Authors: Damien Laudier, HTL(ASCP)QIHC, Laudier Histology</p>
<p>Abstract: Producing quality histological preparations of spider chelicerae with articulated fangs and cheliceral teeth is exceptionally challenging, if not impossible, using conventional histology techniques. Typically, these structures are examined with topographic or radiographic imaging methods, such as scanning electron microcopy (SEM) and micro computed tomography (mIcro-CT). While both are very useful tools for morphological analysis, they’re not capable of revealing the fine tissue structure and cellular details, that a histological section viewed under light microscopy can provide. This study describes a modified petrographic/hard tissue histology technique to prepare high-resolution histology sections, for qualitative and quantitative assessment of both cheliceral soft tissue and fang microstructure.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Title: High-resolution histological preparation of Araneomorphae and Mygalomorphae chelicerae using a modified petrographic technique</p>
<p>Authors: Damien Laudier, HTL(ASCP)QIHC, Laudier Histology</p>
<p>Abstract: Producing quality histological preparations of spider chelicerae with articulated fangs and cheliceral teeth is exceptionally challenging, if not impossible, using conventional histology techniques. Typically, these structures are examined with topographic or radiographic imaging methods, such as scanning electron microcopy (SEM) and micro computed tomography (mIcro-CT). While both are very useful tools for morphological analysis, they’re not capable of revealing the fine tissue structure and cellular details, that a histological section viewed under light microscopy can provide. This study describes a modified petrographic/hard tissue histology technique to prepare high-resolution histology sections, for qualitative and quantitative assessment of both cheliceral soft tissue and fang microstructure.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zucxrhm7sn8gnzyk/E5_P6009.mp3" length="21627342" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Title: High-resolution histological preparation of Araneomorphae and Mygalomorphae chelicerae using a modified petrographic technique
Authors: Damien Laudier, HTL(ASCP)QIHC, Laudier Histology
Abstract: Producing quality histological preparations of spider chelicerae with articulated fangs and cheliceral teeth is exceptionally challenging, if not impossible, using conventional histology techniques. Typically, these structures are examined with topographic or radiographic imaging methods, such as scanning electron microcopy (SEM) and micro computed tomography (mIcro-CT). While both are very useful tools for morphological analysis, they’re not capable of revealing the fine tissue structure and cellular details, that a histological section viewed under light microscopy can provide. This study describes a modified petrographic/hard tissue histology technique to prepare high-resolution histology sections, for qualitative and quantitative assessment of both cheliceral soft tissue and fang microstructure.]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>540</itunes:duration>
                <itunes:episode>193</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/ConventionLogoMaster2025_Circles_onlybfpi5.png" medium="image">
                            <media:title type="html">NSH Poster Podcast (2025): High-resolution histological preparation of Araneomorphae and Mygalomorphae chelicerae using a modified petrographic technique</media:title></media:content>    </item>
    <item>
        <title>NSH Poster Podcast (2025): Enhanced Collagen Detection in Liver Fibrosis: A Comparative Study of Picrosirius Red Staining With and Without Bouin’s Pretreatment</title>
        <itunes:title>NSH Poster Podcast (2025): Enhanced Collagen Detection in Liver Fibrosis: A Comparative Study of Picrosirius Red Staining With and Without Bouin’s Pretreatment</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/nsh-posterpodcast2025enhancedcollagendetectionin-liver-fibrosis-acomparative-study-of-picrosirius-red-staining-with-andwithout-bouins-pretreatment/</link>
                    <comments>https://nshpodcasts.podbean.com/e/nsh-posterpodcast2025enhancedcollagendetectionin-liver-fibrosis-acomparative-study-of-picrosirius-red-staining-with-andwithout-bouins-pretreatment/#comments</comments>        <pubDate>Tue, 09 Dec 2025 11:29:17 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/3ca1cd71-3d10-3c9d-8c34-c6339d4a7c1a</guid>
                                    <description><![CDATA[<p>Title: Enhanced Collagen Detection in Liver Fibrosis: A Comparative Study of Picrosirius Red Staining With and Without Bouin’s Pretreatment  </p>
<p>Authors: Nate Rampy, BS, Amber Moser, BS, HTL(ASCP)cm, Hannah Benton, BS, Brad Bolon, DVM, MS, PhD, DACVP, DABT and Elizabeth A. Chlipala, BS, HTL(ASCP)QIHC, Premier Laboratory, LLC, Longmont, Colorado; GEMpath, Inc., Longmont, Colorado</p>
<p>Abstract: The use of Bouin’s solution as a post-fixation treatment, rather than a primary fixative, remains largely unexplored in Picrosirius Red (PSR) procedures for collagen detection. In this study, we compared the effectiveness of PSR staining in liver samples from mouse, rat, and human with and without Bouin’s solution as a pretreatment step. Liver sections were fixed in 10% neutral buffered formalin, processed and embedded in paraffin before being sectioned at 4 microns and stained with PSR. Bouin’s was applied prior to staining for 60 minutes at 70º C, not as a fixative, but as a mordant to enhance dye-tissue interactions. Stained slides were scanned at 20x with an Aperio AT2. Visual assessment and image analysis in bright field microscopy demonstrated that the slides pretreated with Bouin’s had significantly improved collagen differentiation, with enhanced contrast. By comparison, slides stained without the Bouin’s pretreatment showed weaker and less distinct collagen staining. Our findings suggest that Bouin’s pretreatment significantly improves collagen staining contrast and differentiation. The use of Bouin’s pretreatment may serve as a valuable revision to the standard histology protocol for PSR fibrosis evaluation as well as general collagen visualization.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Title: Enhanced Collagen Detection in Liver Fibrosis: A Comparative Study of Picrosirius Red Staining With and Without Bouin’s Pretreatment  </p>
<p>Authors: Nate Rampy, BS, Amber Moser, BS, HTL(ASCP)cm, Hannah Benton, BS, Brad Bolon, DVM, MS, PhD, DACVP, DABT and Elizabeth A. Chlipala, BS, HTL(ASCP)QIHC, Premier Laboratory, LLC, Longmont, Colorado; GEMpath, Inc., Longmont, Colorado</p>
<p>Abstract: The use of Bouin’s solution as a post-fixation treatment, rather than a primary fixative, remains largely unexplored in Picrosirius Red (PSR) procedures for collagen detection. In this study, we compared the effectiveness of PSR staining in liver samples from mouse, rat, and human with and without Bouin’s solution as a pretreatment step. Liver sections were fixed in 10% neutral buffered formalin, processed and embedded in paraffin before being sectioned at 4 microns and stained with PSR. Bouin’s was applied prior to staining for 60 minutes at 70º C, not as a fixative, but as a mordant to enhance dye-tissue interactions. Stained slides were scanned at 20x with an Aperio AT2. Visual assessment and image analysis in bright field microscopy demonstrated that the slides pretreated with Bouin’s had significantly improved collagen differentiation, with enhanced contrast. By comparison, slides stained without the Bouin’s pretreatment showed weaker and less distinct collagen staining. Our findings suggest that Bouin’s pretreatment significantly improves collagen staining contrast and differentiation. The use of Bouin’s pretreatment may serve as a valuable revision to the standard histology protocol for PSR fibrosis evaluation as well as general collagen visualization.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8fc3jbqzajrmp3em/E4_P6028.mp3" length="13020517" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Title: Enhanced Collagen Detection in Liver Fibrosis: A Comparative Study of Picrosirius Red Staining With and Without Bouin’s Pretreatment  
Authors: Nate Rampy, BS, Amber Moser, BS, HTL(ASCP)cm, Hannah Benton, BS, Brad Bolon, DVM, MS, PhD, DACVP, DABT and Elizabeth A. Chlipala, BS, HTL(ASCP)QIHC, Premier Laboratory, LLC, Longmont, Colorado; GEMpath, Inc., Longmont, Colorado
Abstract: The use of Bouin’s solution as a post-fixation treatment, rather than a primary fixative, remains largely unexplored in Picrosirius Red (PSR) procedures for collagen detection. In this study, we compared the effectiveness of PSR staining in liver samples from mouse, rat, and human with and without Bouin’s solution as a pretreatment step. Liver sections were fixed in 10% neutral buffered formalin, processed and embedded in paraffin before being sectioned at 4 microns and stained with PSR. Bouin’s was applied prior to staining for 60 minutes at 70º C, not as a fixative, but as a mordant to enhance dye-tissue interactions. Stained slides were scanned at 20x with an Aperio AT2. Visual assessment and image analysis in bright field microscopy demonstrated that the slides pretreated with Bouin’s had significantly improved collagen differentiation, with enhanced contrast. By comparison, slides stained without the Bouin’s pretreatment showed weaker and less distinct collagen staining. Our findings suggest that Bouin’s pretreatment significantly improves collagen staining contrast and differentiation. The use of Bouin’s pretreatment may serve as a valuable revision to the standard histology protocol for PSR fibrosis evaluation as well as general collagen visualization.]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>325</itunes:duration>
                <itunes:episode>192</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/ConventionLogoMaster2025_Circles_onlybfpi5.png" medium="image">
                            <media:title type="html">NSH Poster Podcast (2025): Enhanced Collagen Detection in Liver Fibrosis: A Comparative Study of Picrosirius Red Staining With and Without Bouin’s Pretreatment</media:title></media:content>    </item>
    <item>
        <title>NSH Poster Podcast (2025): Wheat Germ Agglutinin (WGA) Staining Optimized for Image Analysis of Muscle Tissue Morphometry</title>
        <itunes:title>NSH Poster Podcast (2025): Wheat Germ Agglutinin (WGA) Staining Optimized for Image Analysis of Muscle Tissue Morphometry</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-2025-wheat-germ-agglutinin-wga-staining-optimized-for-image-analysis-of-muscle-tissue-morphometry/</link>
                    <comments>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-2025-wheat-germ-agglutinin-wga-staining-optimized-for-image-analysis-of-muscle-tissue-morphometry/#comments</comments>        <pubDate>Tue, 09 Dec 2025 11:27:09 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/1afbe37e-4690-3626-8a95-f69150f4c9f4</guid>
                                    <description><![CDATA[<p>Title: Wheat Germ Agglutinin (WGA) Staining Optimized for Image Analysis of Muscle Tissue Morphometry </p>
<p>Authors: Cheru, R. and Wolf, J.C., Experimental Pathology Laboratories, Inc., Sterling, Virginia</p>
<p>Abstract: Wheat Germ Agglutinin (WGA) is a plant-derived lectin and fluorescent stain that binds to N-acetylglucosamine and sialic acid residues in tissues, making it a valuable histochemical tool for visualizing cell membranes and components of the extracellular matrix. In muscle tissue, WGA staining allows clear delineation of the laminin-labeled basal membrane outlining each myofiber, distinguishing it from the residual autofluorescence of the myofiber sarcoplasm. To support digital pathology applications, a WGA staining protocol was optimized for compatibility with image-based quantitative analysis. Formalin-fixed, paraffin-embedded muscle sections were stained with fluorescently labeled WGA, counterstained with DAPI for nuclear visualization, and mounted with antifade medium to preserve fluorescence. Image analysis of WGA-stained skeletal muscle was successfully performed by a pathologist using Image-Pro® Plus software, employing macros to assess myofiber size and count.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Title: Wheat Germ Agglutinin (WGA) Staining Optimized for Image Analysis of Muscle Tissue Morphometry </p>
<p>Authors: Cheru, R. and Wolf, J.C., Experimental Pathology Laboratories, Inc., Sterling, Virginia</p>
<p>Abstract: Wheat Germ Agglutinin (WGA) is a plant-derived lectin and fluorescent stain that binds to N-acetylglucosamine and sialic acid residues in tissues, making it a valuable histochemical tool for visualizing cell membranes and components of the extracellular matrix. In muscle tissue, WGA staining allows clear delineation of the laminin-labeled basal membrane outlining each myofiber, distinguishing it from the residual autofluorescence of the myofiber sarcoplasm. To support digital pathology applications, a WGA staining protocol was optimized for compatibility with image-based quantitative analysis. Formalin-fixed, paraffin-embedded muscle sections were stained with fluorescently labeled WGA, counterstained with DAPI for nuclear visualization, and mounted with antifade medium to preserve fluorescence. Image analysis of WGA-stained skeletal muscle was successfully performed by a pathologist using Image-Pro® Plus software, employing macros to assess myofiber size and count.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mmq562vuk96k9cqb/E3_P6029.mp3" length="9391587" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Title: Wheat Germ Agglutinin (WGA) Staining Optimized for Image Analysis of Muscle Tissue Morphometry 
Authors: Cheru, R. and Wolf, J.C., Experimental Pathology Laboratories, Inc., Sterling, Virginia
Abstract: Wheat Germ Agglutinin (WGA) is a plant-derived lectin and fluorescent stain that binds to N-acetylglucosamine and sialic acid residues in tissues, making it a valuable histochemical tool for visualizing cell membranes and components of the extracellular matrix. In muscle tissue, WGA staining allows clear delineation of the laminin-labeled basal membrane outlining each myofiber, distinguishing it from the residual autofluorescence of the myofiber sarcoplasm. To support digital pathology applications, a WGA staining protocol was optimized for compatibility with image-based quantitative analysis. Formalin-fixed, paraffin-embedded muscle sections were stained with fluorescently labeled WGA, counterstained with DAPI for nuclear visualization, and mounted with antifade medium to preserve fluorescence. Image analysis of WGA-stained skeletal muscle was successfully performed by a pathologist using Image-Pro® Plus software, employing macros to assess myofiber size and count.]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>234</itunes:duration>
                <itunes:episode>191</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/ConventionLogoMaster2025_Circles_onlybfpi5.png" medium="image">
                            <media:title type="html">NSH Poster Podcast (2025): Wheat Germ Agglutinin (WGA) Staining Optimized for Image Analysis of Muscle Tissue Morphometry</media:title></media:content>    </item>
    <item>
        <title>NSH Poster Podcast (2025): CelLockTM and Axlab: A mutual symbiotic relationship resulting in increased patient care quality.</title>
        <itunes:title>NSH Poster Podcast (2025): CelLockTM and Axlab: A mutual symbiotic relationship resulting in increased patient care quality.</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-2025-cellocktm-and-axlab-a-mutual-symbiotic-relationship-resulting-in-increased-patient-care-quality/</link>
                    <comments>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-2025-cellocktm-and-axlab-a-mutual-symbiotic-relationship-resulting-in-increased-patient-care-quality/#comments</comments>        <pubDate>Tue, 09 Dec 2025 11:25:24 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/a2bf9cf9-0502-3cfa-b86a-5a7deae31528</guid>
                                    <description><![CDATA[<p>Poster Title: CelLockTM and Axlab: A mutual symbiotic relationship resulting in increased patient care quality.</p>
<p>Authors: Clifford M Chapman ( Medi-Sci Consultants), Karla Escobar (Axlab -US), Timm Piper (Axlab –US)</p>
<p>Abstract: An ever increasing number of tiny specimens are received in histology laboratories every day. Fine needle aspirates, needle biopsies, gastrointestinal and skin biopsies, along with research specimens such as organelles: all pose challenges in receiving, processing and preparing stained slides from such specimens.

Axlab is a Danish based company founded in 1993 which specializes in finding novel solutions for pathology laboratories. Axlab recently announced the release of their AS-410M automated sectioning equipment. Receiving FDA clearance in 2024, this equipment has been successfully implemented worldwide, resulting in enhanced section quality and increased workflow efficiency.

CelLockTM is an innovative standardized method for collecting individual cells and small tissue fragments for subsequent routine, immunohistochemical and molecular pathology diagnostic and investigative techniques. The CelLock method, which utilizes a novel product CelLGelTM , results in the collection and retention of 99.9% of the original specimen within a paraffin embedded cell-block. In addition, the specimen is precisely located within the paraffin block, close to the surface, and is identified by a marker to cue when sections should be taken.

Axlab is currently investigating the use of CelLock and CelLGel in the preparation of cell blocks which can be precisely sectioned on their automated sectioning equipment. The initial results are presented in this poster.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Poster Title: CelLockTM and Axlab: A mutual symbiotic relationship resulting in increased patient care quality.</p>
<p>Authors: Clifford M Chapman ( Medi-Sci Consultants), Karla Escobar (Axlab -US), Timm Piper (Axlab –US)</p>
<p>Abstract: An ever increasing number of tiny specimens are received in histology laboratories every day. Fine needle aspirates, needle biopsies, gastrointestinal and skin biopsies, along with research specimens such as organelles: all pose challenges in receiving, processing and preparing stained slides from such specimens.<br>
<br>
Axlab is a Danish based company founded in 1993 which specializes in finding novel solutions for pathology laboratories. Axlab recently announced the release of their AS-410M automated sectioning equipment. Receiving FDA clearance in 2024, this equipment has been successfully implemented worldwide, resulting in enhanced section quality and increased workflow efficiency.<br>
<br>
CelLockTM is an innovative standardized method for collecting individual cells and small tissue fragments for subsequent routine, immunohistochemical and molecular pathology diagnostic and investigative techniques. The CelLock method, which utilizes a novel product CelLGelTM , results in the collection and retention of 99.9% of the original specimen within a paraffin embedded cell-block. In addition, the specimen is precisely located within the paraffin block, close to the surface, and is identified by a marker to cue when sections should be taken.<br>
<br>
Axlab is currently investigating the use of CelLock and CelLGel in the preparation of cell blocks which can be precisely sectioned on their automated sectioning equipment. The initial results are presented in this poster.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/egcckg9yx69wn3j5/E2_P6030.mp3" length="22541627" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Poster Title: CelLockTM and Axlab: A mutual symbiotic relationship resulting in increased patient care quality.
Authors: Clifford M Chapman ( Medi-Sci Consultants), Karla Escobar (Axlab -US), Timm Piper (Axlab –US)
Abstract: An ever increasing number of tiny specimens are received in histology laboratories every day. Fine needle aspirates, needle biopsies, gastrointestinal and skin biopsies, along with research specimens such as organelles: all pose challenges in receiving, processing and preparing stained slides from such specimens.Axlab is a Danish based company founded in 1993 which specializes in finding novel solutions for pathology laboratories. Axlab recently announced the release of their AS-410M automated sectioning equipment. Receiving FDA clearance in 2024, this equipment has been successfully implemented worldwide, resulting in enhanced section quality and increased workflow efficiency.CelLockTM is an innovative standardized method for collecting individual cells and small tissue fragments for subsequent routine, immunohistochemical and molecular pathology diagnostic and investigative techniques. The CelLock method, which utilizes a novel product CelLGelTM , results in the collection and retention of 99.9% of the original specimen within a paraffin embedded cell-block. In addition, the specimen is precisely located within the paraffin block, close to the surface, and is identified by a marker to cue when sections should be taken.Axlab is currently investigating the use of CelLock and CelLGel in the preparation of cell blocks which can be precisely sectioned on their automated sectioning equipment. The initial results are presented in this poster.]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>563</itunes:duration>
                <itunes:episode>190</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/ConventionLogoMaster2025_Circles_onlybfpi5.png" medium="image">
                            <media:title type="html">NSH Poster Podcast (2025): CelLockTM and Axlab: A mutual symbiotic relationship resulting in increased patient care quality.</media:title></media:content>    </item>
    <item>
        <title>NSH Poster Podcast (2025): The High Cost of Understaffing: A Case Study in Surgical Pathology Consequences</title>
        <itunes:title>NSH Poster Podcast (2025): The High Cost of Understaffing: A Case Study in Surgical Pathology Consequences</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-2025-the-high-cost-of-understaffing-a-case-study-in-surgical-pathology-consequences/</link>
                    <comments>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-2025-the-high-cost-of-understaffing-a-case-study-in-surgical-pathology-consequences/#comments</comments>        <pubDate>Tue, 09 Dec 2025 11:23:00 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/1a41fc7d-00e1-38a3-bfc5-4e20d9aa7161</guid>
                                    <description><![CDATA[<p>Poster Title: The High Cost of Understaffing: A Case Study in Surgical Pathology Consequences  </p>
<p>Authors: Emily Nangano, MS, PA(ASCP)cm; Gillian Bass; Rob Terranova</p>
<p>Abstract: Laboratories are the diagnostic backbone of healthcare, yet staffing decisions are often driven by budget constraints rather than operational needs. This case study examines the real-world consequences of delayed staffing action within the anatomic pathology department at a large academic medical center. Faced with a predicted shortfall in grossing coverage due to reduced resident support and unchanged PA staffing levels, institutional leadership opted against proactive hiring. As a result, grossing FTEs fell from 6.5 to 3.5, and histology staffing experienced a drop to 3 technicians from the usual 9 due to attrition and burnout.</p>
<p>
This staffing collapse led to turnaround time delays of up to 6–8 weeks and forced the lab to outsource specimen processing. Over the following seven months, the institution spent nearly $4 million on reference lab services. Staff morale declined sharply, clinician trust eroded, and senior PAs and histotechs resigned. Even after additional staff were hired, it took more than a year to stabilize operations.</p>
<p>
This poster presents supporting data, including FTE changes, outsourcing costs, and turnaround time impacts. It also explores how temporary, qualified locum tenens staffing solutions—such as Pathologists’ Assistants and histotechnologists, and cytologists—can help bridge coverage gaps and prevent costly disruptions.
Ultimately, this case underscores the critical importance of timely, proactive staffing strategies. The hidden costs of under-resourcing the laboratory go beyond dollars—they affect staff well-being, institutional reputation, and patient care outcomes.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Poster Title: The High Cost of Understaffing: A Case Study in Surgical Pathology Consequences  </p>
<p>Authors: Emily Nangano, MS, PA(ASCP)cm; Gillian Bass; Rob Terranova</p>
<p>Abstract: Laboratories are the diagnostic backbone of healthcare, yet staffing decisions are often driven by budget constraints rather than operational needs. This case study examines the real-world consequences of delayed staffing action within the anatomic pathology department at a large academic medical center. Faced with a predicted shortfall in grossing coverage due to reduced resident support and unchanged PA staffing levels, institutional leadership opted against proactive hiring. As a result, grossing FTEs fell from 6.5 to 3.5, and histology staffing experienced a drop to 3 technicians from the usual 9 due to attrition and burnout.</p>
<p><br>
This staffing collapse led to turnaround time delays of up to 6–8 weeks and forced the lab to outsource specimen processing. Over the following seven months, the institution spent nearly $4 million on reference lab services. Staff morale declined sharply, clinician trust eroded, and senior PAs and histotechs resigned. Even after additional staff were hired, it took more than a year to stabilize operations.</p>
<p><br>
This poster presents supporting data, including FTE changes, outsourcing costs, and turnaround time impacts. It also explores how temporary, qualified locum tenens staffing solutions—such as Pathologists’ Assistants and histotechnologists, and cytologists—can help bridge coverage gaps and prevent costly disruptions.<br>
Ultimately, this case underscores the critical importance of timely, proactive staffing strategies. The hidden costs of under-resourcing the laboratory go beyond dollars—they affect staff well-being, institutional reputation, and patient care outcomes.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/my62rxxnd5u9mq8v/E1_P6034.mp3" length="15457219" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Poster Title: The High Cost of Understaffing: A Case Study in Surgical Pathology Consequences  
Authors: Emily Nangano, MS, PA(ASCP)cm; Gillian Bass; Rob Terranova
Abstract: Laboratories are the diagnostic backbone of healthcare, yet staffing decisions are often driven by budget constraints rather than operational needs. This case study examines the real-world consequences of delayed staffing action within the anatomic pathology department at a large academic medical center. Faced with a predicted shortfall in grossing coverage due to reduced resident support and unchanged PA staffing levels, institutional leadership opted against proactive hiring. As a result, grossing FTEs fell from 6.5 to 3.5, and histology staffing experienced a drop to 3 technicians from the usual 9 due to attrition and burnout.
This staffing collapse led to turnaround time delays of up to 6–8 weeks and forced the lab to outsource specimen processing. Over the following seven months, the institution spent nearly $4 million on reference lab services. Staff morale declined sharply, clinician trust eroded, and senior PAs and histotechs resigned. Even after additional staff were hired, it took more than a year to stabilize operations.
This poster presents supporting data, including FTE changes, outsourcing costs, and turnaround time impacts. It also explores how temporary, qualified locum tenens staffing solutions—such as Pathologists’ Assistants and histotechnologists, and cytologists—can help bridge coverage gaps and prevent costly disruptions.Ultimately, this case underscores the critical importance of timely, proactive staffing strategies. The hidden costs of under-resourcing the laboratory go beyond dollars—they affect staff well-being, institutional reputation, and patient care outcomes.]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>386</itunes:duration>
                <itunes:episode>189</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/ConventionLogoMaster2025_Circles_onlybfpi5.png" medium="image">
                            <media:title type="html">NSH Poster Podcast (2025): The High Cost of Understaffing: A Case Study in Surgical Pathology Consequences</media:title></media:content>    </item>
    <item>
        <title>Fixation on Histology: The Hunt for the Perfect Slide</title>
        <itunes:title>Fixation on Histology: The Hunt for the Perfect Slide</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/fixation-on-histology-the-hunt-for-the-perfect-slide/</link>
                    <comments>https://nshpodcasts.podbean.com/e/fixation-on-histology-the-hunt-for-the-perfect-slide/#comments</comments>        <pubDate>Wed, 26 Nov 2025 10:57:12 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/9fc0731d-f37d-3dc3-a373-f2ea609b2595</guid>
                                    <description><![CDATA[<p>Fixation on Histology: The Hunt for the Perfect Slide</p>
<p>Written based on the NSH Webinar: Assessing Adhesion Slide Performance Across Histology Applications</p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/11/26/the-hunt-for-the-perfect-slide'>To Read the Blog, Click Here. </a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Fixation on Histology: The Hunt for the Perfect Slide</p>
<p>Written based on the NSH Webinar: Assessing Adhesion Slide Performance Across Histology Applications</p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/11/26/the-hunt-for-the-perfect-slide'>To Read the Blog, Click Here. </a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fbaq7jr4euwmtj2z/Hunt_for_the_Perfect_Slide_2025au3cy.mp3" length="3299883" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fixation on Histology: The Hunt for the Perfect Slide
Written based on the NSH Webinar: Assessing Adhesion Slide Performance Across Histology Applications
To Read the Blog, Click Here. ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>206</itunes:duration>
                <itunes:episode>188</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/fixationblogvideoimage.png" medium="image">
                            <media:title type="html">Fixation on Histology: The Hunt for the Perfect Slide</media:title></media:content>    </item>
    <item>
        <title>Fixation on Histology: From Professional to Patient, A Med Tech's Organ Donation Journey</title>
        <itunes:title>Fixation on Histology: From Professional to Patient, A Med Tech's Organ Donation Journey</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/fixation-on-histology-from-professional-to-patient-a-med-techs-organ-donation-journey/</link>
                    <comments>https://nshpodcasts.podbean.com/e/fixation-on-histology-from-professional-to-patient-a-med-techs-organ-donation-journey/#comments</comments>        <pubDate>Mon, 10 Nov 2025 13:51:55 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/278c76ad-9dd9-32e7-aa32-0cf4dc808238</guid>
                                    <description><![CDATA[<p style="text-align: left;">Fixation on Histology: From Professional to Patient, A Med Tech's Organ Donation Journey</p>
<p style="text-align: left;">Written based on the NSH Laboratory Webinar- When Worlds Collide Through Organ Donation</p>
<p style="text-align: left;"><a href='https://www.nsh.org/blogs/ashley-stewart/2025/11/10/from-professional-to-patient?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>To Read the Blog, Click Here</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p style="text-align: left;">Fixation on Histology: From Professional to Patient, A Med Tech's Organ Donation Journey</p>
<p style="text-align: left;">Written based on the NSH Laboratory Webinar- When Worlds Collide Through Organ Donation</p>
<p style="text-align: left;"><a href='https://www.nsh.org/blogs/ashley-stewart/2025/11/10/from-professional-to-patient?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>To Read the Blog, Click Here</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ywehbdycijjr3phb/Organ_Donation_20258aeyp.mp3" length="3687331" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fixation on Histology: From Professional to Patient, A Med Tech's Organ Donation Journey
Written based on the NSH Laboratory Webinar- When Worlds Collide Through Organ Donation
To Read the Blog, Click Here. ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>230</itunes:duration>
                <itunes:episode>187</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/fixationblogvideoimage.png" medium="image">
                            <media:title type="html">Fixation on Histology: From Professional to Patient, A Med Tech&#039;s Organ Donation Journey</media:title></media:content>    </item>
    <item>
        <title>Fixation on Histology: Dementia Demystifying</title>
        <itunes:title>Fixation on Histology: Dementia Demystifying</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/fixation-on-histology-demystifying-dementia/</link>
                    <comments>https://nshpodcasts.podbean.com/e/fixation-on-histology-demystifying-dementia/#comments</comments>        <pubDate>Fri, 31 Oct 2025 10:46:59 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/47773300-5ec6-30c6-b557-774086e9ffce</guid>
                                    <description><![CDATA[<p>Fixation on Histology: Dementia Demystifying </p>
<p>Written based on the NSH Laboratory Webinar Forget-Me-Not: Demystifying Dementia</p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/10/31/dementia-demystified?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>To Read the Blog, Click Here</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Fixation on Histology: Dementia Demystifying </p>
<p>Written based on the NSH Laboratory Webinar Forget-Me-Not: Demystifying Dementia</p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/10/31/dementia-demystified?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>To Read the Blog, Click Here</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/z3ndw2zi6sj2nb8n/Demystifying_Dementia_202567ld4.mp3" length="3518894" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fixation on Histology: Dementia Demystifying 
Written based on the NSH Laboratory Webinar Forget-Me-Not: Demystifying Dementia
To Read the Blog, Click Here]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>219</itunes:duration>
                <itunes:episode>186</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/fixationblogvideoimage.png" medium="image">
                            <media:title type="html">Fixation on Histology: Dementia Demystifying</media:title></media:content>    </item>
    <item>
        <title>Fixation on Histology: So You Want To Be A Manager?</title>
        <itunes:title>Fixation on Histology: So You Want To Be A Manager?</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/fixation-on-histology-so-you-want-to-be-a-manager/</link>
                    <comments>https://nshpodcasts.podbean.com/e/fixation-on-histology-so-you-want-to-be-a-manager/#comments</comments>        <pubDate>Fri, 17 Oct 2025 11:50:01 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/3ed37553-e90a-38dc-b715-51126c506ec6</guid>
                                    <description><![CDATA[<p>Fixation on Histology: So You Want To Be A Manager?</p>
<p>Written by: Jordan Terrell, HT(ASCP)cm</p>
<p>To Read the Blog, <a href='https://www.nsh.org/blogs/ashley-stewart/2025/10/17/so-you-want-to-be-a-manager'>Click Here</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Fixation on Histology: So You Want To Be A Manager?</p>
<p>Written by: Jordan Terrell, HT(ASCP)cm</p>
<p>To Read the Blog, <a href='https://www.nsh.org/blogs/ashley-stewart/2025/10/17/so-you-want-to-be-a-manager'>Click Here</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vabvta627rq4uzr9/Leadership_2025.mp3" length="5226675" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fixation on Histology: So You Want To Be A Manager?
Written by: Jordan Terrell, HT(ASCP)cm
To Read the Blog, Click Here]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>326</itunes:duration>
                <itunes:episode>185</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/fixationblogvideoimage.png" medium="image">
                            <media:title type="html">Fixation on Histology: So You Want To Be A Manager?</media:title></media:content>    </item>
    <item>
        <title>Fixation on Histology: Meet Nicole Leon, NSH’s 2025 Histotechnologist of the Year</title>
        <itunes:title>Fixation on Histology: Meet Nicole Leon, NSH’s 2025 Histotechnologist of the Year</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/fixation-on-histology-meet-nicole-leon-nsh-s-2025-histotechnologist-of-the-year/</link>
                    <comments>https://nshpodcasts.podbean.com/e/fixation-on-histology-meet-nicole-leon-nsh-s-2025-histotechnologist-of-the-year/#comments</comments>        <pubDate>Fri, 03 Oct 2025 12:18:30 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/24ae1d42-9c6d-3668-a936-cda59a52e0d1</guid>
                                    <description><![CDATA[<p>Fixation on Histology: Meet Nicole Leon, NSH’s 2025 Histotechnologist of the Year</p>
<p> </p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/09/30/meet-nicole-leon'>To read the blog, click here</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Fixation on Histology: Meet Nicole Leon, NSH’s 2025 Histotechnologist of the Year</p>
<p> </p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/09/30/meet-nicole-leon'>To read the blog, click here</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/juk5yfh5rz2a5ym5/HoY_2025.mp3" length="4007855" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fixation on Histology: Meet Nicole Leon, NSH’s 2025 Histotechnologist of the Year
 
To read the blog, click here]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>250</itunes:duration>
                <itunes:episode>184</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/fixationblogvideoimage.png" medium="image">
                            <media:title type="html">Fixation on Histology: Meet Nicole Leon, NSH’s 2025 Histotechnologist of the Year</media:title></media:content>    </item>
    <item>
        <title>Fixation on Histology: How Digital Image Analysis Strengthens H&amp;E Staining Quality Control</title>
        <itunes:title>Fixation on Histology: How Digital Image Analysis Strengthens H&amp;E Staining Quality Control</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/fixation-on-histology-how-digital-image-analysis-strengthens-he-staining-quality-control/</link>
                    <comments>https://nshpodcasts.podbean.com/e/fixation-on-histology-how-digital-image-analysis-strengthens-he-staining-quality-control/#comments</comments>        <pubDate>Fri, 19 Sep 2025 12:41:20 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/ffda8dae-4c96-37e3-84a8-4a14b15c4ded</guid>
                                    <description><![CDATA[<p>Fixation on Histology: How Digital Image Analysis Strengthens H&amp;E Staining Quality Control</p>
<p>Based on the article <a href='https://www.tandfonline.com/doi/full/10.1080/01478885.2025.2517906?src=exp-oa'>Utilizing image analysis by optical density to evaluate changes in hematoxylin and eosin staining quality after reagent overuse</a>” published in the Journal of Histotechnology.</p>
<p>To read the full blog, click <a href='https://www.nsh.org/blogs/ashley-stewart/2025/09/19/how-digital-image-analysis-strengthens-he-staining'>here</a>. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Fixation on Histology: How Digital Image Analysis Strengthens H&amp;E Staining Quality Control</p>
<p>Based on the article <a href='https://www.tandfonline.com/doi/full/10.1080/01478885.2025.2517906?src=exp-oa'>Utilizing image analysis by optical density to evaluate changes in hematoxylin and eosin staining quality after reagent overuse</a>” published in the Journal of Histotechnology.</p>
<p>To read the full blog, click <a href='https://www.nsh.org/blogs/ashley-stewart/2025/09/19/how-digital-image-analysis-strengthens-he-staining'>here</a>. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pawjdi3khj9sz8zk/JOH_H_E_Staining_202592wl0.mp3" length="4299224" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fixation on Histology: How Digital Image Analysis Strengthens H&amp;E Staining Quality Control
Based on the article Utilizing image analysis by optical density to evaluate changes in hematoxylin and eosin staining quality after reagent overuse” published in the Journal of Histotechnology.
To read the full blog, click here. ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>268</itunes:duration>
                <itunes:episode>183</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/fixationblogvideoimage.png" medium="image">
                            <media:title type="html">Fixation on Histology: How Digital Image Analysis Strengthens H&amp;E Staining Quality Control</media:title></media:content>    </item>
    <item>
        <title>Fixation on Histology: U.S. Cancer Research at a Breaking Point: NIH’s Grant Race Tightens Sharply</title>
        <itunes:title>Fixation on Histology: U.S. Cancer Research at a Breaking Point: NIH’s Grant Race Tightens Sharply</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/fixation-on-histology-us-cancer-research-at-a-breaking-point-nih-s-grant-race-tightens-sharply/</link>
                    <comments>https://nshpodcasts.podbean.com/e/fixation-on-histology-us-cancer-research-at-a-breaking-point-nih-s-grant-race-tightens-sharply/#comments</comments>        <pubDate>Fri, 05 Sep 2025 10:53:15 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/a802e044-653b-33f5-b2e7-78888353e7c8</guid>
                                    <description><![CDATA[<p>Fixation on Histology: U.S. Cancer Research at a Breaking Point: NIH’s Grant Race Tightens Sharply</p>
<p>Written by Antoinette EF Lona MSc., HTL(ASCP)cm </p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/09/05/nihs-grant-race-tightens-sharply'>To Read the Full Article Click Here</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Fixation on Histology: U.S. Cancer Research at a Breaking Point: NIH’s Grant Race Tightens Sharply</p>
<p>Written by Antoinette EF Lona MSc., HTL(ASCP)cm </p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/09/05/nihs-grant-race-tightens-sharply'>To Read the Full Article Click Here</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kbywrvt5iyqdux5k/NIH_Funding_202567e1f.mp3" length="5454463" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fixation on Histology: U.S. Cancer Research at a Breaking Point: NIH’s Grant Race Tightens Sharply
Written by Antoinette EF Lona MSc., HTL(ASCP)cm 
To Read the Full Article Click Here]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>340</itunes:duration>
                <itunes:episode>182</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/fixationblogvideoimage.png" medium="image">
                            <media:title type="html">Fixation on Histology: U.S. Cancer Research at a Breaking Point: NIH’s Grant Race Tightens Sharply</media:title></media:content>    </item>
    <item>
        <title>Fixation on Histology: The Devil You Know: Common Reasons Change Doesn’t Happen in the Lab</title>
        <itunes:title>Fixation on Histology: The Devil You Know: Common Reasons Change Doesn’t Happen in the Lab</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/fixation-on-histology-the-devil-you-know-the-devil-you-know-common-reasons-change-doesn-t-happen-in-the-lab/</link>
                    <comments>https://nshpodcasts.podbean.com/e/fixation-on-histology-the-devil-you-know-the-devil-you-know-common-reasons-change-doesn-t-happen-in-the-lab/#comments</comments>        <pubDate>Fri, 22 Aug 2025 12:32:02 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/0b9e04ec-fcb0-32dd-b39d-49918c5c941a</guid>
                                    <description><![CDATA[<p>Fixation on Histology: The Devil You Know: Common Reasons Change Doesn’t Happen in the Lab</p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/08/22/common-reasons-change-doesnt-happen'>To Read the Full Blog, Click Here</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Fixation on Histology: The Devil You Know: Common Reasons Change Doesn’t Happen in the Lab</p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/08/22/common-reasons-change-doesnt-happen'>To Read the Full Blog, Click Here</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ck4pasardnx38txd/Change_Whats_in_it_for_me_20257524n.mp3" length="4964615" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fixation on Histology: The Devil You Know: Common Reasons Change Doesn’t Happen in the Lab
To Read the Full Blog, Click Here]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>310</itunes:duration>
                <itunes:episode>181</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/fixationblogvideoimage.png" medium="image">
                            <media:title type="html">Fixation on Histology: The Devil You Know: Common Reasons Change Doesn’t Happen in the Lab</media:title></media:content>    </item>
    <item>
        <title>Fixation on Histology: Are You Making Time to Invest in Your Career?</title>
        <itunes:title>Fixation on Histology: Are You Making Time to Invest in Your Career?</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/fixation-on-histology-are-you-making-time-to-invest-in-your-career/</link>
                    <comments>https://nshpodcasts.podbean.com/e/fixation-on-histology-are-you-making-time-to-invest-in-your-career/#comments</comments>        <pubDate>Fri, 08 Aug 2025 11:49:25 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/9b8f4cfd-ccca-31be-8dcb-ba9092a0c65f</guid>
                                    <description><![CDATA[<p>Fixation on Histology: Are You Making Time to Invest in Your Career?</p>
<p>Written by: Ashley Stewart, Membership &amp; Publications Manager</p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/08/08/are-you-making-time-to-invest-in-your-career'>To Read the Full Blog, Click Here.</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Fixation on Histology: Are You Making Time to Invest in Your Career?</p>
<p><em>Written by: Ashley Stewart, Membership &amp; Publications Manager</em></p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/08/08/are-you-making-time-to-invest-in-your-career'>To Read the Full Blog, Click Here.</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dza6rajzn779iv94/Invest_in_Your_Career_20258s501.mp3" length="2555865" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fixation on Histology: Are You Making Time to Invest in Your Career?
Written by: Ashley Stewart, Membership &amp; Publications Manager
To Read the Full Blog, Click Here.]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>159</itunes:duration>
                <itunes:episode>180</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/fixationblogvideoimage.png" medium="image">
                            <media:title type="html">Fixation on Histology: Are You Making Time to Invest in Your Career?</media:title></media:content>    </item>
    <item>
        <title>Fixation on Histology: Remembering the Person Behind the Pieces of Tissue</title>
        <itunes:title>Fixation on Histology: Remembering the Person Behind the Pieces of Tissue</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/fixation-on-histology-remembering-the-person-behind-the-pieces-of-tissue/</link>
                    <comments>https://nshpodcasts.podbean.com/e/fixation-on-histology-remembering-the-person-behind-the-pieces-of-tissue/#comments</comments>        <pubDate>Fri, 25 Jul 2025 10:59:56 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/9e8795a6-c0c5-3f61-84c5-dce66b7e88e6</guid>
                                    <description><![CDATA[<p>Fixation on Histology: Remembering the Person Behind the Pieces of Tissue</p>
<p>Written based on the webinar <a href='https://elearn.nsh.org/products/remembering-why-a-review-of-patient-case-studies-3'>Remembering Why—a Review of Patient Case Studies</a> </p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/07/25/remembering-the-person-behind-the-pieces-of-tissue?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>To Read the Full Blog Click Here</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Fixation on Histology: Remembering the Person Behind the Pieces of Tissue</p>
<p>Written based on the webinar <a href='https://elearn.nsh.org/products/remembering-why-a-review-of-patient-case-studies-3'>Remembering Why—a Review of Patient Case Studies</a> </p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/07/25/remembering-the-person-behind-the-pieces-of-tissue?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>To Read the Full Blog Click Here</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/z67ubueubyb9xcbq/Remembering_Why_20259jsiz.mp3" length="3917994" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fixation on Histology: Remembering the Person Behind the Pieces of Tissue
Written based on the webinar Remembering Why—a Review of Patient Case Studies 
To Read the Full Blog Click Here]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>244</itunes:duration>
                <itunes:episode>179</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/fixationblogvideoimage.png" medium="image">
                            <media:title type="html">Fixation on Histology: Remembering the Person Behind the Pieces of Tissue</media:title></media:content>    </item>
    <item>
        <title>Fixation on Histology: CAP Made Competency Assessment a Tiny Bit Less… Confusing (Yes, really!)</title>
        <itunes:title>Fixation on Histology: CAP Made Competency Assessment a Tiny Bit Less… Confusing (Yes, really!)</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/fixation-on-histology-cap-made-competency-assessment-a-tiny-bit-less%e2%80%a6-confusing-yes-really/</link>
                    <comments>https://nshpodcasts.podbean.com/e/fixation-on-histology-cap-made-competency-assessment-a-tiny-bit-less%e2%80%a6-confusing-yes-really/#comments</comments>        <pubDate>Fri, 11 Jul 2025 10:44:30 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/a98971f6-3668-3d43-865c-0782692ad5fd</guid>
                                    <description><![CDATA[<p>Fixation on Histology: CAP Made Competency Assessment a Tiny Bit Less… Confusing (Yes, really!)</p>
<p>Written by: Nicole Leon BS, HTL(ASCP)</p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/07/11/cap-made-competency-assessment-less-confusing?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>To read the full blog, click here. </a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Fixation on Histology: CAP Made Competency Assessment a Tiny Bit Less… Confusing (Yes, really!)</p>
<p>Written by: Nicole Leon BS, HTL(ASCP)</p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/07/11/cap-made-competency-assessment-less-confusing?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>To read the full blog, click here. </a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pj2r389hvss9nbep/CAP_Made_Competency_Less_Confusing_202570f7w.mp3" length="2102379" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fixation on Histology: CAP Made Competency Assessment a Tiny Bit Less… Confusing (Yes, really!)
Written by: Nicole Leon BS, HTL(ASCP)
To read the full blog, click here. ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>131</itunes:duration>
                <itunes:episode>178</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/fixationblogvideoimage.png" medium="image">
                            <media:title type="html">Fixation on Histology: CAP Made Competency Assessment a Tiny Bit Less… Confusing (Yes, really!)</media:title></media:content>    </item>
    <item>
        <title>Fixation on Histology: The Role of Images in Research Reproducibility</title>
        <itunes:title>Fixation on Histology: The Role of Images in Research Reproducibility</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/fixation-on-histology-the-role-of-images-in-research-reproducibility/</link>
                    <comments>https://nshpodcasts.podbean.com/e/fixation-on-histology-the-role-of-images-in-research-reproducibility/#comments</comments>        <pubDate>Fri, 27 Jun 2025 14:04:51 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/7aeae6e6-86e0-302b-b9ac-02899180e2af</guid>
                                    <description><![CDATA[<p>Fixation on Histology: The Role of Images in Research Reproducibility</p>
<p>This blog was written based on Framework for Reporting Materials and Methods for Histology Assays webinar</p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/06/27/the-role-of-images-in-research-reproducibility'>To Read the Full Blog, Click Here. </a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Fixation on Histology: The Role of Images in Research Reproducibility</p>
<p><em>This blog was written based on Framework for Reporting Materials and Methods for Histology Assays webinar</em></p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/06/27/the-role-of-images-in-research-reproducibility'>To Read the Full Blog, Click Here. </a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gc3jt67vdfmvrta5/The_Role_of_Images_in_Research_Reproducibility_20258cfr2.mp3" length="3868171" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fixation on Histology: The Role of Images in Research Reproducibility
This blog was written based on Framework for Reporting Materials and Methods for Histology Assays webinar
To Read the Full Blog, Click Here. ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>241</itunes:duration>
                <itunes:episode>177</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/fixationblogvideoimage.png" medium="image">
                            <media:title type="html">Fixation on Histology: The Role of Images in Research Reproducibility</media:title></media:content>    </item>
    <item>
        <title>Fixation on Histology: Enhanced Method for PGP 9.5 Immunohistochemical Labeling in Small Fiber Neuropathy</title>
        <itunes:title>Fixation on Histology: Enhanced Method for PGP 9.5 Immunohistochemical Labeling in Small Fiber Neuropathy</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/fixation-on-histology-enhanced-method-for-pgp-95-immunohistochemical-labeling-in-small-fiber-neuropathy/</link>
                    <comments>https://nshpodcasts.podbean.com/e/fixation-on-histology-enhanced-method-for-pgp-95-immunohistochemical-labeling-in-small-fiber-neuropathy/#comments</comments>        <pubDate>Fri, 13 Jun 2025 10:46:21 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/460d11ac-682b-322e-8a8e-3e335540c5c7</guid>
                                    <description><![CDATA[<p>Fixation on Histology: Enhanced Method for PGP 9.5 Immunohistochemical Labeling in Small Fiber Neuropathy</p>
<p>Blog is based on article in the June 2025 Journal of Histotechnology</p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/06/13/enhanced-method-for-pgp-95-immunohistochemical?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>To read the full blog, click here. </a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Fixation on Histology: Enhanced Method for PGP 9.5 Immunohistochemical Labeling in Small Fiber Neuropathy</p>
<p><em>Blog is based on article in the June 2025 Journal of Histotechnology</em></p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/06/13/enhanced-method-for-pgp-95-immunohistochemical?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>To read the full blog, click here. </a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qj8ea2hgsk3xntxp/PGP_95_202577kn8.mp3" length="3108407" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fixation on Histology: Enhanced Method for PGP 9.5 Immunohistochemical Labeling in Small Fiber Neuropathy
Blog is based on article in the June 2025 Journal of Histotechnology
To read the full blog, click here. ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>194</itunes:duration>
                <itunes:episode>176</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/fixationblogvideoimage.png" medium="image">
                            <media:title type="html">Fixation on Histology: Enhanced Method for PGP 9.5 Immunohistochemical Labeling in Small Fiber Neuropathy</media:title></media:content>    </item>
    <item>
        <title>Fixation on Histology: The Lena Spencer Scholarship Fund</title>
        <itunes:title>Fixation on Histology: The Lena Spencer Scholarship Fund</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/fixation-on-histology-the-lena-spencer-scholarship-fund/</link>
                    <comments>https://nshpodcasts.podbean.com/e/fixation-on-histology-the-lena-spencer-scholarship-fund/#comments</comments>        <pubDate>Fri, 30 May 2025 15:44:07 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/ac782ef8-57c3-3051-a4bc-f72ea7237f78</guid>
                                    <description><![CDATA[<p>Fixation on Histology: The Lena Spencer Scholarship Fund</p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/05/30/honoring-a-legacy-the-lena-spencer-scholarship?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>You can read the full blog here.</a> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Fixation on Histology: The Lena Spencer Scholarship Fund</p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/05/30/honoring-a-legacy-the-lena-spencer-scholarship?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>You can read the full blog here.</a> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mfkxewtkqanpkfax/Honoring_a_Legacy_The_Lena_Spencer_Scholarship_Fund_2025bcuoh.mp3" length="3609540" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fixation on Histology: The Lena Spencer Scholarship Fund
You can read the full blog here. ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>225</itunes:duration>
                <itunes:episode>175</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/fixationblogvideoimage.png" medium="image">
                            <media:title type="html">Fixation on Histology: The Lena Spencer Scholarship Fund</media:title></media:content>    </item>
    <item>
        <title>Fixation on Histology: Veteran Histologist Cristi Rigazio Recognized for Her Dedicated Leadership</title>
        <itunes:title>Fixation on Histology: Veteran Histologist Cristi Rigazio Recognized for Her Dedicated Leadership</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/fixation-on-histology-veteran-histologist-cristi-rigazio-recognized-for-her-dedicated-leadership/</link>
                    <comments>https://nshpodcasts.podbean.com/e/fixation-on-histology-veteran-histologist-cristi-rigazio-recognized-for-her-dedicated-leadership/#comments</comments>        <pubDate>Wed, 14 May 2025 16:53:53 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/e2af3d39-1b4e-3980-bc83-ca526421cd52</guid>
                                    <description><![CDATA[<p>Fixation on Histology: Veteran Histologist Cristi Rigazio Recognized for Her Dedicated Leadership</p>
<p>Based on an interview with Cristi Rigazio</p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/05/14/rigazio-recognized-for-her-dedicated-leadership'>Click to Read The Full Blog Here</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Fixation on Histology: Veteran Histologist Cristi Rigazio Recognized for Her Dedicated Leadership</p>
<p><em>Based on an interview with Cristi Rigazio</em></p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/05/14/rigazio-recognized-for-her-dedicated-leadership'>Click to Read The Full Blog Here</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xzafb8bnyqamby9r/Veteran_Histologist_Cristi_Rigazio_Recognized_for_Her_Dedicated_Leadership_20257eekm.mp3" length="4765197" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fixation on Histology: Veteran Histologist Cristi Rigazio Recognized for Her Dedicated Leadership
Based on an interview with Cristi Rigazio
Click to Read The Full Blog Here]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>297</itunes:duration>
                <itunes:episode>174</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/fixationblogvideoimage.png" medium="image">
                            <media:title type="html">Fixation on Histology: Veteran Histologist Cristi Rigazio Recognized for Her Dedicated Leadership</media:title></media:content>    </item>
    <item>
        <title>President's Message: May 2025</title>
        <itunes:title>President's Message: May 2025</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/presidents-message-may-2025/</link>
                    <comments>https://nshpodcasts.podbean.com/e/presidents-message-may-2025/#comments</comments>        <pubDate>Mon, 05 May 2025 13:10:22 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/983d2896-acf2-3d11-99d7-6cadb956dac4</guid>
                                    <description><![CDATA[<p>President's Message: May 2025</p>
<p>Written by: Lamar Jones, NSH President</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>President's Message: May 2025</p>
<p><em>Written by: Lamar Jones, NSH President</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3qcgidfvjachwr64/President_s_Message_May_2025axogn.mp3" length="3927607" type="audio/mpeg"/>
        <itunes:summary><![CDATA[President's Message: May 2025
Written by: Lamar Jones, NSH President]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>245</itunes:duration>
                <itunes:episode>173</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/Full_Card_Presidents_Messagear17d.png" medium="image">
                            <media:title type="html">President&#039;s Message: May 2025</media:title></media:content>    </item>
    <item>
        <title>Fixation on Histology: The Vital Role Histotechnologists Play in Veterinary Medicine</title>
        <itunes:title>Fixation on Histology: The Vital Role Histotechnologists Play in Veterinary Medicine</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/fixation-on-histology-the-vital-role-histotechnologists-play-in-veterinary-medicine/</link>
                    <comments>https://nshpodcasts.podbean.com/e/fixation-on-histology-the-vital-role-histotechnologists-play-in-veterinary-medicine/#comments</comments>        <pubDate>Fri, 02 May 2025 10:44:11 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/321ed353-d8cd-3a72-8fab-a52d91c77be0</guid>
                                    <description><![CDATA[<p>Fixation on Histology Blog: The Vital Role Histotechnologists Play in Veterinary Medicine</p>
<p>Based on the Webinar By: Kei Kuroki, DVM, PhD, DACVP, of the University of Missouri</p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/05/02/the-vital-role-histotechnologists-play?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>Click to Read this Post</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Fixation on Histology Blog: The Vital Role Histotechnologists Play in Veterinary Medicine</p>
<p><em>Based on the Webinar By: Kei Kuroki, DVM, PhD, DACVP, of the University of Missouri</em></p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/05/02/the-vital-role-histotechnologists-play?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>Click to Read this Post</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cvnrvdfutrz939v4/The_Vital_Role_Histotechnologists_Play_in_Veterinary_Medicine_2025b9bqv.mp3" length="4257377" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fixation on Histology Blog: The Vital Role Histotechnologists Play in Veterinary Medicine
Based on the Webinar By: Kei Kuroki, DVM, PhD, DACVP, of the University of Missouri
Click to Read this Post]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>266</itunes:duration>
                <itunes:episode>172</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/fixationblogvideoimage.png" medium="image">
                            <media:title type="html">Fixation on Histology: The Vital Role Histotechnologists Play in Veterinary Medicine</media:title></media:content>    </item>
    <item>
        <title>Fixation on Histology Blog: The Man Behind the Award: Dr. Jules Elias and the Power of Pursuing Passion</title>
        <itunes:title>Fixation on Histology Blog: The Man Behind the Award: Dr. Jules Elias and the Power of Pursuing Passion</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/fixation-on-histology-blog-the-man-behind-the-award-dr-jules-elias-and-the-power-of-pursuing-passion/</link>
                    <comments>https://nshpodcasts.podbean.com/e/fixation-on-histology-blog-the-man-behind-the-award-dr-jules-elias-and-the-power-of-pursuing-passion/#comments</comments>        <pubDate>Fri, 18 Apr 2025 12:13:06 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/2020675f-2288-3db1-ad61-e49b06b81934</guid>
                                    <description><![CDATA[<p>Fixation on Histology Blog: The Man Behind the Award: Dr. Jules Elias and the Power of Pursuing Passion</p>
<p>Written by: Dr. Jules Elias, PhD</p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/04/18/the-man-behind-the-award?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>Click to Read this Post</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Fixation on Histology Blog: The Man Behind the Award: Dr. Jules Elias and the Power of Pursuing Passion</p>
<p><em>Written by: Dr. Jules Elias, PhD</em></p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/04/18/the-man-behind-the-award?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>Click to Read this Post</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5ju9pk8gnrfe67wn/The_Man_Behind_the_Award_Dr_Jules_Elias_and_the_Power_of_Pursuing_Passion_20258odih.mp3" length="4768123" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fixation on Histology Blog: The Man Behind the Award: Dr. Jules Elias and the Power of Pursuing Passion
Written by: Dr. Jules Elias, PhD
Click to Read this Post]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>298</itunes:duration>
                <itunes:episode>171</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/fixationblogvideoimage.png" medium="image">
                            <media:title type="html">Fixation on Histology Blog: The Man Behind the Award: Dr. Jules Elias and the Power of Pursuing Passion</media:title></media:content>    </item>
    <item>
        <title>Fixation on Histology Blog: Enhancing Organoid Research with Histogel-Based Embedding Techniques</title>
        <itunes:title>Fixation on Histology Blog: Enhancing Organoid Research with Histogel-Based Embedding Techniques</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/fixation-on-histology-blog-enhancing-organoid-research-with-histogel-based-embedding-techniques/</link>
                    <comments>https://nshpodcasts.podbean.com/e/fixation-on-histology-blog-enhancing-organoid-research-with-histogel-based-embedding-techniques/#comments</comments>        <pubDate>Fri, 11 Apr 2025 14:48:27 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/10c5cf57-e376-3cd1-92d4-0edb2476d094</guid>
                                    <description><![CDATA[<p>Fixation on Histology Blog: Enhancing Organoid Research with Histogel-Based Embedding Techniques</p>
<p>Based on an Article By: Havnar, C., Holokai, L., Ichikawa, R., Chen, W., Scherl, A., &amp; Shamir, E. R. (2024)</p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/03/21/enhancing-organoid-research-with-histogel?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>Click to read this post.</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Fixation on Histology Blog: Enhancing Organoid Research with Histogel-Based Embedding Techniques</p>
<p><em>Based on an Article By: Havnar, C., Holokai, L., Ichikawa, R., Chen, W., Scherl, A., &amp; Shamir, E. R. (2024)</em></p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/03/21/enhancing-organoid-research-with-histogel?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>Click to read this post.</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3z5tirud7c4ur2nc/Organoid_Histogel_20259sp5v.mp3" length="4127397" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fixation on Histology Blog: Enhancing Organoid Research with Histogel-Based Embedding Techniques
Based on an Article By: Havnar, C., Holokai, L., Ichikawa, R., Chen, W., Scherl, A., &amp; Shamir, E. R. (2024)
Click to read this post.]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>257</itunes:duration>
                <itunes:episode>170</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/fixationblogvideoimage.png" medium="image">
                            <media:title type="html">Fixation on Histology Blog: Enhancing Organoid Research with Histogel-Based Embedding Techniques</media:title></media:content>    </item>
    <item>
        <title>Fixation on Histology Blog: Phlebotomy to Research: A Journey Through Histotechnology</title>
        <itunes:title>Fixation on Histology Blog: Phlebotomy to Research: A Journey Through Histotechnology</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/fixation-on-histology-blog-phlebotomy-to-research-a-journey-through-histotechnology/</link>
                    <comments>https://nshpodcasts.podbean.com/e/fixation-on-histology-blog-phlebotomy-to-research-a-journey-through-histotechnology/#comments</comments>        <pubDate>Fri, 11 Apr 2025 14:09:24 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/b98eb828-ae7c-3bba-b920-c996b0a4b589</guid>
                                    <description><![CDATA[<p>Fixation on Histology Blog: Phlebotomy to Research: A Journey Through Histotechnology</p>
<p>Written By: Andrea Transou BS,HTL(ASCP), QIHC(ASCP)</p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/03/07/a-journey-through-histotechnology?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>Click to read this post.</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Fixation on Histology Blog: Phlebotomy to Research: A Journey Through Histotechnology</p>
<p><em>Written By: Andrea Transou BS,HTL(ASCP), QIHC(ASCP)</em></p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/03/07/a-journey-through-histotechnology?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>Click to read this post.</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/m6e7eeg2kdmc26ny/My_Path_Andrea_Transou_20259efof.mp3" length="4172006" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fixation on Histology Blog: Phlebotomy to Research: A Journey Through Histotechnology
Written By: Andrea Transou BS,HTL(ASCP), QIHC(ASCP)
Click to read this post.]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>260</itunes:duration>
                <itunes:episode>169</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/fixationblogvideoimage.png" medium="image">
                            <media:title type="html">Fixation on Histology Blog: Phlebotomy to Research: A Journey Through Histotechnology</media:title></media:content>    </item>
    <item>
        <title>Fixation on Histology Blog: My Histology Journey - Jeniesha Russell, HT(ASCP)</title>
        <itunes:title>Fixation on Histology Blog: My Histology Journey - Jeniesha Russell, HT(ASCP)</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/fixation-on-histology-blog-my-histology-journey-jeniesha-russell-htascp/</link>
                    <comments>https://nshpodcasts.podbean.com/e/fixation-on-histology-blog-my-histology-journey-jeniesha-russell-htascp/#comments</comments>        <pubDate>Fri, 11 Apr 2025 13:56:45 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/9c985fa9-697c-3bc4-8d67-1d683b57f5b1</guid>
                                    <description><![CDATA[<p>Fixation on Histology Blog: My Histology Journey - Jeniesha Russell, HT(ASCP)</p>
<p>Written By: Jeniesha Russell, HT(ASCP)</p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/02/20/embracing-growth-in-histotechnology?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>Click to read this post.</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Fixation on Histology Blog: My Histology Journey - Jeniesha Russell, HT(ASCP)</p>
<p><em>Written By: Jeniesha Russell, HT(ASCP)</em></p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/02/20/embracing-growth-in-histotechnology?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>Click to read this post.</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5j5y3kgt72kfp5nv/My_Path_Jennisha_Russel_20257b1om.mp3" length="5770353" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fixation on Histology Blog: My Histology Journey - Jeniesha Russell, HT(ASCP)
Written By: Jeniesha Russell, HT(ASCP)
Click to read this post.]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>360</itunes:duration>
                <itunes:episode>168</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/fixationblogvideoimage.png" medium="image">
                            <media:title type="html">Fixation on Histology Blog: My Histology Journey - Jeniesha Russell, HT(ASCP)</media:title></media:content>    </item>
    <item>
        <title>Fixation on Histology Blog: My Histology Journey - Toysha Mayer</title>
        <itunes:title>Fixation on Histology Blog: My Histology Journey - Toysha Mayer</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/fixation-on-histology-blog-my-histology-journey-toysha-mayer/</link>
                    <comments>https://nshpodcasts.podbean.com/e/fixation-on-histology-blog-my-histology-journey-toysha-mayer/#comments</comments>        <pubDate>Fri, 11 Apr 2025 13:49:02 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/f9fbc22f-68bf-3162-9dd2-99e50da9ba94</guid>
                                    <description><![CDATA[<p>Fixation on Histology Blog: My Histology Journey - Toysha Mayer</p>
<p>Written By: Toysha Mayer, DHSc, MBA, HT(ASCP)</p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/02/07/30-years-in-the-making?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>Click to read this post.</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Fixation on Histology Blog: My Histology Journey - Toysha Mayer</p>
<p><em>Written By: Toysha Mayer, DHSc, MBA, HT(ASCP)</em></p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/02/07/30-years-in-the-making?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>Click to read this post.</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/v44pjrcncsxkzu2c/My_Path_Toysha_Mayer_2025br6l3.mp3" length="3264724" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fixation on Histology Blog: My Histology Journey - Toysha Mayer
Written By: Toysha Mayer, DHSc, MBA, HT(ASCP)
Click to read this post.]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>204</itunes:duration>
                <itunes:episode>167</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/fixationblogvideoimage.png" medium="image">
                            <media:title type="html">Fixation on Histology Blog: My Histology Journey - Toysha Mayer</media:title></media:content>    </item>
    <item>
        <title>Fixation on Histology Blog: Mastering the Art of Immunohistochemistry: Essential Techniques for Reliable Diagnostic Results</title>
        <itunes:title>Fixation on Histology Blog: Mastering the Art of Immunohistochemistry: Essential Techniques for Reliable Diagnostic Results</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/fixation-on-histology-blog-mastering-the-art-of-immunohistochemistry-essential-techniques-for-reliable-diagnostic-results/</link>
                    <comments>https://nshpodcasts.podbean.com/e/fixation-on-histology-blog-mastering-the-art-of-immunohistochemistry-essential-techniques-for-reliable-diagnostic-results/#comments</comments>        <pubDate>Fri, 11 Apr 2025 13:27:30 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/163dd4ae-77c6-3712-9ebc-48c662228974</guid>
                                    <description><![CDATA[<p>Fixation on Histology Blog: Mastering the Art of Immunohistochemistry: Essential Techniques for Reliable Diagnostic Results</p>
<p>Written By: Khulood Ayad Majeed; College of Dentistry, University of Kirkuk</p>
<p><a href='http://w'>Click to read this post.</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Fixation on Histology Blog: Mastering the Art of Immunohistochemistry: Essential Techniques for Reliable Diagnostic Results</p>
<p><em>Written By: Khulood Ayad Majeed; College of Dentistry, University of Kirkuk</em></p>
<p><a href='http://w'>Click to read this post.</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kgkbd957jfvfvvqg/Mastering_IHC_20256918a.mp3" length="5396734" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fixation on Histology Blog: Mastering the Art of Immunohistochemistry: Essential Techniques for Reliable Diagnostic Results
Written By: Khulood Ayad Majeed; College of Dentistry, University of Kirkuk
Click to read this post.]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>337</itunes:duration>
                <itunes:episode>166</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/fixationblogvideoimage.png" medium="image">
                            <media:title type="html">Fixation on Histology Blog: Mastering the Art of Immunohistochemistry: Essential Techniques for Reliable Diagnostic Results</media:title></media:content>    </item>
    <item>
        <title>Fixation on Histology Blog: Where Does Tissue Contamination Happen Most?</title>
        <itunes:title>Fixation on Histology Blog: Where Does Tissue Contamination Happen Most?</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/fixation-on-histology-blog-where-does-tissue-contamination-happen-most/</link>
                    <comments>https://nshpodcasts.podbean.com/e/fixation-on-histology-blog-where-does-tissue-contamination-happen-most/#comments</comments>        <pubDate>Fri, 11 Apr 2025 08:38:53 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/a1c3428a-70e8-3b75-bba5-2a4d6d4e200f</guid>
                                    <description><![CDATA[<p>Fixation on Histology Blog: Where Does Tissue Contamination Happen Most?</p>
<p>Based on the Webinar By: Valerie Cortright, BA, HT(ASCP), HTL(ASCP), QIHC</p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/04/04/where-does-tissue-contamination-happen-most?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>Click to read this post.</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Fixation on Histology Blog: Where Does Tissue Contamination Happen Most?</p>
<p><em>Based on the Webinar By: Valerie Cortright, BA, HT(ASCP), HTL(ASCP), QIHC</em></p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/04/04/where-does-tissue-contamination-happen-most?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>Click to read this post.</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/27fb4gf9ui6gcr76/Tissue_Contaiments_2025a4qp2.mp3" length="3263637" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fixation on Histology Blog: Where Does Tissue Contamination Happen Most?
Based on the Webinar By: Valerie Cortright, BA, HT(ASCP), HTL(ASCP), QIHC
Click to read this post.]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>202</itunes:duration>
                <itunes:episode>165</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/fixationblogvideoimage.png" medium="image">
                            <media:title type="html">Fixation on Histology Blog: Where Does Tissue Contamination Happen Most?</media:title></media:content>    </item>
    <item>
        <title>Fixation on Histology Blog: 10 Game-Changing Leadership Lessons</title>
        <itunes:title>Fixation on Histology Blog: 10 Game-Changing Leadership Lessons</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/fixation-on-histology-blog-10-game-changing-leadership-lessons/</link>
                    <comments>https://nshpodcasts.podbean.com/e/fixation-on-histology-blog-10-game-changing-leadership-lessons/#comments</comments>        <pubDate>Wed, 12 Mar 2025 12:04:49 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/678a59f9-65ee-36af-817c-fab81691050e</guid>
                                    <description><![CDATA[<p>Fixation on Histology Blog: 10 Game-Changing Leadership Lessons</p>
<p>Written By: Cathay García Lauzurique, MHA, MSc, HTL(ASCP)</p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/01/23/10-game-changing-leadership-lessons?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>Click to read this post.</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Fixation on Histology Blog: 10 Game-Changing Leadership Lessons</p>
<p><em>Written By: Cathay García Lauzurique, MHA, MSc, HTL(ASCP)</em></p>
<p><a href='https://www.nsh.org/blogs/ashley-stewart/2025/01/23/10-game-changing-leadership-lessons?CommunityKey=9c4467fa-cc5a-473c-84e3-66c73535c39d'>Click to read this post.</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zzt8r8a2q4tq6c4d/10_Game-Changing_Leadership_Lessons_20259xxvv.mp3" length="5095758" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Fixation on Histology Blog: 10 Game-Changing Leadership Lessons
Written By: Cathay García Lauzurique, MHA, MSc, HTL(ASCP)
Click to read this post.]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>318</itunes:duration>
                <itunes:episode>164</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/fixationblogvideoimage.png" medium="image">
                            <media:title type="html">Fixation on Histology Blog: 10 Game-Changing Leadership Lessons</media:title></media:content>    </item>
    <item>
        <title>Hot Dog as an Alternative Source for Control Tissue</title>
        <itunes:title>Hot Dog as an Alternative Source for Control Tissue</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/hot-dog-as-an-alternative-source-for-control-tissue/</link>
                    <comments>https://nshpodcasts.podbean.com/e/hot-dog-as-an-alternative-source-for-control-tissue/#comments</comments>        <pubDate>Fri, 31 Jan 2025 11:11:22 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/625c43ab-242d-383e-94b4-8650e852c800</guid>
                                    <description><![CDATA[<p>Audio reading from the July 2023 NSH Fixation on Histology Blog, Hot Dog as an Alternative Source for Control Tissue. <a href='https://www.nsh.org/blogs/alisha-yocum/2023/07/27/hot-dog-as-an-alternative-source-for-control-tissu'>Read entire article.</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Audio reading from the July 2023 NSH Fixation on Histology Blog, Hot Dog as an Alternative Source for Control Tissue. <a href='https://www.nsh.org/blogs/alisha-yocum/2023/07/27/hot-dog-as-an-alternative-source-for-control-tissu'>Read entire article.</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/89gs647kdpk8abj2/HotDogs_7202383sls.mp3" length="2876813" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Audio reading from the July 2023 NSH Fixation on Histology Blog, Hot Dog as an Alternative Source for Control Tissue. Read entire article.]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>179</itunes:duration>
                <itunes:episode>163</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/fixationblogvideoimage.png" medium="image">
                            <media:title type="html">Hot Dog as an Alternative Source for Control Tissue</media:title></media:content>    </item>
    <item>
        <title>NSH Poster Podcast: P08/P11 (2024)</title>
        <itunes:title>NSH Poster Podcast: P08/P11 (2024)</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p08p11/</link>
                    <comments>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p08p11/#comments</comments>        <pubDate>Fri, 06 Dec 2024 23:18:00 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/35e5a3bd-4032-39bc-9b69-d1f2c2228312</guid>
                                    <description><![CDATA[


P08-Diagnostic Cytopathology Cell Block Preparation Methods- Anna Patterson FIBMS MSc CSci Diagnostic Cytology Scheme Coordinator
Helen Naylor MSc Diagnostic Cytology Technical Specialist



<p>Cell blocks from Cytopathology samples have always had value in the diagnostic process as a complement to the traditional Cytopathology stains – Papanicolaou and Romanowsky.  This has become more important to provide material for Immunocytochemistry to refine malignant diagnosis, and more recently, for the use of molecular testing to aid in the choice of tailored chemotherapy regimens.  If this information can be obtained from Cytopathology samples, which are less invasive than biopsy samples, the patient will benefit.
A variety of preparation methods are available for the preparation of cell blocks from cells from Diagnostic Cytopathology samples.  The most popular methods will be discussed and how they can be used to optimise the quality of cell preservation if used correctly.
Information garnered from the results of the recently introduced UK NEQAS CPT Diagnostic Cytopathology Cell block scheme will be presented and how this information can be circulated to laboratories experiencing difficulties with their preparation methods as an advisory service. This will include.
• Understanding the clinical importance and diagnostic purpose of correct procedures in Diagnostic Cytopathology Cell Block preparation.
• Identifying and determining factors affecting best practice and quality in Diagnostic Cytopathology Cell Block practice and how to resolve them.
• Identifying and understanding the causes of artefacts experienced in Diagnostic Cytopathology Cell Block preparation methods and how to eliminate and prevent them.</p>
<p>P11- Participating In A Digital Diagnostic Cytopathology Interpretive Proficiency Testing (iEQA) Scheme -Helen Naylor, Anna Patterson, Chantell Hodgson, Ashley Makela</p>
<p>The iLabXCell Digital Diagnostic Cytopathology Interpretive Proficiency Testing Scheme or iEQA is facilitated by UK NEQAS Cellular Pathology Technique (CPT), and is designed to promote quality, excellence, and education for all involved in screening and reporting of Diagnostic Cytopathology. It is open to medical and non-medical staff, trainees, advanced practitioners, and staff associated with Cytopathology. iEQA provides superior, outstanding, and representative case examples for individuals to examine in a remote setting and submit an opinion via the user-friendly digital platform. 
Offering 2 circulations annually it provides
• Easy access for registration 
• Ability to choose specimen types 
• Advanced slide viewing
• Clinical details to assist diagnoses
• Categorisation of images using benign or malignant </p>
<p>Flexibility
Remote learning allows participants to continue learning alongside their peers, in an environment accommodating their needs. It allows the flexibility of international participants to access the platform at any time, convenient to them. Remote learning via the iEQA platform, offers the flexibility for users to pick up learning where they left it – anywhere, anytime, from any location.
Self-paced learning
Traditional learning has long failed to acknowledge the individualised nature of learning, opting instead for a generalised approach that may not be optimised for everyone. One of the many benefits of this iEQA is providing participants more independence to:
• Spend more time on cases/case types they find difficult
• Revisit the images as often as they need </p>
<p>Environmental benefits
Digitising slides has led to a decrease in physical resources previously necessary for iEQA to function. Everything participants need is accessible on-line, eliminating the historical environmental impact and the time taken for circulations to be distributed and completed.  </p>
<p>Future developments
An on-line educational image library, containing images of Diagnostic Cytopathology cases of urines, serous fluids, respiratory and head and neck cases used in previous circulations for educational and training purposes. </p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[


P08-Diagnostic Cytopathology Cell Block Preparation Methods- <em>Anna Patterson FIBMS MSc CSci Diagnostic Cytology Scheme Coordinator</em><br>
<em>Helen Naylor MSc Diagnostic Cytology Technical Specialist</em>



<p>Cell blocks from Cytopathology samples have always had value in the diagnostic process as a complement to the traditional Cytopathology stains – Papanicolaou and Romanowsky.  This has become more important to provide material for Immunocytochemistry to refine malignant diagnosis, and more recently, for the use of molecular testing to aid in the choice of tailored chemotherapy regimens.  If this information can be obtained from Cytopathology samples, which are less invasive than biopsy samples, the patient will benefit.<br>
A variety of preparation methods are available for the preparation of cell blocks from cells from Diagnostic Cytopathology samples.  The most popular methods will be discussed and how they can be used to optimise the quality of cell preservation if used correctly.<br>
Information garnered from the results of the recently introduced UK NEQAS CPT Diagnostic Cytopathology Cell block scheme will be presented and how this information can be circulated to laboratories experiencing difficulties with their preparation methods as an advisory service. This will include.<br>
• Understanding the clinical importance and diagnostic purpose of correct procedures in Diagnostic Cytopathology Cell Block preparation.<br>
• Identifying and determining factors affecting best practice and quality in Diagnostic Cytopathology Cell Block practice and how to resolve them.<br>
• Identifying and understanding the causes of artefacts experienced in Diagnostic Cytopathology Cell Block preparation methods and how to eliminate and prevent them.</p>
<p>P11- Participating In A Digital Diagnostic Cytopathology Interpretive Proficiency Testing (iEQA) Scheme -<em>Helen Naylor, Anna Patterson, Chantell Hodgson, Ashley Makela</em></p>
<p>The iLabXCell Digital Diagnostic Cytopathology Interpretive Proficiency Testing Scheme or iEQA is facilitated by UK NEQAS Cellular Pathology Technique (CPT), and is designed to promote quality, excellence, and education for all involved in screening and reporting of Diagnostic Cytopathology. It is open to medical and non-medical staff, trainees, advanced practitioners, and staff associated with Cytopathology. iEQA provides superior, outstanding, and representative case examples for individuals to examine in a remote setting and submit an opinion via the user-friendly digital platform. <br>
Offering 2 circulations annually it provides<br>
• Easy access for registration <br>
• Ability to choose specimen types <br>
• Advanced slide viewing<br>
• Clinical details to assist diagnoses<br>
• Categorisation of images using benign or malignant </p>
<p>Flexibility<br>
Remote learning allows participants to continue learning alongside their peers, in an environment accommodating their needs. It allows the flexibility of international participants to access the platform at any time, convenient to them. Remote learning via the iEQA platform, offers the flexibility for users to pick up learning where they left it – anywhere, anytime, from any location.<br>
Self-paced learning<br>
Traditional learning has long failed to acknowledge the individualised nature of learning, opting instead for a generalised approach that may not be optimised for everyone. One of the many benefits of this iEQA is providing participants more independence to:<br>
• Spend more time on cases/case types they find difficult<br>
• Revisit the images as often as they need </p>
<p>Environmental benefits<br>
Digitising slides has led to a decrease in physical resources previously necessary for iEQA to function. Everything participants need is accessible on-line, eliminating the historical environmental impact and the time taken for circulations to be distributed and completed.  </p>
<p>Future developments<br>
An on-line educational image library, containing images of Diagnostic Cytopathology cases of urines, serous fluids, respiratory and head and neck cases used in previous circulations for educational and training purposes. </p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/86p6bvmv66da67xt/P08-11_Final.mp3" length="13951521" type="audio/mpeg"/>
        <itunes:summary><![CDATA[


P08-Diagnostic Cytopathology Cell Block Preparation Methods- Anna Patterson FIBMS MSc CSci Diagnostic Cytology Scheme CoordinatorHelen Naylor MSc Diagnostic Cytology Technical Specialist



Cell blocks from Cytopathology samples have always had value in the diagnostic process as a complement to the traditional Cytopathology stains – Papanicolaou and Romanowsky.  This has become more important to provide material for Immunocytochemistry to refine malignant diagnosis, and more recently, for the use of molecular testing to aid in the choice of tailored chemotherapy regimens.  If this information can be obtained from Cytopathology samples, which are less invasive than biopsy samples, the patient will benefit.A variety of preparation methods are available for the preparation of cell blocks from cells from Diagnostic Cytopathology samples.  The most popular methods will be discussed and how they can be used to optimise the quality of cell preservation if used correctly.Information garnered from the results of the recently introduced UK NEQAS CPT Diagnostic Cytopathology Cell block scheme will be presented and how this information can be circulated to laboratories experiencing difficulties with their preparation methods as an advisory service. This will include.• Understanding the clinical importance and diagnostic purpose of correct procedures in Diagnostic Cytopathology Cell Block preparation.• Identifying and determining factors affecting best practice and quality in Diagnostic Cytopathology Cell Block practice and how to resolve them.• Identifying and understanding the causes of artefacts experienced in Diagnostic Cytopathology Cell Block preparation methods and how to eliminate and prevent them.
P11- Participating In A Digital Diagnostic Cytopathology Interpretive Proficiency Testing (iEQA) Scheme -Helen Naylor, Anna Patterson, Chantell Hodgson, Ashley Makela
The iLabXCell Digital Diagnostic Cytopathology Interpretive Proficiency Testing Scheme or iEQA is facilitated by UK NEQAS Cellular Pathology Technique (CPT), and is designed to promote quality, excellence, and education for all involved in screening and reporting of Diagnostic Cytopathology. It is open to medical and non-medical staff, trainees, advanced practitioners, and staff associated with Cytopathology. iEQA provides superior, outstanding, and representative case examples for individuals to examine in a remote setting and submit an opinion via the user-friendly digital platform. Offering 2 circulations annually it provides• Easy access for registration • Ability to choose specimen types • Advanced slide viewing• Clinical details to assist diagnoses• Categorisation of images using benign or malignant 
FlexibilityRemote learning allows participants to continue learning alongside their peers, in an environment accommodating their needs. It allows the flexibility of international participants to access the platform at any time, convenient to them. Remote learning via the iEQA platform, offers the flexibility for users to pick up learning where they left it – anywhere, anytime, from any location.Self-paced learningTraditional learning has long failed to acknowledge the individualised nature of learning, opting instead for a generalised approach that may not be optimised for everyone. One of the many benefits of this iEQA is providing participants more independence to:• Spend more time on cases/case types they find difficult• Revisit the images as often as they need 
Environmental benefitsDigitising slides has led to a decrease in physical resources previously necessary for iEQA to function. Everything participants need is accessible on-line, eliminating the historical environmental impact and the time taken for circulations to be distributed and completed.  
Future developmentsAn on-line educational image library, containing images of Diagnostic Cytopathology cases of urines, serous fluids, respiratory and head and neck cases used in previous circulations fo]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>348</itunes:duration>
                <itunes:episode>162</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>NSH Poster Podcast: P06/ P15 (2024)</title>
        <itunes:title>NSH Poster Podcast: P06/ P15 (2024)</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p06-p15/</link>
                    <comments>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p06-p15/#comments</comments>        <pubDate>Fri, 06 Dec 2024 22:47:00 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/204b8c2e-7a76-38fd-8d56-e0d9cfacda44</guid>
                                    <description><![CDATA[



<p>P06-Understanding the Quality of your Electron Microscopy Provider in this Era of Outsourcing of Services- Tracey de Haro MSc, FIBMS, UK NEQAS CPT TEM Scheme Coordinator Specialist Scientific Lead for Electron Microscopy University Hospitals Of Leicester NHS Trust, UK </p>




<p>Background
Electron Microscopy (EM) remains vital to the diagnostic repertoire for the diagnosis of pathologies. Surveys of diagnostic TEM units in the UK were carried out in 2012, in 2019 (unpublished) and is currently being repeated. These surveys showed that a large amount of EM is now outsourced to units away from the originating trust.</p>
<p>Whether UK or globally, when pathology departments are looking for a supplier of diagnostic EM services, the only
questions they ask of the EM units are “how much does it cost” and “what is your turnaround time?” Are these the only relevant questions to ask?
Considerations</p>
<p>The following relevant issues should be considered alongside cost and speed;
The technical quality of an electron microscopy service;</p>
<p>Can the EM unit produce good quality sections and images that maximizes the chances of observing relevant pathologies?
Data from UK NEQAS CPT show that only 50% of EM units participating in the diagnostic TEM scheme
achieve excellent scores of 9 or 10 out of 102 not achieving excellent quality could potentially compromise a diagnosis.
The knowledge the staff have of ultrastructural pathology
• Do the staff assessing your samples know what to look for? Having proof of EM staff’s knowledge in ultrastructural
pathology is essential when relying on them to provide relevant images and a considered report on features seen
or not seen.</p>
<p>Questions to Ask Your EM Provider
To ensure that the EM service you are sending your samples to is ‘fit for purpose’, you should not only consider the speed and cost of the service but also;
• Ensure that your potential provider is accredited to ISO 15189 standards.
• Ask for evidence of participation in an EQA scheme specifically for technical TEM.
• Ask for TEM EQA results over the past 12 months and ensure they are consistently achieving excellent marks.
• Do the EM staff participate in regular knowledge and competence competency review specifically for TEM
and ultrastructural assessment?
• How much experience of ultrastructural pathology do the members of staff examining your samples have
and do they have any qualifications in this area?
• Get endorsements from other users of the EM service to evidence the quality of work offered.</p>
<p>Summary</p>
<p>Access to EM services remains vital across the globe, but in the UK is increasingly being outsourced to units remote from the originating trust. In this case, the pathologist is reliant on the images and ultrastructural report being accurate to inform diagnosis.
To ensure accuracy, the EM unit, whether they be UK based or part of our international community, all should participate in a quality EQA scheme and all staff should be experienced and have access to training to ensure
they are educated to a high level in ultrastructural pathology.
Without this, the referring trust cannot be guaranteed the service they are paying for is fit for purpose.</p>




<p>P15-Understanding the Quality of your Electron Microscopy Provider in this Era of Outsourcing of Services: How does a Technical EQA Scheme Add Value? -Tracey de Haro MSc, FIBMS, UK NEQAS CPT TEM Scheme Coordinator Specialist Scientific Lead for Electron Microscopy University Hospitals Of Leicester NHS Trust, UK</p>
<p>Background
Benefit of Participation in an EQA Scheme 
Summary
The Transmission Electron Microscopy (TEM) Scheme was developed in 2018 as a means of assessing the quality of the final output of diagnostic TEM Units against a defined assessment standard. The aim of this EQA scheme is to allow EM units to have their work regularly assessed and measured against other TEM units in an anonymous and supportive manner. This ensures that results are reliable and comparable no matter where
they are performed. Education in technical aspects of the TEM process is also offered as a knowledge and competence exercise as part of each EQA assessment.</p>
<p>EQY Scheme Organization</p>
<p>TEM scheme Participants are asked to submit 4 digital images from each of 2 contrasted TEM cases. There are 6 EQA assessment runs per year. Specific tissue types for each case are requested for each assessment run. Renal cases are requested for each run as case 1 and muscle or nerve are requested in rotation for case 2. However alternative tissue types can be submitted for either case if participants do not
examine those tissue types.</p>
<p>Details of technical fixation, processing and imaging for each case are required to be submitted as part of Data Entry. This allows generation of ‘best method’ reports for high achieving EQA scores to be issued to Participants. Each image is anonymously assessed against the defined assessment  criteria by a pair of expert peer assessors. Each assessor will award a score out of 5 giving a total score for each image out of 10.</p>
<p>Participants receive the following for each run;</p>
<p>• EM Individualized report detailing the scores awarded for each image, along with information about where marks were lost and why
• EM best method report detailing methods that achieved high scores
• EM image report giving examples of images that achieved a range of scores from the maximum score to low scoring images, along with why those scores were allocated </p>
<p>Summary
Participation in a technical TEM EQA scheme provides factual information that can also be used to advertise and promote an EM unit as providing a proven quality service.  Whilst being participating in an educational exercise within each EQA assessment, allows individual and laboratory knowledge and competence to be assess and demonstrated.

Evidencing your EM unit provides a high quality, gold standard service is vital when diagnostic electron microscopy is often being outsourced to external EM units. Cost of service and turn round times for results are often asked, but quality of work for diagnostic results
should also be considered. Consistency of technical quality is important to ensure pathologists receive high quality diagnostic information.
This mitigates against misinterpretation from poor quality images, assuring a safe, accurate diagnosis. This is good
news for the participating EM units, good news for the diagnostic process and ultimately, good news for patients.</p>
<p> </p>



]]></description>
                                                            <content:encoded><![CDATA[



<p>P06-Understanding the Quality of your Electron Microscopy Provider in this Era of Outsourcing of Services- <em>Tracey de Haro MSc, FIBMS, UK NEQAS CPT TEM Scheme Coordinator </em><em>Specialist Scientific Lead for Electron Microscopy </em><em>University Hospitals Of Leicester NHS Trust, UK</em> </p>




<p>Background<br>
Electron Microscopy (EM) remains vital to the diagnostic repertoire for the diagnosis of pathologies. Surveys of diagnostic TEM units in the UK were carried out in 2012, in 2019 (unpublished) and is currently being repeated. These surveys showed that a large amount of EM is now outsourced to units away from the originating trust.</p>
<p>Whether UK or globally, when pathology departments are looking for a supplier of diagnostic EM services, the only<br>
questions they ask of the EM units are “how much does it cost” and “what is your turnaround time?” Are these the only relevant questions to ask?<br>
Considerations</p>
<p>The following relevant issues should be considered alongside cost and speed;<br>
The technical quality of an electron microscopy service;</p>
<p>Can the EM unit produce good quality sections and images that maximizes the chances of observing relevant pathologies?<br>
Data from UK NEQAS CPT show that only 50% of EM units participating in the diagnostic TEM scheme<br>
achieve excellent scores of 9 or 10 out of 102 not achieving excellent quality could potentially compromise a diagnosis.<br>
The knowledge the staff have of ultrastructural pathology<br>
• Do the staff assessing your samples know what to look for? Having proof of EM staff’s knowledge in ultrastructural<br>
pathology is essential when relying on them to provide relevant images and a considered report on features seen<br>
or not seen.</p>
<p>Questions to Ask Your EM Provider<br>
To ensure that the EM service you are sending your samples to is ‘fit for purpose’, you should not only consider the speed and cost of the service but also;<br>
• Ensure that your potential provider is accredited to ISO 15189 standards.<br>
• Ask for evidence of participation in an EQA scheme specifically for technical TEM.<br>
• Ask for TEM EQA results over the past 12 months and ensure they are consistently achieving excellent marks.<br>
• Do the EM staff participate in regular knowledge and competence competency review specifically for TEM<br>
and ultrastructural assessment?<br>
• How much experience of ultrastructural pathology do the members of staff examining your samples have<br>
and do they have any qualifications in this area?<br>
• Get endorsements from other users of the EM service to evidence the quality of work offered.</p>
<p>Summary</p>
<p>Access to EM services remains vital across the globe, but in the UK is increasingly being outsourced to units remote from the originating trust. In this case, the pathologist is reliant on the images and ultrastructural report being accurate to inform diagnosis.<br>
To ensure accuracy, the EM unit, whether they be UK based or part of our international community, all should participate in a quality EQA scheme and all staff should be experienced and have access to training to ensure<br>
they are educated to a high level in ultrastructural pathology.<br>
Without this, the referring trust cannot be guaranteed the service they are paying for is fit for purpose.</p>




<p>P15-Understanding the Quality of your Electron Microscopy Provider in this Era of Outsourcing of Services: How does a Technical EQA Scheme Add Value? -Tracey de Haro MSc, FIBMS, UK NEQAS CPT TEM Scheme Coordinator Specialist Scientific Lead for Electron Microscopy University Hospitals Of Leicester NHS Trust, UK</p>
<p>Background<br>
Benefit of Participation in an EQA Scheme <br>
Summary<br>
The Transmission Electron Microscopy (TEM) Scheme was developed in 2018 as a means of assessing the quality of the final output of diagnostic TEM Units against a defined assessment standard. The aim of this EQA scheme is to allow EM units to have their work regularly assessed and measured against other TEM units in an anonymous and supportive manner. This ensures that results are reliable and comparable no matter where<br>
they are performed. Education in technical aspects of the TEM process is also offered as a knowledge and competence exercise as part of each EQA assessment.</p>
<p>EQY Scheme Organization</p>
<p>TEM scheme Participants are asked to submit 4 digital images from each of 2 contrasted TEM cases. There are 6 EQA assessment runs per year. Specific tissue types for each case are requested for each assessment run. Renal cases are requested for each run as case 1 and muscle or nerve are requested in rotation for case 2. However alternative tissue types can be submitted for either case if participants do not<br>
examine those tissue types.</p>
<p>Details of technical fixation, processing and imaging for each case are required to be submitted as part of Data Entry. This allows generation of ‘best method’ reports for high achieving EQA scores to be issued to Participants. Each image is anonymously assessed against the defined assessment  criteria by a pair of expert peer assessors. Each assessor will award a score out of 5 giving a total score for each image out of 10.</p>
<p>Participants receive the following for each run;</p>
<p>• EM Individualized report detailing the scores awarded for each image, along with information about where marks were lost and why<br>
• EM best method report detailing methods that achieved high scores<br>
• EM image report giving examples of images that achieved a range of scores from the maximum score to low scoring images, along with why those scores were allocated </p>
<p>Summary<br>
Participation in a technical TEM EQA scheme provides factual information that can also be used to advertise and promote an EM unit as providing a proven quality service.  Whilst being participating in an educational exercise within each EQA assessment, allows individual and laboratory knowledge and competence to be assess and demonstrated.<br>
<br>
Evidencing your EM unit provides a high quality, gold standard service is vital when diagnostic electron microscopy is often being outsourced to external EM units. Cost of service and turn round times for results are often asked, but quality of work for diagnostic results<br>
should also be considered. Consistency of technical quality is important to ensure pathologists receive high quality diagnostic information.<br>
This mitigates against misinterpretation from poor quality images, assuring a safe, accurate diagnosis. This is good<br>
news for the participating EM units, good news for the diagnostic process and ultimately, good news for patients.</p>
<p> </p>



]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fumyq262didixtww/P06P15_Final.mp3" length="16920076" type="audio/mpeg"/>
        <itunes:summary><![CDATA[



P06-Understanding the Quality of your Electron Microscopy Provider in this Era of Outsourcing of Services- Tracey de Haro MSc, FIBMS, UK NEQAS CPT TEM Scheme Coordinator Specialist Scientific Lead for Electron Microscopy University Hospitals Of Leicester NHS Trust, UK 




BackgroundElectron Microscopy (EM) remains vital to the diagnostic repertoire for the diagnosis of pathologies. Surveys of diagnostic TEM units in the UK were carried out in 2012, in 2019 (unpublished) and is currently being repeated. These surveys showed that a large amount of EM is now outsourced to units away from the originating trust.
Whether UK or globally, when pathology departments are looking for a supplier of diagnostic EM services, the onlyquestions they ask of the EM units are “how much does it cost” and “what is your turnaround time?” Are these the only relevant questions to ask?Considerations
The following relevant issues should be considered alongside cost and speed;The technical quality of an electron microscopy service;
Can the EM unit produce good quality sections and images that maximizes the chances of observing relevant pathologies?Data from UK NEQAS CPT show that only 50% of EM units participating in the diagnostic TEM schemeachieve excellent scores of 9 or 10 out of 102 not achieving excellent quality could potentially compromise a diagnosis.The knowledge the staff have of ultrastructural pathology• Do the staff assessing your samples know what to look for? Having proof of EM staff’s knowledge in ultrastructuralpathology is essential when relying on them to provide relevant images and a considered report on features seenor not seen.
Questions to Ask Your EM ProviderTo ensure that the EM service you are sending your samples to is ‘fit for purpose’, you should not only consider the speed and cost of the service but also;• Ensure that your potential provider is accredited to ISO 15189 standards.• Ask for evidence of participation in an EQA scheme specifically for technical TEM.• Ask for TEM EQA results over the past 12 months and ensure they are consistently achieving excellent marks.• Do the EM staff participate in regular knowledge and competence competency review specifically for TEMand ultrastructural assessment?• How much experience of ultrastructural pathology do the members of staff examining your samples haveand do they have any qualifications in this area?• Get endorsements from other users of the EM service to evidence the quality of work offered.
Summary
Access to EM services remains vital across the globe, but in the UK is increasingly being outsourced to units remote from the originating trust. In this case, the pathologist is reliant on the images and ultrastructural report being accurate to inform diagnosis.To ensure accuracy, the EM unit, whether they be UK based or part of our international community, all should participate in a quality EQA scheme and all staff should be experienced and have access to training to ensurethey are educated to a high level in ultrastructural pathology.Without this, the referring trust cannot be guaranteed the service they are paying for is fit for purpose.




P15-Understanding the Quality of your Electron Microscopy Provider in this Era of Outsourcing of Services: How does a Technical EQA Scheme Add Value? -Tracey de Haro MSc, FIBMS, UK NEQAS CPT TEM Scheme Coordinator Specialist Scientific Lead for Electron Microscopy University Hospitals Of Leicester NHS Trust, UK
BackgroundBenefit of Participation in an EQA Scheme SummaryThe Transmission Electron Microscopy (TEM) Scheme was developed in 2018 as a means of assessing the quality of the final output of diagnostic TEM Units against a defined assessment standard. The aim of this EQA scheme is to allow EM units to have their work regularly assessed and measured against other TEM units in an anonymous and supportive manner. This ensures that results are reliable and comparable no matter wherethey are performed. Education in techn]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>422</itunes:duration>
                <itunes:episode>161</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>NSH Poster Podcast: P37 (2024)</title>
        <itunes:title>NSH Poster Podcast: P37 (2024)</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p37-2024-1733456944/</link>
                    <comments>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p37-2024-1733456944/#comments</comments>        <pubDate>Fri, 06 Dec 2024 22:44:00 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/c817a8ef-930b-3ffd-9d4b-eb0de6e76fbf</guid>
                                    <description><![CDATA[<p>Research Requires Flexibility: Protease-Free Permeabilization Expands FISH Tissue Applications.-Andrelie Branicky, Shared Laboratory Resources, Lerner Research Institute, Cleveland Clinic, Cleveland, OH</p>
<p>Fluorescence in situ hybridization (FISH) visualizes the presence of a specific DNA or RNA sequence in a tissue sample or cell. This method, particularly the mRNA version, detects gene expression when protein might not be present or IHC is impossible. FISH combined with immunohistochemistry enables spatial transcriptomics, which provides significantly more information about the tissue microenvironment.</p>
<p>Formalin-fixed paraffin-embedded (FFPE) tissues are the standard for tissue preservation in the clinical world. Most commercial mRNA probe and amplification systems are built around the model of FFPE tissue that can withstand harsh protease permeabilization. In the research world, tissues are fixed in different fixatives for varying times; all at the discretion of the investigator instead of an organization like the CLIA. </p>
<p>Given the wide range of tissue preparations, the HCR automated FISH-ISH protease-free program provides the flexibility to combine  FISH and fluorescent immunohistochemistry on tissue fixed in a variety of ways such as: 10% NBF, Histochoice (a glyoxal-based fixative), and methanol/acetic acid, with only minor changes to the basic protocol. Additionally, the lack of harsh protease pre-treatment maintains tissue integrity and morphology for staining and imaging. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Research Requires Flexibility: Protease-Free Permeabilization Expands FISH Tissue Applications.-<em>Andrelie Branicky, Shared Laboratory Resources, Lerner Research Institute, Cleveland Clinic, Cleveland, OH</em></p>
<p>Fluorescence in situ hybridization (FISH) visualizes the presence of a specific DNA or RNA sequence in a tissue sample or cell. This method, particularly the mRNA version, detects gene expression when protein might not be present or IHC is impossible. FISH combined with immunohistochemistry enables spatial transcriptomics, which provides significantly more information about the tissue microenvironment.</p>
<p>Formalin-fixed paraffin-embedded (FFPE) tissues are the standard for tissue preservation in the clinical world. Most commercial mRNA probe and amplification systems are built around the model of FFPE tissue that can withstand harsh protease permeabilization. In the research world, tissues are fixed in different fixatives for varying times; all at the discretion of the investigator instead of an organization like the CLIA. </p>
<p>Given the wide range of tissue preparations, the HCR automated FISH-ISH protease-free program provides the flexibility to combine  FISH and fluorescent immunohistochemistry on tissue fixed in a variety of ways such as: 10% NBF, Histochoice (a glyoxal-based fixative), and methanol/acetic acid, with only minor changes to the basic protocol. Additionally, the lack of harsh protease pre-treatment maintains tissue integrity and morphology for staining and imaging. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3y99c2/P37_Final.mp3" length="12773921" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Research Requires Flexibility: Protease-Free Permeabilization Expands FISH Tissue Applications.-Andrelie Branicky, Shared Laboratory Resources, Lerner Research Institute, Cleveland Clinic, Cleveland, OH
Fluorescence in situ hybridization (FISH) visualizes the presence of a specific DNA or RNA sequence in a tissue sample or cell. This method, particularly the mRNA version, detects gene expression when protein might not be present or IHC is impossible. FISH combined with immunohistochemistry enables spatial transcriptomics, which provides significantly more information about the tissue microenvironment.
Formalin-fixed paraffin-embedded (FFPE) tissues are the standard for tissue preservation in the clinical world. Most commercial mRNA probe and amplification systems are built around the model of FFPE tissue that can withstand harsh protease permeabilization. In the research world, tissues are fixed in different fixatives for varying times; all at the discretion of the investigator instead of an organization like the CLIA. 
Given the wide range of tissue preparations, the HCR automated FISH-ISH protease-free program provides the flexibility to combine  FISH and fluorescent immunohistochemistry on tissue fixed in a variety of ways such as: 10% NBF, Histochoice (a glyoxal-based fixative), and methanol/acetic acid, with only minor changes to the basic protocol. Additionally, the lack of harsh protease pre-treatment maintains tissue integrity and morphology for staining and imaging. ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>319</itunes:duration>
                <itunes:episode>160</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>NSH Poster Podcast: P35 (2024)</title>
        <itunes:title>NSH Poster Podcast: P35 (2024)</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p35-2024/</link>
                    <comments>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p35-2024/#comments</comments>        <pubDate>Fri, 06 Dec 2024 22:40:00 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/3cf511b5-58fa-35d1-9c83-21b7b0396e2a</guid>
                                    <description><![CDATA[<p>The Development of a Cocktail of Microglia and GFAP For Easy Diagnosis - Anisha Bhasin B.S, Sarah Holguin, MBA. B.S, Joe Vargas, M.S</p>



Microglia and GFAP are distinct neural markers, typically used separately to diagnose the degree of neurological infection and injury. Microglia, a glial cell, is used in the immune response of the central nervous system. GFAP is an astrocyte marker; astrocytes provide structural support and make up the blood-brain barrier. Using the two in conjugation with one another would prove to be an efficient diagnostic tool. A cocktail was constructed with optimal titration to observe the two markers in unison. In clinical usage, it will provide an efficient diagnosis of chronic inflammatory conditions of the central nervous system. The staining was conducted in IHC and fluorescence to compare morphology and count. Due to anatomical similarities, there tends to be morphological confusion between microglia and GFAP. However, when stained in conjunction with one another, notable differences can allow for easy distinction. This is why a cocktail run with a dual staining technique would be a superior diagnostic tool in comparison to testing the two markers independently.


]]></description>
                                                            <content:encoded><![CDATA[<p>The Development of a Cocktail of Microglia and GFAP For Easy Diagnosis - <em>Anisha Bhasin B.S, Sarah Holguin, MBA. B.S, Joe Vargas, M.S</em></p>



Microglia and GFAP are distinct neural markers, typically used separately to diagnose the degree of neurological infection and injury. Microglia, a glial cell, is used in the immune response of the central nervous system. GFAP is an astrocyte marker; astrocytes provide structural support and make up the blood-brain barrier. Using the two in conjugation with one another would prove to be an efficient diagnostic tool. A cocktail was constructed with optimal titration to observe the two markers in unison. In clinical usage, it will provide an efficient diagnosis of chronic inflammatory conditions of the central nervous system. The staining was conducted in IHC and fluorescence to compare morphology and count. Due to anatomical similarities, there tends to be morphological confusion between microglia and GFAP. However, when stained in conjunction with one another, notable differences can allow for easy distinction. This is why a cocktail run with a dual staining technique would be a superior diagnostic tool in comparison to testing the two markers independently.


]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/axrt6sgccayjk5es/P35_Final.mp3" length="9877464" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The Development of a Cocktail of Microglia and GFAP For Easy Diagnosis - Anisha Bhasin B.S, Sarah Holguin, MBA. B.S, Joe Vargas, M.S



Microglia and GFAP are distinct neural markers, typically used separately to diagnose the degree of neurological infection and injury. Microglia, a glial cell, is used in the immune response of the central nervous system. GFAP is an astrocyte marker; astrocytes provide structural support and make up the blood-brain barrier. Using the two in conjugation with one another would prove to be an efficient diagnostic tool. A cocktail was constructed with optimal titration to observe the two markers in unison. In clinical usage, it will provide an efficient diagnosis of chronic inflammatory conditions of the central nervous system. The staining was conducted in IHC and fluorescence to compare morphology and count. Due to anatomical similarities, there tends to be morphological confusion between microglia and GFAP. However, when stained in conjunction with one another, notable differences can allow for easy distinction. This is why a cocktail run with a dual staining technique would be a superior diagnostic tool in comparison to testing the two markers independently.


]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>246</itunes:duration>
                <itunes:episode>159</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>NSH Poster Podcast: P36 (2024)</title>
        <itunes:title>NSH Poster Podcast: P36 (2024)</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p37-2024/</link>
                    <comments>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p37-2024/#comments</comments>        <pubDate>Fri, 06 Dec 2024 22:34:00 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/fec76cfc-190c-33cd-bdc8-64681e40dfde</guid>
                                    <description><![CDATA[


Study tools for the histotechnologist (HTL) Histotechnician (HT) certification exam- Amber Moser1, BS, Hannah Benton1, BS, Taylor Wallace1, BS, and Elizabeth A. Chlipala1, BS, HTL(ASCP)QIHC Premier Labs, Longmont, CO






Histology laboratories have seen an increase in workplace shortages since the COVID-19 pandemic and an increase in noncertified applicants to fill open positions. The traditional route for histology certification is the completion of a histology education series with an accredited institution; however, there are many other routes to qualify for certification. With declines in histology program graduate numbers, and the change in work force after the COVID-19 pandemic, it is expected that nontechnical positions will continue to be filled by noncertified individuals. This may lead to an increase in alternative routes of certification, specifically through laboratory experience. 
These tools provide additional resources for individuals studying for the HT/HTL certification exams. They are catered to individuals without access to an accredited educational program. Information has been organized in ways that focus on areas that may be particularly difficult, information heavy or exam relevant. They utilize multiple learning modalities, specifically written, spoken, and visual information retrieval methods, with opportunities for auditory and group learning. They are also intended to be cost effective. Materials include laminated study templates, laminated scratch paper, flashcards, a slideshow for visual tissue assessment, and a general study topic list. Questions are both simple and complex, and representative of exam questions. It should be noted, however, that this is not a comprehensive study guide and is intended to be used in addition to an online study program or exam preparation course and textbook resources. These tools are incomplete guides which can be added to and personalized.



<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[


Study tools for the histotechnologist (HTL) Histotechnician (HT) certification exam-<em> Amber Moser1, BS, Hannah Benton1, BS, Taylor Wallace1, BS, and Elizabeth A. Chlipala1, BS, HTL(ASCP)QIHC Premier Labs, Longmont, CO</em>






Histology laboratories have seen an increase in workplace shortages since the COVID-19 pandemic and an increase in noncertified applicants to fill open positions. The traditional route for histology certification is the completion of a histology education series with an accredited institution; however, there are many other routes to qualify for certification. With declines in histology program graduate numbers, and the change in work force after the COVID-19 pandemic, it is expected that nontechnical positions will continue to be filled by noncertified individuals. This may lead to an increase in alternative routes of certification, specifically through laboratory experience. <br>
These tools provide additional resources for individuals studying for the HT/HTL certification exams. They are catered to individuals without access to an accredited educational program. Information has been organized in ways that focus on areas that may be particularly difficult, information heavy or exam relevant. They utilize multiple learning modalities, specifically written, spoken, and visual information retrieval methods, with opportunities for auditory and group learning. They are also intended to be cost effective. Materials include laminated study templates, laminated scratch paper, flashcards, a slideshow for visual tissue assessment, and a general study topic list. Questions are both simple and complex, and representative of exam questions. It should be noted, however, that this is not a comprehensive study guide and is intended to be used in addition to an online study program or exam preparation course and textbook resources. These tools are incomplete guides which can be added to and personalized.



<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3y99c2/P37_Final.mp3" length="12773921" type="audio/mpeg"/>
        <itunes:summary><![CDATA[


Study tools for the histotechnologist (HTL) Histotechnician (HT) certification exam- Amber Moser1, BS, Hannah Benton1, BS, Taylor Wallace1, BS, and Elizabeth A. Chlipala1, BS, HTL(ASCP)QIHC Premier Labs, Longmont, CO






Histology laboratories have seen an increase in workplace shortages since the COVID-19 pandemic and an increase in noncertified applicants to fill open positions. The traditional route for histology certification is the completion of a histology education series with an accredited institution; however, there are many other routes to qualify for certification. With declines in histology program graduate numbers, and the change in work force after the COVID-19 pandemic, it is expected that nontechnical positions will continue to be filled by noncertified individuals. This may lead to an increase in alternative routes of certification, specifically through laboratory experience. These tools provide additional resources for individuals studying for the HT/HTL certification exams. They are catered to individuals without access to an accredited educational program. Information has been organized in ways that focus on areas that may be particularly difficult, information heavy or exam relevant. They utilize multiple learning modalities, specifically written, spoken, and visual information retrieval methods, with opportunities for auditory and group learning. They are also intended to be cost effective. Materials include laminated study templates, laminated scratch paper, flashcards, a slideshow for visual tissue assessment, and a general study topic list. Questions are both simple and complex, and representative of exam questions. It should be noted, however, that this is not a comprehensive study guide and is intended to be used in addition to an online study program or exam preparation course and textbook resources. These tools are incomplete guides which can be added to and personalized.



 ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>319</itunes:duration>
                <itunes:episode>158</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>NSH Poster Podcast: P46 (2024)</title>
        <itunes:title>NSH Poster Podcast: P46 (2024)</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p46-2024/</link>
                    <comments>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p46-2024/#comments</comments>        <pubDate>Fri, 06 Dec 2024 22:31:00 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/9429a879-85d9-3ee9-be7f-ff4842544e62</guid>
                                    <description><![CDATA[


Somagen Method of Alcohol Reagent Tracking (SMART) Optimization to Realize Workflow Efficiencies within the Laboratory-Anne de Wolf, BSc MLT Somagen Diagnostics, Edmonton, Alberta, Canada; Christine Chiu MLT Somagen Diagnostics, Toronto, Ontario, Canada; Annie Vallee Somagen Diagnostics, Montreal, Quebec, Canada; James Tang, BSc MLT Somagen Diagnostics, Edmonton, Alberta, Canada






Tissue processing in recent decades has changed without subsequent changes to reagent maintenance. Reagent maintenance protocols have been ‘Grandfathered down’ without consideration for the reagent quality and how this is related to tissue types and block numbers processed. The concentration of the last absolute alcohol station needs to be &gt;98 % to effectively remove water from tissue before clearing and paraffin infiltration.1, 2 Using the Eagle Eye Digital hydrometer can provide reagent quality information which could also provide potential downstream efficiencies to laboratory workflow and cost savings in labour and reagents.


]]></description>
                                                            <content:encoded><![CDATA[


Somagen Method of Alcohol Reagent Tracking (SMART) Optimization to Realize Workflow Efficiencies within the Laboratory-<em>Anne de Wolf, BSc MLT Somagen Diagnostics, Edmonton, Alberta, Canada; Christine Chiu MLT Somagen Diagnostics, Toronto, Ontario, Canada; Annie Vallee Somagen Diagnostics, Montreal, Quebec, Canada; James Tang, BSc MLT Somagen Diagnostics, Edmonton, Alberta, Canada</em>






Tissue processing in recent decades has changed without subsequent changes to reagent maintenance. Reagent maintenance protocols have been ‘Grandfathered down’ without consideration for the reagent quality and how this is related to tissue types and block numbers processed. The concentration of the last absolute alcohol station needs to be &gt;98 % to effectively remove water from tissue before clearing and paraffin infiltration.1, 2 Using the Eagle Eye Digital hydrometer can provide reagent quality information which could also provide potential downstream efficiencies to laboratory workflow and cost savings in labour and reagents.


]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/aiuu7c3bbq2nt5bi/P46_Final.mp3" length="9490852" type="audio/mpeg"/>
        <itunes:summary><![CDATA[


Somagen Method of Alcohol Reagent Tracking (SMART) Optimization to Realize Workflow Efficiencies within the Laboratory-Anne de Wolf, BSc MLT Somagen Diagnostics, Edmonton, Alberta, Canada; Christine Chiu MLT Somagen Diagnostics, Toronto, Ontario, Canada; Annie Vallee Somagen Diagnostics, Montreal, Quebec, Canada; James Tang, BSc MLT Somagen Diagnostics, Edmonton, Alberta, Canada






Tissue processing in recent decades has changed without subsequent changes to reagent maintenance. Reagent maintenance protocols have been ‘Grandfathered down’ without consideration for the reagent quality and how this is related to tissue types and block numbers processed. The concentration of the last absolute alcohol station needs to be &gt;98 % to effectively remove water from tissue before clearing and paraffin infiltration.1, 2 Using the Eagle Eye Digital hydrometer can provide reagent quality information which could also provide potential downstream efficiencies to laboratory workflow and cost savings in labour and reagents.


]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>237</itunes:duration>
                <itunes:episode>157</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>NSH Poster Podcase: P54 (2024)</title>
        <itunes:title>NSH Poster Podcase: P54 (2024)</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/nsh-poster-podcase-p54-2024/</link>
                    <comments>https://nshpodcasts.podbean.com/e/nsh-poster-podcase-p54-2024/#comments</comments>        <pubDate>Fri, 06 Dec 2024 22:24:00 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/438becc8-3db0-3fe1-a6be-6f12e00ce6a2</guid>
                                    <description><![CDATA[


Method for FFPE Organ-Chip -Lindsay Parmelee HTL(ASCP) 1,2,3, Stephanie Pei Tung Yiu PhD 1,2,3,4, Chi Ngai Chan PhD 1,2,3, Sizun Jiang PhD 1,2,31 Center for Virology and Vaccine Research 2 Beth Israel Deaconess Medical Center 3 Harvard Medical School 4 Wyss Institute






Organoids are currently being developed for applications in biomedicine such as drug development and disease research. With many organoid models emerging on the market there is growing need to develop methods to adapt organoids to the established work flows and assays that are the foundations of modern research.  A method was developed for processing, embedding, and sectioning Organ-Chips for FFPE workflows. Organ-Chips were treated with Histogel and trimmed to fit standard sized cassettes. Followed by processing and embedding as usual before proceeding to the microtome. The resulting slides have successfully been stained with hematoxylin and eosin and immunohistochemistry, as well as shown promising results for use on multiplexing platforms. Although the process is laborious and requires continued refinement the slides should be sufficient for highplex proteomics and transcriptomics methods and can be used in addition to FFPE tissues for research into immunology, oncology, and virology.


]]></description>
                                                            <content:encoded><![CDATA[


Method for FFPE Organ-Chip -<em>Lindsay Parmelee HTL(ASCP) 1,2,3, Stephanie Pei Tung Yiu PhD 1,2,3,4, Chi Ngai Chan PhD 1,2,3, Sizun Jiang PhD 1,2,31 Center for Virology and Vaccine Research 2 Beth Israel Deaconess Medical Center 3 Harvard Medical School 4 Wyss Institute</em>






Organoids are currently being developed for applications in biomedicine such as drug development and disease research. With many organoid models emerging on the market there is growing need to develop methods to adapt organoids to the established work flows and assays that are the foundations of modern research.  A method was developed for processing, embedding, and sectioning Organ-Chips for FFPE workflows. Organ-Chips were treated with Histogel and trimmed to fit standard sized cassettes. Followed by processing and embedding as usual before proceeding to the microtome. The resulting slides have successfully been stained with hematoxylin and eosin and immunohistochemistry, as well as shown promising results for use on multiplexing platforms. Although the process is laborious and requires continued refinement the slides should be sufficient for highplex proteomics and transcriptomics methods and can be used in addition to FFPE tissues for research into immunology, oncology, and virology.


]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fwn8a2eya77dtxi3/P54_Final.mp3" length="5707276" type="audio/mpeg"/>
        <itunes:summary><![CDATA[


Method for FFPE Organ-Chip -Lindsay Parmelee HTL(ASCP) 1,2,3, Stephanie Pei Tung Yiu PhD 1,2,3,4, Chi Ngai Chan PhD 1,2,3, Sizun Jiang PhD 1,2,31 Center for Virology and Vaccine Research 2 Beth Israel Deaconess Medical Center 3 Harvard Medical School 4 Wyss Institute






Organoids are currently being developed for applications in biomedicine such as drug development and disease research. With many organoid models emerging on the market there is growing need to develop methods to adapt organoids to the established work flows and assays that are the foundations of modern research.  A method was developed for processing, embedding, and sectioning Organ-Chips for FFPE workflows. Organ-Chips were treated with Histogel and trimmed to fit standard sized cassettes. Followed by processing and embedding as usual before proceeding to the microtome. The resulting slides have successfully been stained with hematoxylin and eosin and immunohistochemistry, as well as shown promising results for use on multiplexing platforms. Although the process is laborious and requires continued refinement the slides should be sufficient for highplex proteomics and transcriptomics methods and can be used in addition to FFPE tissues for research into immunology, oncology, and virology.


]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>142</itunes:duration>
                <itunes:episode>156</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>NSH Poster Podcast: P51 (2024)</title>
        <itunes:title>NSH Poster Podcast: P51 (2024)</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p51-2024/</link>
                    <comments>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p51-2024/#comments</comments>        <pubDate>Fri, 06 Dec 2024 20:19:00 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/5c5d9168-f8b7-3780-a998-86f8d15f2cd2</guid>
                                    <description><![CDATA[


Assessing Adhesion Slide Performance Across Histology Applications -Colin Brewer, CellPath, Newtown, Wales; Rachel Finn, HTL, StatLab, McKinney, TX; Neil Haine, PhD, CellPath, Newtown, Wales; Arielle Hobson, StatLab, McKinney, TX; Moritz Kamphenkel, Knittel Glass, Braunschweig, Germany; Ronja-Melinda Komoll, Ph.D, Knittel Glass, Braunschweig, Germany; Racheal Moore, HT, StatLab, McKinney, TX; Nicole Romer, Knittel Glass, Braunschweig, Germany; Edeltraud Schikora, Knittel Glass, Braunschweig, Germany; Stefan Welsch, Knittel Glass, Braunschweig, Germany; Susan Willis, CellPath, Newtown, Wales



<p>Adhesion slides are widely preferred for IHC to aid in securing tissue sections to the slide and prevent reworks that could potentially postpone a patient diagnosis and drive-up costs in the lab. The cost of reworking a failed IHC slide due to poor tissue adhesion is estimated to be ~$80 per slide, considering the reagent cost and workload administration.1 Adhesion slides reinforce tissue adherence and integrity, minimizing the need to recut and restain the sample to ensure proper tissue morphological characteristics. Adhesion slides may also be used for H&amp;E stains and special stains for added adhesion, but could retain excess reagent, or background staining, on the slide. In this study the differences in contact angle and in tissue adherence during microtomy were analyzed,  investigation was done on whether different adhesion slides exhibit similar levels of background staining during histological staining procedures, and evaluation and comparison of the tissue adhesion properties of adhesion slide brands across different tissue types and applications was performed. 
After wide-ranging testing of adhesion slide characteristics, this study exhibited that not all adhesion slides are created equal. While water bath behavior showed to not be a relevant factor, there was considerable variation in background staining and tissue adhesion between slides. The results of this study suggested that it is important to determine what the needs are for your laboratory based on the types of staining done and tissue types used. It is also important to test adhesion slides to find the right slide or slides for your laboratory applications.</p>
]]></description>
                                                            <content:encoded><![CDATA[


Assessing Adhesion Slide Performance Across Histology Applications -<em>Colin Brewer, CellPath, Newtown, Wales; Rachel Finn, HTL, StatLab, McKinney, TX; Neil Haine, PhD, CellPath, Newtown, Wales; Arielle Hobson, StatLab, McKinney, TX; Moritz Kamphenkel, Knittel Glass, Braunschweig, Germany; Ronja-Melinda Komoll, Ph.D, Knittel Glass, Braunschweig, Germany; Racheal Moore, HT, StatLab, McKinney, TX; Nicole Romer, Knittel Glass, Braunschweig, Germany; Edeltraud Schikora, Knittel Glass, Braunschweig, Germany; Stefan Welsch, Knittel Glass, Braunschweig, Germany; Susan Willis, CellPath, Newtown, Wales</em>



<p>Adhesion slides are widely preferred for IHC to aid in securing tissue sections to the slide and prevent reworks that could potentially postpone a patient diagnosis and drive-up costs in the lab. The cost of reworking a failed IHC slide due to poor tissue adhesion is estimated to be ~$80 per slide, considering the reagent cost and workload administration.1 Adhesion slides reinforce tissue adherence and integrity, minimizing the need to recut and restain the sample to ensure proper tissue morphological characteristics. Adhesion slides may also be used for H&amp;E stains and special stains for added adhesion, but could retain excess reagent, or background staining, on the slide. In this study the differences in contact angle and in tissue adherence during microtomy were analyzed,  investigation was done on whether different adhesion slides exhibit similar levels of background staining during histological staining procedures, and evaluation and comparison of the tissue adhesion properties of adhesion slide brands across different tissue types and applications was performed. <br>
After wide-ranging testing of adhesion slide characteristics, this study exhibited that not all adhesion slides are created equal. While water bath behavior showed to not be a relevant factor, there was considerable variation in background staining and tissue adhesion between slides. The results of this study suggested that it is important to determine what the needs are for your laboratory based on the types of staining done and tissue types used. It is also important to test adhesion slides to find the right slide or slides for your laboratory applications.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nsjz8mv3maf4jh6h/P51_Final.mp3" length="9566085" type="audio/mpeg"/>
        <itunes:summary><![CDATA[


Assessing Adhesion Slide Performance Across Histology Applications -Colin Brewer, CellPath, Newtown, Wales; Rachel Finn, HTL, StatLab, McKinney, TX; Neil Haine, PhD, CellPath, Newtown, Wales; Arielle Hobson, StatLab, McKinney, TX; Moritz Kamphenkel, Knittel Glass, Braunschweig, Germany; Ronja-Melinda Komoll, Ph.D, Knittel Glass, Braunschweig, Germany; Racheal Moore, HT, StatLab, McKinney, TX; Nicole Romer, Knittel Glass, Braunschweig, Germany; Edeltraud Schikora, Knittel Glass, Braunschweig, Germany; Stefan Welsch, Knittel Glass, Braunschweig, Germany; Susan Willis, CellPath, Newtown, Wales



Adhesion slides are widely preferred for IHC to aid in securing tissue sections to the slide and prevent reworks that could potentially postpone a patient diagnosis and drive-up costs in the lab. The cost of reworking a failed IHC slide due to poor tissue adhesion is estimated to be ~$80 per slide, considering the reagent cost and workload administration.1 Adhesion slides reinforce tissue adherence and integrity, minimizing the need to recut and restain the sample to ensure proper tissue morphological characteristics. Adhesion slides may also be used for H&amp;E stains and special stains for added adhesion, but could retain excess reagent, or background staining, on the slide. In this study the differences in contact angle and in tissue adherence during microtomy were analyzed,  investigation was done on whether different adhesion slides exhibit similar levels of background staining during histological staining procedures, and evaluation and comparison of the tissue adhesion properties of adhesion slide brands across different tissue types and applications was performed. After wide-ranging testing of adhesion slide characteristics, this study exhibited that not all adhesion slides are created equal. While water bath behavior showed to not be a relevant factor, there was considerable variation in background staining and tissue adhesion between slides. The results of this study suggested that it is important to determine what the needs are for your laboratory based on the types of staining done and tissue types used. It is also important to test adhesion slides to find the right slide or slides for your laboratory applications.]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>239</itunes:duration>
                <itunes:episode>155</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>NSH Poster Podcast: P32 (2024)</title>
        <itunes:title>NSH Poster Podcast: P32 (2024)</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p32-2024/</link>
                    <comments>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p32-2024/#comments</comments>        <pubDate>Fri, 06 Dec 2024 20:13:00 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/748e2c8a-00f4-3ba2-85b5-02e48f05814f</guid>
                                    <description><![CDATA[<p>The Use of Immunohistochemistry vs. qPCR to Detect BRAFV600E in Thyroid Cancer- Kannitha Chek HTL (ASCP), Nicholas Hoo-Fatt, MS, HTL (ASCP), DP, Samantha Diamond, M.D., Haresh Mani, M.D., Myong Ho “Lucy” Nam, M.D.</p>



Introduction: This study aimed to validate the effectiveness of the Ventana anti-BRAFV600E antibody in detecting the BRAFV600E mutation in thyroid cancer using immunohistochemistry (IHC) as an initial screening test. The BRAFV600E mutation is a common genetic alteration in thyroid cancer, particularly papillary thyroid carcinoma (PTC), and detection is crucial for prognosis and treatment decisions. 

Methods: The research examined 12 thyroid cancer cases (11 PTC and 1 anaplastic thyroid carcinoma) and 12 non-cancerous thyroid cases. This study was conducted by using both the IHC BRAFV600E antibody as well as genetic testing methods including Next-Generation Sequencing (NGS) and the Biocartis Idylla rapid qPCR module for BRAF mutation. 

Results: The antibody successfully identified the BRAFV600E mutation in all cancer cases, aligning with results from other genetic testing methods, and as expected, non-cancerous cases showed no mutation-specific staining. The study highlighted important considerations in interpreting IHC results, such as the presence of non-specific brown staining due to colloid containing brown pigments in negative cases. It also emphasized the importance of proper tissue representation, as demonstrated by one case that initially lacked staining. While the research provides strong evidence for the accuracy of the Ventana anti-BRAFV600E antibody, it also identified limitations. The study lacked PTC cases negative for the BRAFV600E mutation, which would have provided a more comprehensive validation. 

Conclusion: The researchers suggest further investigation with a broader range of samples, including more anaplastic thyroid carcinoma cases and follicular variant of PTC, to explore potential correlations between tumor heterogeneity and staining intensity. This validation study contributes to improving thyroid cancer diagnosis and treatment by authenticating the reliability IHC methods in detecting a key genetic mutation. It also highlights the importance of continued research to optimize diagnostic methods in thyroid cancer.


]]></description>
                                                            <content:encoded><![CDATA[<p>The Use of Immunohistochemistry vs. qPCR to Detect BRAFV600E in Thyroid Cancer- <em>Kannitha Chek HTL (ASCP), Nicholas Hoo-Fatt, MS, HTL (ASCP), DP, Samantha Diamond, M.D., Haresh Mani, M.D., Myong Ho “Lucy” Nam, M.D.</em></p>



Introduction: This study aimed to validate the effectiveness of the Ventana anti-BRAFV600E antibody in detecting the BRAFV600E mutation in thyroid cancer using immunohistochemistry (IHC) as an initial screening test. The BRAFV600E mutation is a common genetic alteration in thyroid cancer, particularly papillary thyroid carcinoma (PTC), and detection is crucial for prognosis and treatment decisions. <br>
<br>
Methods: The research examined 12 thyroid cancer cases (11 PTC and 1 anaplastic thyroid carcinoma) and 12 non-cancerous thyroid cases. This study was conducted by using both the IHC BRAFV600E antibody as well as genetic testing methods including Next-Generation Sequencing (NGS) and the Biocartis Idylla rapid qPCR module for BRAF mutation. <br>
<br>
Results: The antibody successfully identified the BRAFV600E mutation in all cancer cases, aligning with results from other genetic testing methods, and as expected, non-cancerous cases showed no mutation-specific staining. The study highlighted important considerations in interpreting IHC results, such as the presence of non-specific brown staining due to colloid containing brown pigments in negative cases. It also emphasized the importance of proper tissue representation, as demonstrated by one case that initially lacked staining. While the research provides strong evidence for the accuracy of the Ventana anti-BRAFV600E antibody, it also identified limitations. The study lacked PTC cases negative for the BRAFV600E mutation, which would have provided a more comprehensive validation. <br>
<br>
Conclusion: The researchers suggest further investigation with a broader range of samples, including more anaplastic thyroid carcinoma cases and follicular variant of PTC, to explore potential correlations between tumor heterogeneity and staining intensity. This validation study contributes to improving thyroid cancer diagnosis and treatment by authenticating the reliability IHC methods in detecting a key genetic mutation. It also highlights the importance of continued research to optimize diagnostic methods in thyroid cancer.


]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/dx39qw/P32_Final.mp3" length="13999587" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The Use of Immunohistochemistry vs. qPCR to Detect BRAFV600E in Thyroid Cancer- Kannitha Chek HTL (ASCP), Nicholas Hoo-Fatt, MS, HTL (ASCP), DP, Samantha Diamond, M.D., Haresh Mani, M.D., Myong Ho “Lucy” Nam, M.D.



Introduction: This study aimed to validate the effectiveness of the Ventana anti-BRAFV600E antibody in detecting the BRAFV600E mutation in thyroid cancer using immunohistochemistry (IHC) as an initial screening test. The BRAFV600E mutation is a common genetic alteration in thyroid cancer, particularly papillary thyroid carcinoma (PTC), and detection is crucial for prognosis and treatment decisions. Methods: The research examined 12 thyroid cancer cases (11 PTC and 1 anaplastic thyroid carcinoma) and 12 non-cancerous thyroid cases. This study was conducted by using both the IHC BRAFV600E antibody as well as genetic testing methods including Next-Generation Sequencing (NGS) and the Biocartis Idylla rapid qPCR module for BRAF mutation. Results: The antibody successfully identified the BRAFV600E mutation in all cancer cases, aligning with results from other genetic testing methods, and as expected, non-cancerous cases showed no mutation-specific staining. The study highlighted important considerations in interpreting IHC results, such as the presence of non-specific brown staining due to colloid containing brown pigments in negative cases. It also emphasized the importance of proper tissue representation, as demonstrated by one case that initially lacked staining. While the research provides strong evidence for the accuracy of the Ventana anti-BRAFV600E antibody, it also identified limitations. The study lacked PTC cases negative for the BRAFV600E mutation, which would have provided a more comprehensive validation. Conclusion: The researchers suggest further investigation with a broader range of samples, including more anaplastic thyroid carcinoma cases and follicular variant of PTC, to explore potential correlations between tumor heterogeneity and staining intensity. This validation study contributes to improving thyroid cancer diagnosis and treatment by authenticating the reliability IHC methods in detecting a key genetic mutation. It also highlights the importance of continued research to optimize diagnostic methods in thyroid cancer.


]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>349</itunes:duration>
                <itunes:episode>154</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>NSH Poster Podcast: P17 (2024)</title>
        <itunes:title>NSH Poster Podcast: P17 (2024)</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p17-2024/</link>
                    <comments>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p17-2024/#comments</comments>        <pubDate>Fri, 06 Dec 2024 20:10:00 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/8e53d176-5a68-3a4e-ab91-9cb82cda7f85</guid>
                                    <description><![CDATA[<p>Whole NHP Brain Microtomy Technique- S Wessel, MS, HTL (ASCP),AskBio, Discovery 1, Morrisville, North Carolina T Marais, AskBio France, Paris Brain Institute (ICM), Paris, France
M Martini, PhD, PhD, AskBio, Discovery 1, Morrisville, North Carolina, M Faridounnia, PhD, MSc, AskBio, Discovery 1, Morrisville, North Carolina, D Gregorowicz, HTL (ASCP),AskBio, Discovery 1, Morrisville, North Carolina, L Haertel, HT (ASCP), AskBio, Discovery 1, Morrisville, North Carolina
M Hamilton, HTL (ASCP), AskBio, Discovery 1, Morrisville, North Carolina, M Vallucci, AskBio France, Paris Brain Institute (ICM), Paris, France ,S Alves, PhD, MSc, AskBio France, Paris Brain Institute (ICM), Paris, France, J Mysore, BVSc, MVSc, PhD, DACVP, AskBio, Discovery 1, Morrisville, North Carolina</p>



Preserving the integrity and conformation of capsid proteins, enzymes, and antigens while working with large tissue sections presents a “big” challenge in histology laboratories. With our Whole NHP (Non-Human Primate) Brain microtomy technique, we maintained a frozen NHP brain as a single piece while coronally sectioning through the entire cerebral hemispheres followed by cerebellum/brain stem. The brain remained frozen on a sliding microtome by utilizing a freezing stage and molds filled with powdered dry ice. As the brain was sectioned at 40um the molds were removed to uncover additional tissue for cutting until the tissue had been entirely sectioned. Serial pictures and an organized series of well plates were used to preserve anatomical order. By sectioning the brain as a whole and maintaining control over anatomical context we achieved results that may enhance the accuracy and thoroughness of histopathological examinations. Furthermore, serial sectioning of the Paraformaldehyde-fixed frozen brain preserved the antigenicity for various immunohistochemical assays. We believe this technique offered certain advantages over the routine paraffin-embedded sectioning method, especially for the biodistribution studies practiced during the developmental stage of gene therapies. 


]]></description>
                                                            <content:encoded><![CDATA[<p>Whole NHP Brain Microtomy Technique-<em> S Wessel, MS, HTL (ASCP),AskBio, Discovery 1, Morrisville, North Carolina T Marais, AskBio France, Paris Brain Institute (ICM), Paris, France</em><br>
<em>M Martini, PhD, PhD, AskBio, Discovery 1, Morrisville, North Carolina, M Faridounnia, PhD, MSc, AskBio, Discovery 1, Morrisville, North Carolina, D Gregorowicz, HTL (ASCP),AskBio, Discovery 1, Morrisville, North Carolina, L Haertel, HT (ASCP), AskBio, Discovery 1, Morrisville, North Carolina</em><br>
<em>M Hamilton, HTL (ASCP), AskBio, Discovery 1, Morrisville, North Carolina, M Vallucci, AskBio France, Paris Brain Institute (ICM), Paris, France ,S Alves, PhD, MSc, AskBio France, Paris Brain Institute (ICM), Paris, France, J Mysore, BVSc, MVSc, PhD, DACVP, AskBio, Discovery 1, Morrisville, North Carolina</em></p>



Preserving the integrity and conformation of capsid proteins, enzymes, and antigens while working with large tissue sections presents a “big” challenge in histology laboratories. With our Whole NHP (Non-Human Primate) Brain microtomy technique, we maintained a frozen NHP brain as a single piece while coronally sectioning through the entire cerebral hemispheres followed by cerebellum/brain stem. The brain remained frozen on a sliding microtome by utilizing a freezing stage and molds filled with powdered dry ice. As the brain was sectioned at 40um the molds were removed to uncover additional tissue for cutting until the tissue had been entirely sectioned. Serial pictures and an organized series of well plates were used to preserve anatomical order. By sectioning the brain as a whole and maintaining control over anatomical context we achieved results that may enhance the accuracy and thoroughness of histopathological examinations. Furthermore, serial sectioning of the Paraformaldehyde-fixed frozen brain preserved the antigenicity for various immunohistochemical assays. We believe this technique offered certain advantages over the routine paraffin-embedded sectioning method, especially for the biodistribution studies practiced during the developmental stage of gene therapies. 


]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jbegucqkcr5vkuwn/P17_Final.mp3" length="8114721" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Whole NHP Brain Microtomy Technique- S Wessel, MS, HTL (ASCP),AskBio, Discovery 1, Morrisville, North Carolina T Marais, AskBio France, Paris Brain Institute (ICM), Paris, FranceM Martini, PhD, PhD, AskBio, Discovery 1, Morrisville, North Carolina, M Faridounnia, PhD, MSc, AskBio, Discovery 1, Morrisville, North Carolina, D Gregorowicz, HTL (ASCP),AskBio, Discovery 1, Morrisville, North Carolina, L Haertel, HT (ASCP), AskBio, Discovery 1, Morrisville, North CarolinaM Hamilton, HTL (ASCP), AskBio, Discovery 1, Morrisville, North Carolina, M Vallucci, AskBio France, Paris Brain Institute (ICM), Paris, France ,S Alves, PhD, MSc, AskBio France, Paris Brain Institute (ICM), Paris, France, J Mysore, BVSc, MVSc, PhD, DACVP, AskBio, Discovery 1, Morrisville, North Carolina



Preserving the integrity and conformation of capsid proteins, enzymes, and antigens while working with large tissue sections presents a “big” challenge in histology laboratories. With our Whole NHP (Non-Human Primate) Brain microtomy technique, we maintained a frozen NHP brain as a single piece while coronally sectioning through the entire cerebral hemispheres followed by cerebellum/brain stem. The brain remained frozen on a sliding microtome by utilizing a freezing stage and molds filled with powdered dry ice. As the brain was sectioned at 40um the molds were removed to uncover additional tissue for cutting until the tissue had been entirely sectioned. Serial pictures and an organized series of well plates were used to preserve anatomical order. By sectioning the brain as a whole and maintaining control over anatomical context we achieved results that may enhance the accuracy and thoroughness of histopathological examinations. Furthermore, serial sectioning of the Paraformaldehyde-fixed frozen brain preserved the antigenicity for various immunohistochemical assays. We believe this technique offered certain advantages over the routine paraffin-embedded sectioning method, especially for the biodistribution studies practiced during the developmental stage of gene therapies. 


]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>202</itunes:duration>
                <itunes:episode>153</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>NSH Poster Podcast: P14 (2024)</title>
        <itunes:title>NSH Poster Podcast: P14 (2024)</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p14-2024/</link>
                    <comments>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p14-2024/#comments</comments>        <pubDate>Fri, 06 Dec 2024 20:01:00 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/82d23431-35c9-3d7c-903a-5169ce7987a4</guid>
                                    <description><![CDATA[


Encapsulated Cell Therapies in Sheep as a Translational Model - Trisha M. Fabijanic, B.S., University of Arizona, Tucson, AZ, Amy C. Kelly, Ph.D, University of Arizona, Tucson, AZ, Eliza H. Johnson, University of Arizona, Tucson, AZ, Delaney A. Drew, B.S., University of Arizona, Tucson, AZ, Demetri A. Vlachos, B.S., University of Arizona, Tucson, AZ, Charles W. Putnam, M.D., Ph.D., University of Arizona, Tucson, AZ, Sean W. Limesand, Ph.D., University of Arizona, Tucson, AZ, Klearchos K. Papas, Ph.D., University of Arizona, Tucson, AZ






Introduction:
Cell therapy has become increasingly studied for therapeutic use in drug delivery and regenerative medicine. Devices intended for implantation of cells require construction of membranes that can safely contain transplanted cells, provide a barrier to the host immune system and an outer vascularizing membrane to induce close vessel formation. Sheep make an excellent model because of their nearly comparable size, physiology, and disease profile with humans, as well as their docility, capacity for repeated blood draws, and ability to tolerate numerous implants during a single operation. In this study, sheep were implanted with devices containing allogeneic primary fetal sheep or xenogeneic Rat-2 fibroblasts to determine cell survival and immune response.

Methods:
Primary fetal sheep fibroblasts were isolated and cultured in RPMI. Rat-2 fibroblasts (ATCC) were cultured in DMEM. Cells were loaded into devices at different densities and transplanted subcutaneously. Sheep underwent allogeneic or xenogeneic transplantation with empty control and perforated devices transplanted as well. Devices were explanted at days 3, 7, 21 and 38 to evaluate host responses, vascularization, and cell survival through histological evaluation.

Results:
Sheep fibroblasts survived at different densities, confirming alloprotection with good vascularization and absence of a major foreign body response or extensive inflammation around the implants. Devices overloaded at the highest densities exhibited some host immune responses. Perforated devices exhibited a greater immune response that infiltrated the device. A robust immune response was seen around xenogeneic transplants with no encapsulated cells surviving.

Conclusion:
Sheep make a valuable translational animal model in cell therapy research. The results of this study concluded alloprotection in immunoisolating devices, allorejection in purposely perforated devices, and host immune response to xenogeneic transplantation, representing a feasible model for translational development of cell therapies. Future work will include continued allogeneic studies while avoiding xenogeneic rejection by incorporating immunomodulatory technologies.


]]></description>
                                                            <content:encoded><![CDATA[


Encapsulated Cell Therapies in Sheep as a Translational Model - <em>Trisha M. Fabijanic, B.S., University of Arizona, Tucson, AZ, Amy C. Kelly, Ph.D, University of Arizona, Tucson, AZ, Eliza H. Johnson, University of Arizona, Tucson, AZ, Delaney A. Drew, B.S., University of Arizona, Tucson, AZ, Demetri A. Vlachos, B.S., University of Arizona, Tucson, AZ, Charles W. Putnam, M.D., Ph.D., University of Arizona, Tucson, AZ, Sean W. Limesand, Ph.D., University of Arizona, Tucson, AZ, Klearchos K. Papas, Ph.D., University of Arizona, Tucson, AZ</em>






Introduction:<br>
Cell therapy has become increasingly studied for therapeutic use in drug delivery and regenerative medicine. Devices intended for implantation of cells require construction of membranes that can safely contain transplanted cells, provide a barrier to the host immune system and an outer vascularizing membrane to induce close vessel formation. Sheep make an excellent model because of their nearly comparable size, physiology, and disease profile with humans, as well as their docility, capacity for repeated blood draws, and ability to tolerate numerous implants during a single operation. In this study, sheep were implanted with devices containing allogeneic primary fetal sheep or xenogeneic Rat-2 fibroblasts to determine cell survival and immune response.<br>
<br>
Methods:<br>
Primary fetal sheep fibroblasts were isolated and cultured in RPMI. Rat-2 fibroblasts (ATCC) were cultured in DMEM. Cells were loaded into devices at different densities and transplanted subcutaneously. Sheep underwent allogeneic or xenogeneic transplantation with empty control and perforated devices transplanted as well. Devices were explanted at days 3, 7, 21 and 38 to evaluate host responses, vascularization, and cell survival through histological evaluation.<br>
<br>
Results:<br>
Sheep fibroblasts survived at different densities, confirming alloprotection with good vascularization and absence of a major foreign body response or extensive inflammation around the implants. Devices overloaded at the highest densities exhibited some host immune responses. Perforated devices exhibited a greater immune response that infiltrated the device. A robust immune response was seen around xenogeneic transplants with no encapsulated cells surviving.<br>
<br>
Conclusion:<br>
Sheep make a valuable translational animal model in cell therapy research. The results of this study concluded alloprotection in immunoisolating devices, allorejection in purposely perforated devices, and host immune response to xenogeneic transplantation, representing a feasible model for translational development of cell therapies. Future work will include continued allogeneic studies while avoiding xenogeneic rejection by incorporating immunomodulatory technologies.


]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/v836vx29izx9aynn/P14_Final.mp3" length="21128925" type="audio/mpeg"/>
        <itunes:summary><![CDATA[


Encapsulated Cell Therapies in Sheep as a Translational Model - Trisha M. Fabijanic, B.S., University of Arizona, Tucson, AZ, Amy C. Kelly, Ph.D, University of Arizona, Tucson, AZ, Eliza H. Johnson, University of Arizona, Tucson, AZ, Delaney A. Drew, B.S., University of Arizona, Tucson, AZ, Demetri A. Vlachos, B.S., University of Arizona, Tucson, AZ, Charles W. Putnam, M.D., Ph.D., University of Arizona, Tucson, AZ, Sean W. Limesand, Ph.D., University of Arizona, Tucson, AZ, Klearchos K. Papas, Ph.D., University of Arizona, Tucson, AZ






Introduction:Cell therapy has become increasingly studied for therapeutic use in drug delivery and regenerative medicine. Devices intended for implantation of cells require construction of membranes that can safely contain transplanted cells, provide a barrier to the host immune system and an outer vascularizing membrane to induce close vessel formation. Sheep make an excellent model because of their nearly comparable size, physiology, and disease profile with humans, as well as their docility, capacity for repeated blood draws, and ability to tolerate numerous implants during a single operation. In this study, sheep were implanted with devices containing allogeneic primary fetal sheep or xenogeneic Rat-2 fibroblasts to determine cell survival and immune response.Methods:Primary fetal sheep fibroblasts were isolated and cultured in RPMI. Rat-2 fibroblasts (ATCC) were cultured in DMEM. Cells were loaded into devices at different densities and transplanted subcutaneously. Sheep underwent allogeneic or xenogeneic transplantation with empty control and perforated devices transplanted as well. Devices were explanted at days 3, 7, 21 and 38 to evaluate host responses, vascularization, and cell survival through histological evaluation.Results:Sheep fibroblasts survived at different densities, confirming alloprotection with good vascularization and absence of a major foreign body response or extensive inflammation around the implants. Devices overloaded at the highest densities exhibited some host immune responses. Perforated devices exhibited a greater immune response that infiltrated the device. A robust immune response was seen around xenogeneic transplants with no encapsulated cells surviving.Conclusion:Sheep make a valuable translational animal model in cell therapy research. The results of this study concluded alloprotection in immunoisolating devices, allorejection in purposely perforated devices, and host immune response to xenogeneic transplantation, representing a feasible model for translational development of cell therapies. Future work will include continued allogeneic studies while avoiding xenogeneic rejection by incorporating immunomodulatory technologies.


]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>528</itunes:duration>
                <itunes:episode>152</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>NSH Poster Podcast: P12 (2024)</title>
        <itunes:title>NSH Poster Podcast: P12 (2024)</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p12-2024/</link>
                    <comments>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p12-2024/#comments</comments>        <pubDate>Fri, 06 Dec 2024 11:18:00 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/ac73b22a-c2cf-3221-98d6-d1426b77fbb6</guid>
                                    <description><![CDATA[<p>Cellular localization of the pink bollworm Cry1Ac Bt protein receptor PgCad1 in cultured insect cells</p>
<p>Authors: Melanie Miranda (BS, HTL- ASCP, University of Arizona-Comparative Pathology Core Laboratory, Tucson, AZ)
Jeff Fabrick (PhD, United States Department of Agriculture, Phoenix, AZ)
</p>
<p>Transgenic cotton genetically engineered to produce insecticidal proteins from the bacterium Bacillus thuringiensis (Bt) are used to manage insect pests, including the pink bollworm (Pectinophora gossypiella), a globally invasive pest of cotton. However, the evolution of resistance to Bt Cry proteins (Cry1Ac and Cry2Ab) by the pink bollworm in parts of Asia has reduced the effectiveness of Bt cotton. Several mutations in the midgut cadherin gene PgCad1 are genetically linked with the resistance of the Cry1Ac Bt toxin, which can result in disrupted cellular trafficking of the cadherin receptor to the surface of the midgut membrane and decrease toxin binding. Here, we established specialized insect histology and immunohistochemistry (IHC) protocols for reliable localization the PgCad1 receptor in cultured Tni insect cell lines. Such protocols may be useful for in situ localization of wild type PgCad1 and mutant variants in midgut cells of the pink bollworm.</p>
<p> </p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Cellular localization of the pink bollworm Cry1Ac Bt protein receptor PgCad1 in cultured insect cells</p>
<p><em>Authors: Melanie Miranda (BS, HTL- ASCP, University of Arizona-Comparative Pathology Core Laboratory, Tucson, AZ)<br>
Jeff Fabrick (PhD, United States Department of Agriculture, Phoenix, AZ)<br>
</em></p>
<p>Transgenic cotton genetically engineered to produce insecticidal proteins from the bacterium Bacillus thuringiensis (Bt) are used to manage insect pests, including the pink bollworm (Pectinophora gossypiella), a globally invasive pest of cotton. However, the evolution of resistance to Bt Cry proteins (Cry1Ac and Cry2Ab) by the pink bollworm in parts of Asia has reduced the effectiveness of Bt cotton. Several mutations in the midgut cadherin gene PgCad1 are genetically linked with the resistance of the Cry1Ac Bt toxin, which can result in disrupted cellular trafficking of the cadherin receptor to the surface of the midgut membrane and decrease toxin binding. Here, we established specialized insect histology and immunohistochemistry (IHC) protocols for reliable localization the PgCad1 receptor in cultured Tni insect cell lines. Such protocols may be useful for in situ localization of wild type PgCad1 and mutant variants in midgut cells of the pink bollworm.</p>
<p> </p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/956eekmyhkmmu6wr/P012_Part_16wife.mp3" length="5486803" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Cellular localization of the pink bollworm Cry1Ac Bt protein receptor PgCad1 in cultured insect cells
Authors: Melanie Miranda (BS, HTL- ASCP, University of Arizona-Comparative Pathology Core Laboratory, Tucson, AZ)Jeff Fabrick (PhD, United States Department of Agriculture, Phoenix, AZ)
Transgenic cotton genetically engineered to produce insecticidal proteins from the bacterium Bacillus thuringiensis (Bt) are used to manage insect pests, including the pink bollworm (Pectinophora gossypiella), a globally invasive pest of cotton. However, the evolution of resistance to Bt Cry proteins (Cry1Ac and Cry2Ab) by the pink bollworm in parts of Asia has reduced the effectiveness of Bt cotton. Several mutations in the midgut cadherin gene PgCad1 are genetically linked with the resistance of the Cry1Ac Bt toxin, which can result in disrupted cellular trafficking of the cadherin receptor to the surface of the midgut membrane and decrease toxin binding. Here, we established specialized insect histology and immunohistochemistry (IHC) protocols for reliable localization the PgCad1 receptor in cultured Tni insect cell lines. Such protocols may be useful for in situ localization of wild type PgCad1 and mutant variants in midgut cells of the pink bollworm.
 
 ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>137</itunes:duration>
                <itunes:episode>151</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Presenting at the NSH Convention: Our Histology Community is Amazing!</title>
        <itunes:title>Presenting at the NSH Convention: Our Histology Community is Amazing!</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/presenting-at-the-nsh-convention-our-histology-community-is-amazing/</link>
                    <comments>https://nshpodcasts.podbean.com/e/presenting-at-the-nsh-convention-our-histology-community-is-amazing/#comments</comments>        <pubDate>Thu, 04 Jan 2024 16:33:46 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/bfec2fae-c2ed-3b85-bb62-2ce76e386060</guid>
                                    <description><![CDATA[<p>2023 NSH co-presenters Gabriela De la Cruz and Lauren Ralph give great advice on selecting a topic and share why they decided to co-present at the 2023 NSH Convention. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>2023 NSH co-presenters Gabriela De la Cruz and Lauren Ralph give great advice on selecting a topic and share why they decided to co-present at the 2023 NSH Convention. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/zarrgk/CruzRalph_Advice.mp3" length="4327738" type="audio/mpeg"/>
        <itunes:summary><![CDATA[2023 NSH co-presenters Gabriela De la Cruz and Lauren Ralph give great advice on selecting a topic and share why they decided to co-present at the 2023 NSH Convention. ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>428</itunes:duration>
                <itunes:episode>150</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Presenting Advice for the NSH Convention: Just Do It!</title>
        <itunes:title>Presenting Advice for the NSH Convention: Just Do It!</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/presenting-advice-for-the-nsh-convention-just-do-it/</link>
                    <comments>https://nshpodcasts.podbean.com/e/presenting-advice-for-the-nsh-convention-just-do-it/#comments</comments>        <pubDate>Thu, 04 Jan 2024 15:28:45 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/0639784e-804f-3e59-8822-6188ee49555a</guid>
                                    <description><![CDATA[<p>NSH member Ariel (Ari) Liberda discusses her decision to present at the 2023 NSH Convention.  She shares her journey and advice to anyone who is considering taking the leap!</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>NSH member Ariel (Ari) Liberda discusses her decision to present at the 2023 NSH Convention.  She shares her journey and advice to anyone who is considering taking the leap!</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rp52tq/ALiberda_Presenting_Journeyad1z3.mp3" length="1904362" type="audio/mpeg"/>
        <itunes:summary><![CDATA[NSH member Ariel (Ari) Liberda discusses her decision to present at the 2023 NSH Convention.  She shares her journey and advice to anyone who is considering taking the leap!]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>203</itunes:duration>
                <itunes:episode>149</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>NSH Poster Podcast: P033 (2023)</title>
        <itunes:title>NSH Poster Podcast: P033 (2023)</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p033-2023/</link>
                    <comments>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p033-2023/#comments</comments>        <pubDate>Tue, 02 Jan 2024 16:35:18 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/3bb9d7b0-331c-3d98-84d1-af69c64ffed8</guid>
                                    <description><![CDATA[<p>Making the FNA Count</p>
<p>Author: Jeffery Rinker</p>
<p>The hospital at Sanford Bemidji Medical Center has 119 beds and performs an average of 150 FNAs each year. Our histologists do both histology and cytology, with FNAs comprising the majority of our cytology. Since 2020, our non-diagnostic rates on FNA samples have fluctuated. In 2022, our rate was as high as 28%. Compared to the non-diagnostic rate of 10% outlined in The Bethesda System for Reporting Thyroid Cytopathology, our results were over two times the accepted rate. To bring non-diagnostic rates down at our facility, a look at processing from beginning to end. </p>
<p>Radiology was the first place to start an overview of the process. During observation, we discovered that multiple passes of the needle contributed the bloodier samples, which affected the specimens processed later. To counter this, we reduced the number of smears and increased the amount of specimen deposited into CytoLyt (ThinPrep).</p>
<p>Next, the cytology department process was examined. During this examination, it was discovered the CytoLyt (Thinprep) specimen was not being processed because of lack of specimen. When it was processed the slides were being dried to long leading to artifact on the slide. By increasing the sample size in radiology and using a slide dryer to regulate the drying, the lab was able to produce a more consistent result. </p>
<p>Following these changes, the lab projected to meet or exceed the goal of less than 10% non-diagnostic slide results by the end of 2023.
</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Making the FNA Count</p>
<p><em>Author: Jeffery Rinker</em></p>
<p>The hospital at Sanford Bemidji Medical Center has 119 beds and performs an average of 150 FNAs each year. Our histologists do both histology and cytology, with FNAs comprising the majority of our cytology. Since 2020, our non-diagnostic rates on FNA samples have fluctuated. In 2022, our rate was as high as 28%. Compared to the non-diagnostic rate of 10% outlined in The Bethesda System for Reporting Thyroid Cytopathology, our results were over two times the accepted rate. To bring non-diagnostic rates down at our facility, a look at processing from beginning to end. </p>
<p>Radiology was the first place to start an overview of the process. During observation, we discovered that multiple passes of the needle contributed the bloodier samples, which affected the specimens processed later. To counter this, we reduced the number of smears and increased the amount of specimen deposited into CytoLyt (ThinPrep).</p>
<p>Next, the cytology department process was examined. During this examination, it was discovered the CytoLyt (Thinprep) specimen was not being processed because of lack of specimen. When it was processed the slides were being dried to long leading to artifact on the slide. By increasing the sample size in radiology and using a slide dryer to regulate the drying, the lab was able to produce a more consistent result. </p>
<p>Following these changes, the lab projected to meet or exceed the goal of less than 10% non-diagnostic slide results by the end of 2023.<em><br>
</em></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hescf9/P033_2023.mp3" length="11940000" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Making the FNA Count
Author: Jeffery Rinker
The hospital at Sanford Bemidji Medical Center has 119 beds and performs an average of 150 FNAs each year. Our histologists do both histology and cytology, with FNAs comprising the majority of our cytology. Since 2020, our non-diagnostic rates on FNA samples have fluctuated. In 2022, our rate was as high as 28%. Compared to the non-diagnostic rate of 10% outlined in The Bethesda System for Reporting Thyroid Cytopathology, our results were over two times the accepted rate. To bring non-diagnostic rates down at our facility, a look at processing from beginning to end. 
Radiology was the first place to start an overview of the process. During observation, we discovered that multiple passes of the needle contributed the bloodier samples, which affected the specimens processed later. To counter this, we reduced the number of smears and increased the amount of specimen deposited into CytoLyt (ThinPrep).
Next, the cytology department process was examined. During this examination, it was discovered the CytoLyt (Thinprep) specimen was not being processed because of lack of specimen. When it was processed the slides were being dried to long leading to artifact on the slide. By increasing the sample size in radiology and using a slide dryer to regulate the drying, the lab was able to produce a more consistent result. 
Following these changes, the lab projected to meet or exceed the goal of less than 10% non-diagnostic slide results by the end of 2023.]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>472</itunes:duration>
                <itunes:episode>148</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>NSH Poster Podcast: P031 (2023)</title>
        <itunes:title>NSH Poster Podcast: P031 (2023)</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p031-2023/</link>
                    <comments>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p031-2023/#comments</comments>        <pubDate>Tue, 02 Jan 2024 16:25:49 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/4e2be989-d4c8-322b-a28f-81f9fc30099b</guid>
                                    <description><![CDATA[<p>Alternative Strategies For Analyzing Pre-Clinical Mouse Lungs</p>
<p>Authors: Nicholas Pankow, BA; Gabriela De la Cruz, BS; Hannah Marie Atkins, PhD, DVM</p>
<p>In some diseases or conditions, it is challenging to leverage human tissues to determine patterns and resolve disease progression. Similarities between human and mouse biology make using murine models in pre-clinical studies possible. More specifically, mouse lungs are used to further analyze respiratory illnesses as they provide scalable models that can either be genetically manipulated to elicit human diseases or follow similar phenotypic outcomes. Mice are thus used in several different disease models that can be later translated to human conditions including asthma, COPD, toxicants, cystic fibrosis, as well as viral and bacterial infections. The standard histological embedding orientation of the lung provides an easy view of the main bronchus, alveoli, bronchioles, trachea, and related lymph nodes for distinct research inquiries. However, the standard histological orientation may not demonstrate the specific areas of interest to further investigate these conditions. By trimming the lung lobes in specific ways or altering the orientation during embedding, we can provide a specific focus to a study.  One alternative embedding strategy is the “max airway”, which focuses on showing the main bronchus anatomy on all lung lobes. The “morphometry” embedding strategy allows for multiple cross-sections of the left lung lobe and a cross-section of the main airway.  Another common method is the “lung sampling” strategy which provides a systematically chosen cross-section of the lungs. A “left lobe focus” strategy is used to review the bronchioles and alveolar areas. Finally, “whole lung” embedding can be useful for examining general lung morphology, adjacent mediastinal structures, and other organs. Using these different protocols, we can bring a desired focus to a study and have a more scalable experiment without using human tissue early in the process.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Alternative Strategies For Analyzing Pre-Clinical Mouse Lungs</p>
<p><em>Authors: Nicholas Pankow, BA; Gabriela De la Cruz, BS; Hannah Marie Atkins, PhD, DVM</em></p>
<p>In some diseases or conditions, it is challenging to leverage human tissues to determine patterns and resolve disease progression. Similarities between human and mouse biology make using murine models in pre-clinical studies possible. More specifically, mouse lungs are used to further analyze respiratory illnesses as they provide scalable models that can either be genetically manipulated to elicit human diseases or follow similar phenotypic outcomes. Mice are thus used in several different disease models that can be later translated to human conditions including asthma, COPD, toxicants, cystic fibrosis, as well as viral and bacterial infections. The standard histological embedding orientation of the lung provides an easy view of the main bronchus, alveoli, bronchioles, trachea, and related lymph nodes for distinct research inquiries. However, the standard histological orientation may not demonstrate the specific areas of interest to further investigate these conditions. By trimming the lung lobes in specific ways or altering the orientation during embedding, we can provide a specific focus to a study.  One alternative embedding strategy is the “max airway”, which focuses on showing the main bronchus anatomy on all lung lobes. The “morphometry” embedding strategy allows for multiple cross-sections of the left lung lobe and a cross-section of the main airway.  Another common method is the “lung sampling” strategy which provides a systematically chosen cross-section of the lungs. A “left lobe focus” strategy is used to review the bronchioles and alveolar areas. Finally, “whole lung” embedding can be useful for examining general lung morphology, adjacent mediastinal structures, and other organs. Using these different protocols, we can bring a desired focus to a study and have a more scalable experiment without using human tissue early in the process.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rd9unq/P031_2023.mp3" length="2128944" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Alternative Strategies For Analyzing Pre-Clinical Mouse Lungs
Authors: Nicholas Pankow, BA; Gabriela De la Cruz, BS; Hannah Marie Atkins, PhD, DVM
In some diseases or conditions, it is challenging to leverage human tissues to determine patterns and resolve disease progression. Similarities between human and mouse biology make using murine models in pre-clinical studies possible. More specifically, mouse lungs are used to further analyze respiratory illnesses as they provide scalable models that can either be genetically manipulated to elicit human diseases or follow similar phenotypic outcomes. Mice are thus used in several different disease models that can be later translated to human conditions including asthma, COPD, toxicants, cystic fibrosis, as well as viral and bacterial infections. The standard histological embedding orientation of the lung provides an easy view of the main bronchus, alveoli, bronchioles, trachea, and related lymph nodes for distinct research inquiries. However, the standard histological orientation may not demonstrate the specific areas of interest to further investigate these conditions. By trimming the lung lobes in specific ways or altering the orientation during embedding, we can provide a specific focus to a study.  One alternative embedding strategy is the “max airway”, which focuses on showing the main bronchus anatomy on all lung lobes. The “morphometry” embedding strategy allows for multiple cross-sections of the left lung lobe and a cross-section of the main airway.  Another common method is the “lung sampling” strategy which provides a systematically chosen cross-section of the lungs. A “left lobe focus” strategy is used to review the bronchioles and alveolar areas. Finally, “whole lung” embedding can be useful for examining general lung morphology, adjacent mediastinal structures, and other organs. Using these different protocols, we can bring a desired focus to a study and have a more scalable experiment without using human tissue early in the process.]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>90</itunes:duration>
                <itunes:episode>147</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>NSH Poster Podcast: P024 (2023)</title>
        <itunes:title>NSH Poster Podcast: P024 (2023)</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p024-2023/</link>
                    <comments>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p024-2023/#comments</comments>        <pubDate>Tue, 02 Jan 2024 16:23:52 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/578fcdf0-e477-3834-8767-625ae2931d76</guid>
                                    <description><![CDATA[<p>BENEFITS of Tissue-Tek Paraform Sectionable Cassette System</p>
<p>Authors: Jason (Jay) Innerhofer, PA(ASCP), M.H.S., Albuquerque, NM</p>
<p>The Paraform System eliminates the need to perform manual steps at embedding and great in terms of training, histology and turn around time.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>BENEFITS of Tissue-Tek Paraform Sectionable Cassette System</p>
<p><em>Authors: Jason (Jay) Innerhofer, PA(ASCP), M.H.S., Albuquerque, NM</em></p>
<p>The Paraform System eliminates the need to perform manual steps at embedding and great in terms of training, histology and turn around time.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/seezk4/P024_2023.mp3" length="9189120" type="audio/mpeg"/>
        <itunes:summary><![CDATA[BENEFITS of Tissue-Tek Paraform Sectionable Cassette System
Authors: Jason (Jay) Innerhofer, PA(ASCP), M.H.S., Albuquerque, NM
The Paraform System eliminates the need to perform manual steps at embedding and great in terms of training, histology and turn around time.]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>360</itunes:duration>
                <itunes:episode>146</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>NSH Poster Podcast: P020 (2023)</title>
        <itunes:title>NSH Poster Podcast: P020 (2023)</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p020-2023/</link>
                    <comments>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p020-2023/#comments</comments>        <pubDate>Tue, 02 Jan 2024 16:20:31 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/84e427be-7c4b-329d-8113-f760335fd1bd</guid>
                                    <description><![CDATA[<p>Leveraging preprocessor scanning to improve safety, quality, and lean workflow in the anatomic pathology lab.</p>
<p>Authors: Lilly Guevara, Kristie Wolfe-Steele, Brian Johnson</p>
<p>While procedures exist in AP laboratories to protect patient samples and prevent loss through specimen tracking, misplaced cassettes between grossing and tissue processing are still problematic. Significant time may be spent locating a misplaced cassette in this part of the workflow. Pathologists Bio-Medical (PBM) Pathgroup implemented a new system to address this need for preprocessing sample tracking in their AP workflow. PBM worked to create their own solution for tracking AP samples. This included the use of barcodes, scanners, and high-resolution cameras to track samples throughout the lab. It was a time consuming and costly effort pursued over the course of years. However, visibility in the pre-processing workflow was still problematic. In some instances, cassettes scanned at grossing were not used at all, or a cassette was inadvertently returned to the specimen container. In order to truly advance patient safety, improve quality, and optimize lean workflow, this needed to be addressed. In March 2023, PBM implemented a system that automated data capture for cassettes at preprocessing. This resulted in a reduction in time associated with reconciling misplaced/missing cassettes from grossing to embedding: from as long as a few days to as short as a couple hours. Another benefit of the new system was tracking cassettes by processor retort. This is especially important for laboratories that have multiple dual retort processors supporting various tissue types. In the past, lab staff spent significant time solving processing quality issues and identifying which cassettes were loaded on which processor(s). The new system software enables full reporting of this information. This system has provided a quick method to investigate processing errors with various specimen types. These changes created a more efficient laboratory, reduced stress for staff, and enhanced turnaround times.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Leveraging preprocessor scanning to improve safety, quality, and lean workflow in the anatomic pathology lab.</p>
<p><em>Authors: Lilly Guevara, Kristie Wolfe-Steele, Brian Johnson</em></p>
<p>While procedures exist in AP laboratories to protect patient samples and prevent loss through specimen tracking, misplaced cassettes between grossing and tissue processing are still problematic. Significant time may be spent locating a misplaced cassette in this part of the workflow. Pathologists Bio-Medical (PBM) Pathgroup implemented a new system to address this need for preprocessing sample tracking in their AP workflow. PBM worked to create their own solution for tracking AP samples. This included the use of barcodes, scanners, and high-resolution cameras to track samples throughout the lab. It was a time consuming and costly effort pursued over the course of years. However, visibility in the pre-processing workflow was still problematic. In some instances, cassettes scanned at grossing were not used at all, or a cassette was inadvertently returned to the specimen container. In order to truly advance patient safety, improve quality, and optimize lean workflow, this needed to be addressed. In March 2023, PBM implemented a system that automated data capture for cassettes at preprocessing. This resulted in a reduction in time associated with reconciling misplaced/missing cassettes from grossing to embedding: from as long as a few days to as short as a couple hours. Another benefit of the new system was tracking cassettes by processor retort. This is especially important for laboratories that have multiple dual retort processors supporting various tissue types. In the past, lab staff spent significant time solving processing quality issues and identifying which cassettes were loaded on which processor(s). The new system software enables full reporting of this information. This system has provided a quick method to investigate processing errors with various specimen types. These changes created a more efficient laboratory, reduced stress for staff, and enhanced turnaround times.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pm66va/P020_2023.mp3" length="15493872" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Leveraging preprocessor scanning to improve safety, quality, and lean workflow in the anatomic pathology lab.
Authors: Lilly Guevara, Kristie Wolfe-Steele, Brian Johnson
While procedures exist in AP laboratories to protect patient samples and prevent loss through specimen tracking, misplaced cassettes between grossing and tissue processing are still problematic. Significant time may be spent locating a misplaced cassette in this part of the workflow. Pathologists Bio-Medical (PBM) Pathgroup implemented a new system to address this need for preprocessing sample tracking in their AP workflow. PBM worked to create their own solution for tracking AP samples. This included the use of barcodes, scanners, and high-resolution cameras to track samples throughout the lab. It was a time consuming and costly effort pursued over the course of years. However, visibility in the pre-processing workflow was still problematic. In some instances, cassettes scanned at grossing were not used at all, or a cassette was inadvertently returned to the specimen container. In order to truly advance patient safety, improve quality, and optimize lean workflow, this needed to be addressed. In March 2023, PBM implemented a system that automated data capture for cassettes at preprocessing. This resulted in a reduction in time associated with reconciling misplaced/missing cassettes from grossing to embedding: from as long as a few days to as short as a couple hours. Another benefit of the new system was tracking cassettes by processor retort. This is especially important for laboratories that have multiple dual retort processors supporting various tissue types. In the past, lab staff spent significant time solving processing quality issues and identifying which cassettes were loaded on which processor(s). The new system software enables full reporting of this information. This system has provided a quick method to investigate processing errors with various specimen types. These changes created a more efficient laboratory, reduced stress for staff, and enhanced turnaround times.]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>680</itunes:duration>
                <itunes:episode>145</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>NSH Poster Podcast: P011 (2023)</title>
        <itunes:title>NSH Poster Podcast: P011 (2023)</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p011-2023/</link>
                    <comments>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p011-2023/#comments</comments>        <pubDate>Tue, 02 Jan 2024 16:16:38 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/8f11a3c4-47d4-3baf-b795-e7a9f44cab92</guid>
                                    <description><![CDATA[<p>The Button Mushroom (Agaricus bisporus): An Alternative Control Source for the Grocott Methenamine Silver Technique</p>
<p>Authors: From University of Texas M.D. Anderson Cancer Center Center, Houston, TX- Fatimah Ansar; Carla Arredondo; Tran Huynh; Victoria Jones; Jennifer Le; Duong Nguyen; Andres Ronquillo-Erazo; Minnu Varghese; Kaleena Ramirez; Toysha Mayer; Mark A. Bailey</p>
<p> </p>
<p>Identifying the presence of fungi through special histotechniques is a critical diagnostic histopathology test for patients who may have acquired a fungal infection localized in the lungs. The purpose of this study was to determine if the mushroom species Agaricus bisporus, generally known as the Button Mushroom and, commonly used for cooking, may be used a special stain control slide. Is the Button Mushroom a reliable fungal control to use when performing a Grocott Methenamine Silver technique test?  The investigators hypothesize the Agaricus bisporus mushroom is a good substitute control for result verification  of the GMS staining technique and readily available compared to tissue controls. The button mushrooms were purchased from a local grocer in Houston, TX, subsequently grossed into eight 1.0x1.0x0.4cm representative sections and submitted for routine tissue processing, embedding, sectioning and stained using the H&amp;E and Grocott Methenamine methods. Inclusive, for the test a commercially available human lung tissue control (+) for fungi was compared to the Button Mushroom results and to ensure the GMS technique produced the appropriate result. The processed button mushrooms GMS stain did not yield a definitive result to conclude the outcome of the staining method. The stained GMS slides demonstrated an indistinguishable contrast between the morphology of the mushroom and the presence of fungi; however, the H&amp;E demonstrated the morphology well, however, further studies are necessary to confirm the presence of fungi.   The use of alternative controls are dependent on the specific clinical; research goals or experimental conditions to provide appropriate and relevant results. The limitations of the research was, not together with, the  GMS to perform a PAS stain on the button mushrooms. Subsequently, we will perform the PAS technique on the button mushrooms and test a different alternative source to establish a viable control for the substitution of human tissue (+) for fungi.  </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>The Button Mushroom (Agaricus bisporus): An Alternative Control Source for the Grocott Methenamine Silver Technique</p>
<p><em>Authors: From University of Texas M.D. Anderson Cancer Center Center, Houston, TX- Fatimah Ansar; Carla Arredondo; Tran Huynh; Victoria Jones; Jennifer Le; Duong Nguyen; Andres Ronquillo-Erazo; Minnu Varghese; Kaleena Ramirez; Toysha Mayer; Mark A. Bailey</em></p>
<p> </p>
<p>Identifying the presence of fungi through special histotechniques is a critical diagnostic histopathology test for patients who may have acquired a fungal infection localized in the lungs. The purpose of this study was to determine if the mushroom species Agaricus bisporus, generally known as the Button Mushroom and, commonly used for cooking, may be used a special stain control slide. Is the Button Mushroom a reliable fungal control to use when performing a Grocott Methenamine Silver technique test?  The investigators hypothesize the Agaricus bisporus mushroom is a good substitute control for result verification  of the GMS staining technique and readily available compared to tissue controls. The button mushrooms were purchased from a local grocer in Houston, TX, subsequently grossed into eight 1.0x1.0x0.4cm representative sections and submitted for routine tissue processing, embedding, sectioning and stained using the H&amp;E and Grocott Methenamine methods. Inclusive, for the test a commercially available human lung tissue control (+) for fungi was compared to the Button Mushroom results and to ensure the GMS technique produced the appropriate result. The processed button mushrooms GMS stain did not yield a definitive result to conclude the outcome of the staining method. The stained GMS slides demonstrated an indistinguishable contrast between the morphology of the mushroom and the presence of fungi; however, the H&amp;E demonstrated the morphology well, however, further studies are necessary to confirm the presence of fungi.   The use of alternative controls are dependent on the specific clinical; research goals or experimental conditions to provide appropriate and relevant results. The limitations of the research was, not together with, the  GMS to perform a PAS stain on the button mushrooms. Subsequently, we will perform the PAS technique on the button mushrooms and test a different alternative source to establish a viable control for the substitution of human tissue (+) for fungi.  </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/5sfiv2/P011_2023.mp3" length="8743008" type="audio/mpeg"/>
        <itunes:summary><![CDATA[The Button Mushroom (Agaricus bisporus): An Alternative Control Source for the Grocott Methenamine Silver Technique
Authors: From University of Texas M.D. Anderson Cancer Center Center, Houston, TX- Fatimah Ansar; Carla Arredondo; Tran Huynh; Victoria Jones; Jennifer Le; Duong Nguyen; Andres Ronquillo-Erazo; Minnu Varghese; Kaleena Ramirez; Toysha Mayer; Mark A. Bailey
 
Identifying the presence of fungi through special histotechniques is a critical diagnostic histopathology test for patients who may have acquired a fungal infection localized in the lungs. The purpose of this study was to determine if the mushroom species Agaricus bisporus, generally known as the Button Mushroom and, commonly used for cooking, may be used a special stain control slide. Is the Button Mushroom a reliable fungal control to use when performing a Grocott Methenamine Silver technique test?  The investigators hypothesize the Agaricus bisporus mushroom is a good substitute control for result verification  of the GMS staining technique and readily available compared to tissue controls. The button mushrooms were purchased from a local grocer in Houston, TX, subsequently grossed into eight 1.0x1.0x0.4cm representative sections and submitted for routine tissue processing, embedding, sectioning and stained using the H&amp;E and Grocott Methenamine methods. Inclusive, for the test a commercially available human lung tissue control (+) for fungi was compared to the Button Mushroom results and to ensure the GMS technique produced the appropriate result. The processed button mushrooms GMS stain did not yield a definitive result to conclude the outcome of the staining method. The stained GMS slides demonstrated an indistinguishable contrast between the morphology of the mushroom and the presence of fungi; however, the H&amp;E demonstrated the morphology well, however, further studies are necessary to confirm the presence of fungi.   The use of alternative controls are dependent on the specific clinical; research goals or experimental conditions to provide appropriate and relevant results. The limitations of the research was, not together with, the  GMS to perform a PAS stain on the button mushrooms. Subsequently, we will perform the PAS technique on the button mushrooms and test a different alternative source to establish a viable control for the substitution of human tissue (+) for fungi.  ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>358</itunes:duration>
                <itunes:episode>144</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>NSH Poster Podcast: P007 (2023)</title>
        <itunes:title>NSH Poster Podcast: P007 (2023)</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p007-2023/</link>
                    <comments>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p007-2023/#comments</comments>        <pubDate>Tue, 02 Jan 2024 16:13:15 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/db9abfbf-281e-3010-aef2-8740dfc524ac</guid>
                                    <description><![CDATA[<p> Gene Protein Assay(GPA): Unveiling Tumor Heterogeneity in HER2/neu Positive Breast Cancer</p>
<p>Authors:  Dr. Tanuja Shet, Dr. Aditi Rathi </p>
<p> </p>
<p>Introduction: HER2/neu gene amplification on Fluorescence in-situ hybridization (FISH) is defined as average HER2neu gene signals &gt; 4 and HER2:CEP17 ratio of &gt; 2, in breast cancer. However, with tumor heterogeneity interpretation of these cut-offs is challenging and some cases test as borderline. We attempted a study analyzing Gene protein assay (GPA) which combines HER2/neu immunohistochemistry (IHC), and D-DISH (dual color dual in-situ hybridization) assay to help resolve this issue.   </p>
<p>Methods:  A total of 31 cases reported as HER2/neu amplified with intermixed tumor heterogeneity on FISH were taken for this study. The original HER2/neu count was between 4 to 6 and ratio near 2 in most cases. GPA was done using 4B5 HER2/neu IHC and Roche/Ventana D-DISH kit on Ventana Ultra machine by doing IHC first followed by D-DISH.</p>
<p>Result:  On GPA, 3/31 cases were reported as non-amplified, and the rest were amplified. Advantage of GPA was that it helped count D-DISH as per membrane staining and identified more tumor heterogeneity in contrast to FISH in six cases. The results of the remaining cases were the same.

</p>
]]></description>
                                                            <content:encoded><![CDATA[<p> Gene Protein Assay(GPA): Unveiling Tumor Heterogeneity in HER2/neu Positive Breast Cancer</p>
<p><em>Authors:  Dr. Tanuja Shet, Dr. Aditi Rathi</em> </p>
<p> </p>
<p>Introduction: HER2/neu gene amplification on Fluorescence in-situ hybridization (FISH) is defined as average HER2neu gene signals &gt; 4 and HER2:CEP17 ratio of &gt; 2, in breast cancer. However, with tumor heterogeneity interpretation of these cut-offs is challenging and some cases test as borderline. We attempted a study analyzing Gene protein assay (GPA) which combines HER2/neu immunohistochemistry (IHC), and D-DISH (dual color dual in-situ hybridization) assay to help resolve this issue.   </p>
<p>Methods:  A total of 31 cases reported as HER2/neu amplified with intermixed tumor heterogeneity on FISH were taken for this study. The original HER2/neu count was between 4 to 6 and ratio near 2 in most cases. GPA was done using 4B5 HER2/neu IHC and Roche/Ventana D-DISH kit on Ventana Ultra machine by doing IHC first followed by D-DISH.</p>
<p>Result:  On GPA, 3/31 cases were reported as non-amplified, and the rest were amplified. Advantage of GPA was that it helped count D-DISH as per membrane staining and identified more tumor heterogeneity in contrast to FISH in six cases. The results of the remaining cases were the same.<br>
<br>
</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/6i883x/2023_Posters_P07b1ws7.mp3" length="10539929" type="audio/mpeg"/>
        <itunes:summary><![CDATA[ Gene Protein Assay(GPA): Unveiling Tumor Heterogeneity in HER2/neu Positive Breast Cancer
Authors:  Dr. Tanuja Shet, Dr. Aditi Rathi 
 
Introduction: HER2/neu gene amplification on Fluorescence in-situ hybridization (FISH) is defined as average HER2neu gene signals &gt; 4 and HER2:CEP17 ratio of &gt; 2, in breast cancer. However, with tumor heterogeneity interpretation of these cut-offs is challenging and some cases test as borderline. We attempted a study analyzing Gene protein assay (GPA) which combines HER2/neu immunohistochemistry (IHC), and D-DISH (dual color dual in-situ hybridization) assay to help resolve this issue.   
Methods:  A total of 31 cases reported as HER2/neu amplified with intermixed tumor heterogeneity on FISH were taken for this study. The original HER2/neu count was between 4 to 6 and ratio near 2 in most cases. GPA was done using 4B5 HER2/neu IHC and Roche/Ventana D-DISH kit on Ventana Ultra machine by doing IHC first followed by D-DISH.
Result:  On GPA, 3/31 cases were reported as non-amplified, and the rest were amplified. Advantage of GPA was that it helped count D-DISH as per membrane staining and identified more tumor heterogeneity in contrast to FISH in six cases. The results of the remaining cases were the same.]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>263</itunes:duration>
                <itunes:episode>143</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>NSH Poster Podcast: P006 (2023)</title>
        <itunes:title>NSH Poster Podcast: P006 (2023)</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-2023-p006/</link>
                    <comments>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-2023-p006/#comments</comments>        <pubDate>Tue, 02 Jan 2024 16:10:20 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/7950a915-c992-3f79-9734-05afdaa0c0d9</guid>
                                    <description><![CDATA[<p>Novel Use of Pipette Based Capsules for Glycol Methacrylate, Methyl/Butyl Methacrylate and Epoxy Resin Processing with Mouse Tissue That Reduce Processing Solution Volume and Time.  </p>
<p>Authors: Philip Seifert, HTL(ASCP), Xinyao Hu, Bianai Fan and Darlene A. Dartt, PhD, Schepens Eye Research Institute of Mass Eye and Ear, Boston, MA</p>
<p> </p>
<p>The mPrep/S capsules (Microscopy Innovations) are customized pipette tips with screen inserts designed for various electron microscopy applications. Capsule processing methods were developed for mouse ocular and mineralized bone for histology and transmission electron microscopy (TEM) applications and compared to manual and carousel processed methods. The novel methods tested enable processing larger sized tissues (~3 mm diameter) including whole, anterior or posterior segments of mouse eyes and optic nerves within a single capsule that use 75% less reagents and time. Capsule processed tissue embedded in Glycol Methacrylate, methyl methacrylate/butyl methacrylate and EMBED812 epoxy resin were sectioned for histological staining including H&amp;E, toluidine blue, osmium-paraphenylenediamine, Von Kossa and TEM imaged. Stained slide scanned micrographs and TEM images from capsule processed samples were measured and compared to conventional processed using a carousel processor or manual processing.  There were no detectable differences in tissue preservation, staining, optic nerve axon density or processing related artifacts in any of the tissue processed into the resins.  Use of capsules with pipette propelled mixing delivers accelerated diffusion of reagents and infiltration of embedding media into specimens that decreases both processing volume and time compared to manual or carousel processing.  A variety of embedding media resins may be used with capsules for histology and electron microscopy tissue processing. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Novel Use of Pipette Based Capsules for Glycol Methacrylate, Methyl/Butyl Methacrylate and Epoxy Resin Processing with Mouse Tissue That Reduce Processing Solution Volume and Time.  </p>
<p><em>Authors: Philip Seifert, HTL(ASCP), Xinyao Hu, Bianai Fan and Darlene A. Dartt, PhD, Schepens Eye Research Institute of Mass Eye and Ear, Boston, MA</em></p>
<p> </p>
<p>The mPrep/S capsules (Microscopy Innovations) are customized pipette tips with screen inserts designed for various electron microscopy applications. Capsule processing methods were developed for mouse ocular and mineralized bone for histology and transmission electron microscopy (TEM) applications and compared to manual and carousel processed methods. The novel methods tested enable processing larger sized tissues (~3 mm diameter) including whole, anterior or posterior segments of mouse eyes and optic nerves within a single capsule that use 75% less reagents and time. Capsule processed tissue embedded in Glycol Methacrylate, methyl methacrylate/butyl methacrylate and EMBED812 epoxy resin were sectioned for histological staining including H&amp;E, toluidine blue, osmium-paraphenylenediamine, Von Kossa and TEM imaged. Stained slide scanned micrographs and TEM images from capsule processed samples were measured and compared to conventional processed using a carousel processor or manual processing.  There were no detectable differences in tissue preservation, staining, optic nerve axon density or processing related artifacts in any of the tissue processed into the resins.  Use of capsules with pipette propelled mixing delivers accelerated diffusion of reagents and infiltration of embedding media into specimens that decreases both processing volume and time compared to manual or carousel processing.  A variety of embedding media resins may be used with capsules for histology and electron microscopy tissue processing. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/az898y/P006_2023.mp3" length="5687184" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Novel Use of Pipette Based Capsules for Glycol Methacrylate, Methyl/Butyl Methacrylate and Epoxy Resin Processing with Mouse Tissue That Reduce Processing Solution Volume and Time.  
Authors: Philip Seifert, HTL(ASCP), Xinyao Hu, Bianai Fan and Darlene A. Dartt, PhD, Schepens Eye Research Institute of Mass Eye and Ear, Boston, MA
 
The mPrep/S capsules (Microscopy Innovations) are customized pipette tips with screen inserts designed for various electron microscopy applications. Capsule processing methods were developed for mouse ocular and mineralized bone for histology and transmission electron microscopy (TEM) applications and compared to manual and carousel processed methods. The novel methods tested enable processing larger sized tissues (~3 mm diameter) including whole, anterior or posterior segments of mouse eyes and optic nerves within a single capsule that use 75% less reagents and time. Capsule processed tissue embedded in Glycol Methacrylate, methyl methacrylate/butyl methacrylate and EMBED812 epoxy resin were sectioned for histological staining including H&amp;E, toluidine blue, osmium-paraphenylenediamine, Von Kossa and TEM imaged. Stained slide scanned micrographs and TEM images from capsule processed samples were measured and compared to conventional processed using a carousel processor or manual processing.  There were no detectable differences in tissue preservation, staining, optic nerve axon density or processing related artifacts in any of the tissue processed into the resins.  Use of capsules with pipette propelled mixing delivers accelerated diffusion of reagents and infiltration of embedding media into specimens that decreases both processing volume and time compared to manual or carousel processing.  A variety of embedding media resins may be used with capsules for histology and electron microscopy tissue processing. ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>228</itunes:duration>
                <itunes:episode>142</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AwardsCast: 2023 Immunohistochemistry Education Scholarship</title>
        <itunes:title>AwardsCast: 2023 Immunohistochemistry Education Scholarship</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/awards/</link>
                    <comments>https://nshpodcasts.podbean.com/e/awards/#comments</comments>        <pubDate>Tue, 24 Oct 2023 10:47:00 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/6cadaf7f-6cae-3959-b825-7a981cfa8f20</guid>
                                    <description><![CDATA[<p>Join us for our AwardsCast series as we have short conversations with the 2023 NSH Award &amp; Scholarship Recipients. In this episode, we talk to Colleen Forster of the University of Minnesota, the recipient of the Immunohistochemistry Education Scholarship, where we discuss how every day in a core research lab is different and keeps her learning new things as well as her plans for learning more about the hot new area of spatial omnics.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us for our AwardsCast series as we have short conversations with the 2023 NSH Award &amp; Scholarship Recipients. In this episode, we talk to Colleen Forster of the University of Minnesota, the recipient of the Immunohistochemistry Education Scholarship, where we discuss how every day in a core research lab is different and keeps her learning new things as well as her plans for learning more about the hot new area of spatial omnics.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xn3d5k/Podcast-IHCEducation.mp3" length="37759521" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us for our AwardsCast series as we have short conversations with the 2023 NSH Award &amp; Scholarship Recipients. In this episode, we talk to Colleen Forster of the University of Minnesota, the recipient of the Immunohistochemistry Education Scholarship, where we discuss how every day in a core research lab is different and keeps her learning new things as well as her plans for learning more about the hot new area of spatial omnics.]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>943</itunes:duration>
                <itunes:episode>141</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AwardsCast: 2023 Jules Elias Award for Excellence in IHC &amp; Molecular Techniques</title>
        <itunes:title>AwardsCast: 2023 Jules Elias Award for Excellence in IHC &amp; Molecular Techniques</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/awardscast-2023-julie-elias-award-for-excellence-in-ihc-molecular-techniques/</link>
                    <comments>https://nshpodcasts.podbean.com/e/awardscast-2023-julie-elias-award-for-excellence-in-ihc-molecular-techniques/#comments</comments>        <pubDate>Thu, 28 Sep 2023 16:22:26 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/5e6a144f-439a-3928-8c79-03bc3abd602a</guid>
                                    <description><![CDATA[<p>Join us for our AwardsCast series as we have short conversations with the 2023 NSH Award &amp; Scholarship Recipients. In this episode, we talk to Cindy Lowe, HTL(ASCP), QIHC(ASCP), of Vanderbilt University, the recipient of the Jules Elias Award for Excellence in IHC &amp; Molecular Techniques, where we discuss everything from her work in IHC, including an impactful visit from patients to her lab, to what she does for fun outside the lab.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us for our AwardsCast series as we have short conversations with the 2023 NSH Award &amp; Scholarship Recipients. In this episode, we talk to Cindy Lowe, HTL(ASCP), QIHC(ASCP), of Vanderbilt University, the recipient of the Jules Elias Award for Excellence in IHC &amp; Molecular Techniques, where we discuss everything from her work in IHC, including an impactful visit from patients to her lab, to what she does for fun outside the lab.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/k86mqy/Podcast_JulesElias2023.mp3" length="42635015" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us for our AwardsCast series as we have short conversations with the 2023 NSH Award &amp; Scholarship Recipients. In this episode, we talk to Cindy Lowe, HTL(ASCP), QIHC(ASCP), of Vanderbilt University, the recipient of the Jules Elias Award for Excellence in IHC &amp; Molecular Techniques, where we discuss everything from her work in IHC, including an impactful visit from patients to her lab, to what she does for fun outside the lab.]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1065</itunes:duration>
                <itunes:episode>140</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AwardsCast: 2023 Helping Hand Scholarship for Histotechnology Outreach and Education</title>
        <itunes:title>AwardsCast: 2023 Helping Hand Scholarship for Histotechnology Outreach and Education</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/awardscast-2023-helping-hand-scholarship-for-histotechnology-outreach-and-education/</link>
                    <comments>https://nshpodcasts.podbean.com/e/awardscast-2023-helping-hand-scholarship-for-histotechnology-outreach-and-education/#comments</comments>        <pubDate>Thu, 28 Sep 2023 12:56:48 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/671ca58e-e7a4-3212-b939-900d0d310f05</guid>
                                    <description><![CDATA[<p>Join us for our AwardsCast series as we have short conversations with the 2023 NSH Award &amp; Scholarship Recipients. In this episode, we talk to Beth Cox, CT (ASCP), HT(ASCP), HTL (ASCP), 
QIHC (ASCP), the recipient of the Helping Hands Scholarship for Histotechnology Outreach &amp; Education where she discusses how she will use the funds to help identify and treat gynecologic cancer in women in the Marshall Islands. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us for our AwardsCast series as we have short conversations with the 2023 NSH Award &amp; Scholarship Recipients. In this episode, we talk to Beth Cox, CT (ASCP), HT(ASCP), HTL (ASCP), <br>
QIHC (ASCP), the recipient of the Helping Hands Scholarship for Histotechnology Outreach &amp; Education where she discusses how she will use the funds to help identify and treat gynecologic cancer in women in the Marshall Islands. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ahtw6a/Podcasts_Helpinghands2023.mp3" length="24087031" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us for our AwardsCast series as we have short conversations with the 2023 NSH Award &amp; Scholarship Recipients. In this episode, we talk to Beth Cox, CT (ASCP), HT(ASCP), HTL (ASCP), QIHC (ASCP), the recipient of the Helping Hands Scholarship for Histotechnology Outreach &amp; Education where she discusses how she will use the funds to help identify and treat gynecologic cancer in women in the Marshall Islands. ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>602</itunes:duration>
                <itunes:episode>139</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AwardsCast: 2023 Peggy Wenk Histology Program Scholarship</title>
        <itunes:title>AwardsCast: 2023 Peggy Wenk Histology Program Scholarship</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/awardscast-2023-peggy-wenk-histology-program-scholarship/</link>
                    <comments>https://nshpodcasts.podbean.com/e/awardscast-2023-peggy-wenk-histology-program-scholarship/#comments</comments>        <pubDate>Wed, 27 Sep 2023 19:59:21 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/037c3894-a316-3274-b8af-94da75c71a0a</guid>
                                    <description><![CDATA[<p>Join us for our AwardsCast series as we have short conversations with the 2023 NSH Award &amp; Scholarship Recipients. In this episode, we talk to Program Director, Taiquanda Winbush, from Albany State University about how they will use the funds to improve their program with the funds from the scholarship.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us for our AwardsCast series as we have short conversations with the 2023 NSH Award &amp; Scholarship Recipients. In this episode, we talk to Program Director, Taiquanda Winbush, from Albany State University about how they will use the funds to improve their program with the funds from the scholarship.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/22dkc7/AwardsCast-PeggyWenk2023.mp3" length="19849970" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us for our AwardsCast series as we have short conversations with the 2023 NSH Award &amp; Scholarship Recipients. In this episode, we talk to Program Director, Taiquanda Winbush, from Albany State University about how they will use the funds to improve their program with the funds from the scholarship.]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>496</itunes:duration>
                <itunes:episode>138</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AwardsCast: 2023 Excellence in Management Award</title>
        <itunes:title>AwardsCast: 2023 Excellence in Management Award</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/awardscast-2023-excellence-in-management-award/</link>
                    <comments>https://nshpodcasts.podbean.com/e/awardscast-2023-excellence-in-management-award/#comments</comments>        <pubDate>Wed, 27 Sep 2023 16:13:34 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/911f0969-ffd9-3f38-acff-762f2dd6df99</guid>
                                    <description><![CDATA[<p>Join us for our AwardsCast series as we have short conversations with the 2023 NSH Award &amp; Scholarship Recipients. In this episode, we talk to Thomas Huynh, HT(ASCP) who gives his advice on what it takes to be a good manager and the importance of having a good mentor.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us for our AwardsCast series as we have short conversations with the 2023 NSH Award &amp; Scholarship Recipients. In this episode, we talk to Thomas Huynh, HT(ASCP) who gives his advice on what it takes to be a good manager and the importance of having a good mentor.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2n4g5s/Awards_Podcast_Excellence_in_Management6jv2o.mp3" length="27450558" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us for our AwardsCast series as we have short conversations with the 2023 NSH Award &amp; Scholarship Recipients. In this episode, we talk to Thomas Huynh, HT(ASCP) who gives his advice on what it takes to be a good manager and the importance of having a good mentor.]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>686</itunes:duration>
                <itunes:episode>137</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>AwardsCast - 2023 Histotechnologist of the Year</title>
        <itunes:title>AwardsCast - 2023 Histotechnologist of the Year</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/awardscast-2023-histotechnologist-of-the-year/</link>
                    <comments>https://nshpodcasts.podbean.com/e/awardscast-2023-histotechnologist-of-the-year/#comments</comments>        <pubDate>Wed, 27 Sep 2023 15:59:10 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/2085c20a-2eb1-313b-b2d0-e303d54dcc33</guid>
                                    <description><![CDATA[<p>Join us for our AwardsCast series as we have short conversations with the 2023 NSH Award &amp; Scholarship Recipients. In this episode, we talk to Histotechnologist of the Year, Luis Chiriboga, PhD, HT(ASCP), QIHC(ASCP) and we discuss the importance of advocacy and volunteering.</p>
<p> </p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Join us for our AwardsCast series as we have short conversations with the 2023 NSH Award &amp; Scholarship Recipients. In this episode, we talk to Histotechnologist of the Year, Luis Chiriboga, PhD, HT(ASCP), QIHC(ASCP) and we discuss the importance of advocacy and volunteering.</p>
<p> </p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/i4eria/Podcast-Histotech_of_the_Year202370rwm.mp3" length="31065905" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Join us for our AwardsCast series as we have short conversations with the 2023 NSH Award &amp; Scholarship Recipients. In this episode, we talk to Histotechnologist of the Year, Luis Chiriboga, PhD, HT(ASCP), QIHC(ASCP) and we discuss the importance of advocacy and volunteering.
 
 ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>776</itunes:duration>
                <itunes:episode>136</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>NSH Poster Podcast: P-09 (2022)</title>
        <itunes:title>NSH Poster Podcast: P-09 (2022)</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p-09-2022/</link>
                    <comments>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p-09-2022/#comments</comments>        <pubDate>Sat, 08 Apr 2023 15:13:00 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/0907d4dd-011b-321b-86a1-5065635e9ee9</guid>
                                    <description><![CDATA[<p>Title: Using Metallic Labels and Metal Detection in the Histology Laboratory to Prevent Missing Material</p>
<p>Authors: Elizabeth Druffel, HT ASCP, Mayo Clinic, Rochester, MN; Dr. Joaquin Garcia, MD, Mayo Clinic, Rochester MN</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Title: Using Metallic Labels and Metal Detection in the Histology Laboratory to Prevent Missing Material</p>
<p>Authors: Elizabeth Druffel, HT ASCP, Mayo Clinic, Rochester, MN; Dr. Joaquin Garcia, MD, Mayo Clinic, Rochester MN</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/uz9kff/P09_Podbean.mp3" length="21934542" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Title: Using Metallic Labels and Metal Detection in the Histology Laboratory to Prevent Missing Material
Authors: Elizabeth Druffel, HT ASCP, Mayo Clinic, Rochester, MN; Dr. Joaquin Garcia, MD, Mayo Clinic, Rochester MN]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>548</itunes:duration>
                <itunes:episode>135</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>NSH Poster Podcast: P-13 (2022)</title>
        <itunes:title>NSH Poster Podcast: P-13 (2022)</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p-13-2022/</link>
                    <comments>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p-13-2022/#comments</comments>        <pubDate>Sat, 08 Apr 2023 15:10:00 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/e729d61e-4db3-361e-a8f6-b42bea407fc8</guid>
                                    <description><![CDATA[<p>Title: Anatomical Pathology Patient Interest Association (APPIA) TOPS Tissue Handling Guidelines illustrate an ongoing education initiative to improve the understanding of pre-analytical factors and promote standardization in tissue workflows.</p>
<p>Authors: Robert Lott, HTL(ASCP), Anatomical Pathology Patient Interest Association (APPIA), Raleigh, NC; Joshua Greenlee, MBA IASSC, HTL(ASCP)cm, Anatomical Pathology Patient Interest Association (APPIA), Raleigh, NC; Melissa Alexander, MD PhD, Anatomical Pathology Patient Interest Association (APPIA), Raleigh, NC; Jodi Barrientos, Anatomical Pathology Patient Interest Association (APPIA), Raleigh, NC; David Ferber, MD, Anatomical Pathology Patient Interest Association (APPIA), Raleigh, NC; Beth Sheppard, MBA, Anatomical Pathology Patient Interest Association (APPIA), Raleigh, NC; Shalini Singh, MD, Anatomical Pathology Patient Interest Association (APPIA), Raleigh, NC; Teri Saylor, Anatomical Pathology Patient Interest Association (APPIA), Raleigh, NC; Shanya Scott, Anatomical Pathology Patient Interest Association, Raleigh, NC; Erico von Bueren, MD PhD MOR, Anatomical Pathology Patient Interest Association (APPIA), Raleigh, NC</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Title: Anatomical Pathology Patient Interest Association (APPIA) TOPS Tissue Handling Guidelines illustrate an ongoing education initiative to improve the understanding of pre-analytical factors and promote standardization in tissue workflows.</p>
<p>Authors: Robert Lott, HTL(ASCP), Anatomical Pathology Patient Interest Association (APPIA), Raleigh, NC; Joshua Greenlee, MBA IASSC, HTL(ASCP)cm, Anatomical Pathology Patient Interest Association (APPIA), Raleigh, NC; Melissa Alexander, MD PhD, Anatomical Pathology Patient Interest Association (APPIA), Raleigh, NC; Jodi Barrientos, Anatomical Pathology Patient Interest Association (APPIA), Raleigh, NC; David Ferber, MD, Anatomical Pathology Patient Interest Association (APPIA), Raleigh, NC; Beth Sheppard, MBA, Anatomical Pathology Patient Interest Association (APPIA), Raleigh, NC; Shalini Singh, MD, Anatomical Pathology Patient Interest Association (APPIA), Raleigh, NC; Teri Saylor, Anatomical Pathology Patient Interest Association (APPIA), Raleigh, NC; Shanya Scott, Anatomical Pathology Patient Interest Association, Raleigh, NC; Erico von Bueren, MD PhD MOR, Anatomical Pathology Patient Interest Association (APPIA), Raleigh, NC</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/p42e8u/P13_podbean.mp3" length="24477823" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Title: Anatomical Pathology Patient Interest Association (APPIA) TOPS Tissue Handling Guidelines illustrate an ongoing education initiative to improve the understanding of pre-analytical factors and promote standardization in tissue workflows.
Authors: Robert Lott, HTL(ASCP), Anatomical Pathology Patient Interest Association (APPIA), Raleigh, NC; Joshua Greenlee, MBA IASSC, HTL(ASCP)cm, Anatomical Pathology Patient Interest Association (APPIA), Raleigh, NC; Melissa Alexander, MD PhD, Anatomical Pathology Patient Interest Association (APPIA), Raleigh, NC; Jodi Barrientos, Anatomical Pathology Patient Interest Association (APPIA), Raleigh, NC; David Ferber, MD, Anatomical Pathology Patient Interest Association (APPIA), Raleigh, NC; Beth Sheppard, MBA, Anatomical Pathology Patient Interest Association (APPIA), Raleigh, NC; Shalini Singh, MD, Anatomical Pathology Patient Interest Association (APPIA), Raleigh, NC; Teri Saylor, Anatomical Pathology Patient Interest Association (APPIA), Raleigh, NC; Shanya Scott, Anatomical Pathology Patient Interest Association, Raleigh, NC; Erico von Bueren, MD PhD MOR, Anatomical Pathology Patient Interest Association (APPIA), Raleigh, NC]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>611</itunes:duration>
                <itunes:episode>134</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>NSH Poster Podcast: P-26 (2022)</title>
        <itunes:title>NSH Poster Podcast: P-26 (2022)</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p-26-2022/</link>
                    <comments>https://nshpodcasts.podbean.com/e/nsh-poster-podcast-p-26-2022/#comments</comments>        <pubDate>Sat, 08 Apr 2023 15:09:00 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/3733f3cf-1f3f-3dda-968d-2b8dd2c403f2</guid>
                                    <description><![CDATA[<p>Title: Detection of Human Papillomavirus (HPV) mRNA in FFPE Samples Using AMPIVIEW RNA Probes developed with Novel loop Technology</p>
<p> </p>
<p>Authors: Deborah M. Holzapfel, PhD, Francesca Mazzoni, PhD, Jack Coleman, PhD</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Title: Detection of Human Papillomavirus (HPV) mRNA in FFPE Samples Using AMPIVIEW RNA Probes developed with Novel loop Technology</p>
<p> </p>
<p>Authors: Deborah M. Holzapfel, PhD, Francesca Mazzoni, PhD, Jack Coleman, PhD</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/btwbzx/P26_Podbean.mp3" length="22546852" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Title: Detection of Human Papillomavirus (HPV) mRNA in FFPE Samples Using AMPIVIEW RNA Probes developed with Novel loop Technology
 
Authors: Deborah M. Holzapfel, PhD, Francesca Mazzoni, PhD, Jack Coleman, PhD]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>563</itunes:duration>
                <itunes:episode>133</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>NSH Poster Podcast: P-01 (2022)</title>
        <itunes:title>NSH Poster Podcast: P-01 (2022)</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/2023-nsh-poster-podcasts-p-01/</link>
                    <comments>https://nshpodcasts.podbean.com/e/2023-nsh-poster-podcasts-p-01/#comments</comments>        <pubDate>Sat, 08 Apr 2023 09:37:00 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/257e6b5d-081f-3346-a582-3957beef291d</guid>
                                    <description><![CDATA[<p>Title: Comparative Study of Two Reprocessing Methods for Formalin Fixed Paraffin Embedded Tissue</p>
<p> </p>
<p>Authors: Matthew Lunetta BS HT(ASCP)cm, Cameron Felty DO, Megan Grivois BS HT(ASCP)cm, Chris Hansen HT(ASCP), Chris Jackson MD, and Peter Seery BS PA(ASCP)cm , Liz Rizzo PA(ASCP)cm LSSBB </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Title: Comparative Study of Two Reprocessing Methods for Formalin Fixed Paraffin Embedded Tissue</p>
<p> </p>
<p>Authors: Matthew Lunetta BS HT(ASCP)cm, Cameron Felty DO, Megan Grivois BS HT(ASCP)cm, Chris Hansen HT(ASCP), Chris Jackson MD, and Peter Seery BS PA(ASCP)cm , Liz Rizzo PA(ASCP)cm LSSBB </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fnap3r/P01_Podbean.mp3" length="12509562" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Title: Comparative Study of Two Reprocessing Methods for Formalin Fixed Paraffin Embedded Tissue
 
Authors: Matthew Lunetta BS HT(ASCP)cm, Cameron Felty DO, Megan Grivois BS HT(ASCP)cm, Chris Hansen HT(ASCP), Chris Jackson MD, and Peter Seery BS PA(ASCP)cm , Liz Rizzo PA(ASCP)cm LSSBB ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>312</itunes:duration>
                <itunes:episode>132</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>NSH Poster Podcast: P-03 (2022)</title>
        <itunes:title>NSH Poster Podcast: P-03 (2022)</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/2023-poster-podcasts-p-03/</link>
                    <comments>https://nshpodcasts.podbean.com/e/2023-poster-podcasts-p-03/#comments</comments>        <pubDate>Sat, 08 Apr 2023 09:32:00 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/fbf8707b-55c5-3cb5-9aad-2f27daea5764</guid>
                                    <description><![CDATA[<p>Title:  Histological assessment of C1q expression and deposition at the neuromuscular junction (NMJ) in Tibialis Anterior (TA) Tissue of SOD1G93A Mouse Model</p>
<p> </p>
<p>Authors: Joseph Vereen, MS, Annexon Biosciences, Brisbane, CA
Alessia Tassoni, PhD, Annexon Biosciences, Brisbane, CA
Larry Mattheakis, PhD, Annexon Biosciences, Brisbane, CA
Ellen Cahir-McFarland ,PhD, Annexon Biosciences, Brisbane, CA
Ted Yednock, PhD, Annexon Biosciences, Brisbane, CA
Yaisa Andrews-Zwilling, PhD, Annexon Biosciences, Brisbane, CA</p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Title:  Histological assessment of C1q expression and deposition at the neuromuscular junction (NMJ) in Tibialis Anterior (TA) Tissue of SOD1G93A Mouse Model</p>
<p> </p>
<p>Authors: Joseph Vereen, MS, Annexon Biosciences, Brisbane, CA<br>
Alessia Tassoni, PhD, Annexon Biosciences, Brisbane, CA<br>
Larry Mattheakis, PhD, Annexon Biosciences, Brisbane, CA<br>
Ellen Cahir-McFarland ,PhD, Annexon Biosciences, Brisbane, CA<br>
Ted Yednock, PhD, Annexon Biosciences, Brisbane, CA<br>
Yaisa Andrews-Zwilling, PhD, Annexon Biosciences, Brisbane, CA</p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/hgu5uf/P03_podbean.mp3" length="29007456" type="audio/mpeg"/>
        <itunes:summary>NSH Poster Podcast from 2022</itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>725</itunes:duration>
                <itunes:episode>131</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>What is Mentorship?</title>
        <itunes:title>What is Mentorship?</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/what-is-mentorship/</link>
                    <comments>https://nshpodcasts.podbean.com/e/what-is-mentorship/#comments</comments>        <pubDate>Wed, 23 Nov 2022 22:50:57 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/8e5cc88c-2c9b-3e99-95db-adbc752a9a74</guid>
                                    <description><![CDATA[<p>In this episode, NSH members Ashley Carter and Colleen Wisnieski talk about their experiences with mentorship.  Each explain how they have personally been involved with mentorship and by doing so help to better define how mentor-mentee relationships work.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, NSH members Ashley Carter and Colleen Wisnieski talk about their experiences with mentorship.  Each explain how they have personally been involved with mentorship and by doing so help to better define how mentor-mentee relationships work.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wap6i6/Mentorship.mp3" length="56861301" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, NSH members Ashley Carter and Colleen Wisnieski talk about their experiences with mentorship.  Each explain how they have personally been involved with mentorship and by doing so help to better define how mentor-mentee relationships work.]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1421</itunes:duration>
                <itunes:episode>130</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Celebrating Histotechnologists in the Lab - Pamela Vizcarra</title>
        <itunes:title>Celebrating Histotechnologists in the Lab - Pamela Vizcarra</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/labweek6/</link>
                    <comments>https://nshpodcasts.podbean.com/e/labweek6/#comments</comments>        <pubDate>Sun, 24 Apr 2022 02:25:00 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/9a672e56-0dfb-3689-80d8-3cfb68a321c4</guid>
                                    <description><![CDATA[<p>This podcast celebrates histotechnologists as part of Medical Laboratory Professionals Week. In this series, we celebrate histotechs who work in a variety of different settings including research, clinical, and veterinary labs and a medical examiner's office. </p>
<p>In this episode, Pamela Vizcarra discusses how she started out as a lab assistant and was able to receive on-the-job training to become a histology supervisor in a research lab doing clinical trials. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast celebrates histotechnologists as part of Medical Laboratory Professionals Week. In this series, we celebrate histotechs who work in a variety of different settings including research, clinical, and veterinary labs and a medical examiner's office. </p>
<p>In this episode, Pamela Vizcarra discusses how she started out as a lab assistant and was able to receive on-the-job training to become a histology supervisor in a research lab doing clinical trials. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fhkzwc/LabWeekPamVizcarra_Final.mp3" length="15814574" type="audio/mpeg"/>
        <itunes:summary>This podcast celebrates histotechnologists as part of Medical Laboratory Professionals Week. In this series, we celebrate histotechs who work in a variety of different settings including research, clinical, and veterinary labs and a coroner’s office. 

In this episode, Pamela Vizcarra discusses how she started out as a lab assistant and was able to receive on-the-job training to become a histology supervisor in a research lab doing clinical trials.</itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>395</itunes:duration>
                <itunes:episode>129</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Clelebrating Histotechnologists in the Lab - Peter Socki</title>
        <itunes:title>Clelebrating Histotechnologists in the Lab - Peter Socki</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/labweek5/</link>
                    <comments>https://nshpodcasts.podbean.com/e/labweek5/#comments</comments>        <pubDate>Sun, 24 Apr 2022 02:25:00 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/8f67bc8b-0b41-3a03-a588-0b33fd5dbbec</guid>
                                    <description><![CDATA[<p>This podcast celebrates histotechnologists as part of Medical Laboratory Professionals Week. In this series, we celebrate histotechs who work in a variety of different settings including research, clinical, and veterinary labs and a medical examiner's office. </p>
<p>In this episode, Peter Socki explains how his love of crime shows as a child lead to him becoming a histotechnologist working in a medical examiner's office.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast celebrates histotechnologists as part of Medical Laboratory Professionals Week. In this series, we celebrate histotechs who work in a variety of different settings including research, clinical, and veterinary labs and a medical examiner's office. </p>
<p>In this episode, Peter Socki explains how his love of crime shows as a child lead to him becoming a histotechnologist working in a medical examiner's office.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jugtcq/Peter-Lab_Week_Recording_Finalvs29tm53.mp3" length="13022607" type="audio/mpeg"/>
        <itunes:summary>This podcast celebrates histotechnologists as part of Medical Laboratory Professionals Week. In this series, we celebrate histotechs who work in a variety of different settings including research, clinical, and veterinary labs and a coroner’s office. 

In this episode, Peter Socki explains how his love of crime shows as a child lead to him becoming a histotechnologist working in a medical examiner’s office.</itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>325</itunes:duration>
                <itunes:episode>128</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Celebrating Histotechnologists in the Lab - Sean Moynihan</title>
        <itunes:title>Celebrating Histotechnologists in the Lab - Sean Moynihan</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/labweek4/</link>
                    <comments>https://nshpodcasts.podbean.com/e/labweek4/#comments</comments>        <pubDate>Sun, 24 Apr 2022 02:25:00 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/e63c07c3-087c-31a0-a8bd-c1e9c9e4c98b</guid>
                                    <description><![CDATA[<p>This podcast celebrates histotechnologists as part of Medical Laboratory Professionals Week. In this series, we celebrate histotechs who work in a variety of different settings including research, clinical, and veterinary labs and a medical examiner's office. </p>
<p>In this episode, Sean Moynihan discusses how he applies his degree in biology with a focus on nuclear medicine to what he does on a day-to-day basis working in a dermatopathology outreach lab.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast celebrates histotechnologists as part of Medical Laboratory Professionals Week. In this series, we celebrate histotechs who work in a variety of different settings including research, clinical, and veterinary labs and a medical examiner's office. </p>
<p>In this episode, Sean Moynihan discusses how he applies his degree in biology with a focus on nuclear medicine to what he does on a day-to-day basis working in a dermatopathology outreach lab.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wj9b53/LabWeekSeanMoynihan_Final.mp3" length="10772942" type="audio/mpeg"/>
        <itunes:summary>This podcast celebrates histotechnologists as part of Medical Laboratory Professionals Week. In this series, we celebrate histotechs who work in a variety of different settings including research, clinical, and veterinary labs and a coroner’s office. 

In this episode, Sean Moynihan discusses how he applies his degree in biology with a focus on nuclear medicine to what he does on a day-to-day basis working in a dermatopathology outreach lab.</itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>269</itunes:duration>
                <itunes:episode>127</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Celebrating Histotechnologists in the Lab - Katelin Murphy</title>
        <itunes:title>Celebrating Histotechnologists in the Lab - Katelin Murphy</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/labweek3/</link>
                    <comments>https://nshpodcasts.podbean.com/e/labweek3/#comments</comments>        <pubDate>Sun, 24 Apr 2022 02:25:00 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/6ce95b92-d388-3889-b445-eacec7003936</guid>
                                    <description><![CDATA[<p>This podcast celebrates histotechnologists as part of Medical Laboratory Professionals Week. In this series, we celebrate histotechs who work in a variety of different settings including research, clinical, and veterinary labs and a medical examiner's office. </p>
<p>In this episode, Katelin Murphy discusses how she became interested in histology through a recommendation by her high school guidance counselor and now works in a veterinary pathology lab. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast celebrates histotechnologists as part of Medical Laboratory Professionals Week. In this series, we celebrate histotechs who work in a variety of different settings including research, clinical, and veterinary labs and a medical examiner's office. </p>
<p>In this episode, Katelin Murphy discusses how she became interested in histology through a recommendation by her high school guidance counselor and now works in a veterinary pathology lab. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/y99eec/LabWeekKatelinMurphy.mp3" length="11991293" type="audio/mpeg"/>
        <itunes:summary>This podcast celebrates histotechnologists as part of Medical Laboratory Professionals Week. In this series, we celebrate histotechs who work in a variety of different settings including research, clinical, and veterinary labs and a coroner’s office. 

In this episode, Katelin Murphy discusses how she became interested in histology through a recommendation by her high school guidance counselor and now works in a veterinary pathology lab.</itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>299</itunes:duration>
                <itunes:episode>126</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Celebrating Histotechnologists in the Lab - Jennifer Betustak</title>
        <itunes:title>Celebrating Histotechnologists in the Lab - Jennifer Betustak</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/labweek2/</link>
                    <comments>https://nshpodcasts.podbean.com/e/labweek2/#comments</comments>        <pubDate>Sun, 24 Apr 2022 02:25:00 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/97d2ee9b-1bf6-34e4-ba64-118e2ea49abc</guid>
                                    <description><![CDATA[<p>This podcast celebrates histotechnologists as part of Medical Laboratory Professionals Week. In this series, we celebrate histotechs who work in a variety of different settings including research, clinical, and veterinary labs and a medical examiner's office. </p>
<p>In this episode, Jennifer Betustak explains how she went from being a phlebotomists to becoming a Histology Supervisor.</p>
 ]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast celebrates histotechnologists as part of Medical Laboratory Professionals Week. In this series, we celebrate histotechs who work in a variety of different settings including research, clinical, and veterinary labs and a medical examiner's office. </p>
<p>In this episode, Jennifer Betustak explains how she went from being a phlebotomists to becoming a Histology Supervisor.</p>
 ]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/35yqmm/LabWeekJennyBetustakFinal.mp3" length="8702999" type="audio/mpeg"/>
        <itunes:summary>This podcast celebrates histotechnologists as part of Medical Laboratory Professionals Week. In this series, we celebrate histotechs who work in a variety of different settings including research, clinical, and veterinary labs and a coroner’s office. 

In this episode, Jennifer Betustak explains how she went from being a phlebotomists to becoming a Histology Supervisor.</itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>217</itunes:duration>
                <itunes:episode>125</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Celebrating Histotechnologists in the Lab - Janet Tunnicliffe</title>
        <itunes:title>Celebrating Histotechnologists in the Lab - Janet Tunnicliffe</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/labweek1/</link>
                    <comments>https://nshpodcasts.podbean.com/e/labweek1/#comments</comments>        <pubDate>Sun, 24 Apr 2022 02:25:00 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/1c62ed3f-5746-3e93-8cb2-bb10975b624b</guid>
                                    <description><![CDATA[<p>This podcast celebrates histotechnologists as part of Medical Laboratory Professionals Week. In this series, we celebrate histotechs who work in a variety of different settings including research, clinical, and veterinary labs and a coroner’s office. </p>
<p>In this episode, we speak with Janet Tunnicliffe about her experience in British Columbia working as a histotech and she gives thoughtful advice to those considering Histotechnology as a career.  </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast celebrates histotechnologists as part of Medical Laboratory Professionals Week. In this series, we celebrate histotechs who work in a variety of different settings including research, clinical, and veterinary labs and a coroner’s office. </p>
<p>In this episode, we speak with Janet Tunnicliffe about her experience in British Columbia working as a histotech and she gives thoughtful advice to those considering Histotechnology as a career.  </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/33vpcj/LabWeekJanet_TunnicliffeFinal7vqfu.mp3" length="21438215" type="audio/mpeg"/>
        <itunes:summary>This podcast celebrates histotechnologists as part of Medical Laboratory Professionals Week. In this series, we celebrate histotechs who work in a variety of different settings including research, clinical, and veterinary labs and a coroner’s office. 

In this episode, we speak with Janet Tunnicliffe about her experience in British Columbia working as a histotech and she gives thoughtful advice to those considering Histotechnology as a career.</itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>535</itunes:duration>
                <itunes:episode>124</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Women in Histology 2021 - Haydee Lara Histology Outreach</title>
        <itunes:title>Women in Histology 2021 - Haydee Lara Histology Outreach</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/women-in-histology-2021-haydee-lara-histology-outreach/</link>
                    <comments>https://nshpodcasts.podbean.com/e/women-in-histology-2021-haydee-lara-histology-outreach/#comments</comments>        <pubDate>Thu, 05 Aug 2021 14:02:56 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/a24a0857-781b-3c3d-98bb-94869a66fde6</guid>
                                    <description><![CDATA[<p>In this episode NSH members David Krull and Haydee Lara, Cellular Biomarker Investigator with GSK discuss Ms. Lara's incredible outreach work with STEM programming, her own journey into science and histology, and what is next for her career.  </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode NSH members David Krull and Haydee Lara, Cellular Biomarker Investigator with GSK discuss Ms. Lara's incredible outreach work with STEM programming, her own journey into science and histology, and what is next for her career.  </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/adtuz5/Women_in_Histology_Lara9kgac.mp3" length="49613889" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode NSH members David Krull and Haydee Lara, Cellular Biomarker Investigator with GSK discuss Ms. Lara's incredible outreach work with STEM programming, her own journey into science and histology, and what is next for her career.  ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1240</itunes:duration>
                <itunes:episode>123</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/women_in_histologybro0v.png" medium="image">
                            <media:title type="html">Women in Histology 2021 - Haydee Lara Histology Outreach</media:title></media:content>    </item>
    <item>
        <title>Women in Histology 2021 - Faith Rice Falloposcope</title>
        <itunes:title>Women in Histology 2021 - Faith Rice Falloposcope</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/women-in-histology-2021-faith-rice-falloposcope/</link>
                    <comments>https://nshpodcasts.podbean.com/e/women-in-histology-2021-faith-rice-falloposcope/#comments</comments>        <pubDate>Tue, 03 Aug 2021 16:18:14 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/2778d7e4-625f-3fd2-bc69-cae8693faae2</guid>
                                    <description><![CDATA[<p>In this episode Michelle Bell interviews Faith Rice, Senior Research Specialist from the University of Arizona to discuss Falloposcope, a project that will potentially save lives but providing early detection for ovarian cancer.  They also discuss working in research.  To learn more about this project, <a href='http://bmeoptics.engr.arizona.edu/researchMinis/falloposcope_Overview.html'>click here.</a></p>
<p>Published:</p>
<p>Kelli C. Kiekens, Gabriella Romano, Dominique Galvez, Ricky Cordova, John Heusinkveld, Kenneth Hatch, William Drake, Zaynah Kmeid, Jennifer K. Barton"Re-engineering a Falloposcope Imaging System for Clinical Use", Translational biophotonics, Volume2, Issue4, November 2020, e202000011.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode Michelle Bell interviews Faith Rice, Senior Research Specialist from the University of Arizona to discuss Falloposcope, a project that will potentially save lives but providing early detection for ovarian cancer.  They also discuss working in research.  To learn more about this project, <a href='http://bmeoptics.engr.arizona.edu/researchMinis/falloposcope_Overview.html'>click here.</a></p>
<p>Published:</p>
<p>Kelli C. Kiekens, Gabriella Romano, Dominique Galvez, Ricky Cordova, John Heusinkveld, Kenneth Hatch, William Drake, Zaynah Kmeid, Jennifer K. Barton"Re-engineering a Falloposcope Imaging System for Clinical Use", Translational biophotonics, Volume2, Issue4, November 2020, e202000011.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/aqbjhp/Women_in_Histology_Ricebk5lt.mp3" length="45235766" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode Michelle Bell interviews Faith Rice, Senior Research Specialist from the University of Arizona to discuss Falloposcope, a project that will potentially save lives but providing early detection for ovarian cancer.  They also discuss working in research.  To learn more about this project, click here.
Published:
Kelli C. Kiekens, Gabriella Romano, Dominique Galvez, Ricky Cordova, John Heusinkveld, Kenneth Hatch, William Drake, Zaynah Kmeid, Jennifer K. Barton"Re-engineering a Falloposcope Imaging System for Clinical Use", Translational biophotonics, Volume2, Issue4, November 2020, e202000011.]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1130</itunes:duration>
                <itunes:episode>122</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/women_in_histologybro0v.png" medium="image">
                            <media:title type="html">Women in Histology 2021 - Faith Rice Falloposcope</media:title></media:content>    </item>
    <item>
        <title>Women in Histology 2021 - Dr. Elisa Balducci DYRK1A</title>
        <itunes:title>Women in Histology 2021 - Dr. Elisa Balducci DYRK1A</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/women-in-histology-2021-dr-elisa-balducci-dyrk1a/</link>
                    <comments>https://nshpodcasts.podbean.com/e/women-in-histology-2021-dr-elisa-balducci-dyrk1a/#comments</comments>        <pubDate>Mon, 26 Jul 2021 20:41:28 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/17e6c5ea-d44c-3e75-9ab2-85afa2629c24</guid>
                                    <description><![CDATA[<p>In this episode Dr. Elisa Balducci and Andrea Transou discuss Dr. Balducci's research journey with DYRK1A, her transition from research to industry, and her STEM outreach work.  </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode Dr. Elisa Balducci and Andrea Transou discuss Dr. Balducci's research journey with DYRK1A, her transition from research to industry, and her STEM outreach work.  </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/byg34x/Women_in_Histology_Balducci65a58.mp3" length="73431293" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode Dr. Elisa Balducci and Andrea Transou discuss Dr. Balducci's research journey with DYRK1A, her transition from research to industry, and her STEM outreach work.  ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1835</itunes:duration>
                <itunes:episode>121</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/women_in_histologybro0v.png" medium="image">
                            <media:title type="html">Women in Histology 2021 - Dr. Elisa Balducci DYRK1A</media:title></media:content>    </item>
    <item>
        <title>AwardsCast: Automation, Standardization, and Validation</title>
        <itunes:title>AwardsCast: Automation, Standardization, and Validation</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/awardscast-automation-standardization-and-validation/</link>
                    <comments>https://nshpodcasts.podbean.com/e/awardscast-automation-standardization-and-validation/#comments</comments>        <pubDate>Mon, 26 Apr 2021 09:12:00 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/50880312-54f7-3c6a-abdd-81012b980d00</guid>
                                    <description><![CDATA[<p>In this episode of NSH’s podcast series AwardsCast, Nadia Gale, Region IX Director and member of the IHC Committee talks to Jeremy Johnston, who happens to be Region VIII Director and the 2020 recipient of the Excellence in Standardization of IHC scholarship. They talk about all things IHC; everything from how automation has impacted standardization, to the definition of companion diagnostics, to which antibodies are giving them grief during the validation process. Applications for the 2021 Excellence in Standardization of IHC Scholarship, sponsored by Agilent Dako, are open through June 4th. <a href='https://www.nsh.org/learn/scholarships/ihc-scholarship'>Apply today!</a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode of NSH’s podcast series AwardsCast, Nadia Gale, Region IX Director and member of the IHC Committee talks to Jeremy Johnston, who happens to be Region VIII Director and the 2020 recipient of the Excellence in Standardization of IHC scholarship. They talk about all things IHC; everything from how automation has impacted standardization, to the definition of companion diagnostics, to which antibodies are giving them grief during the validation process. Applications for the 2021 Excellence in Standardization of IHC Scholarship, sponsored by Agilent Dako, are open through June 4th. <a href='https://www.nsh.org/learn/scholarships/ihc-scholarship'>Apply today!</a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/2jxqk6/Excellence_in_Standardization_of_IHC7lc4p.mp3" length="29915666" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode of NSH’s podcast series AwardsCast, Nadia Gale, Region IX Director and member of the IHC Committee talks to Jeremy Johnston, who happens to be Region VIII Director and the 2020 recipient of the Excellence in Standardization of IHC scholarship. They talk about all things IHC; everything from how automation has impacted standardization, to the definition of companion diagnostics, to which antibodies are giving them grief during the validation process. Applications for the 2021 Excellence in Standardization of IHC Scholarship, sponsored by Agilent Dako, are open through June 4th. Apply today!
 ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2782</itunes:duration>
                <itunes:episode>120</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/awardscast_6yze27.png" medium="image">
                            <media:title type="html">AwardsCast: Automation, Standardization, and Validation</media:title></media:content>    </item>
    <item>
        <title>AwardsCast: Visualizing Inflammasome Structure</title>
        <itunes:title>AwardsCast: Visualizing Inflammasome Structure</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/awardscast-visualizing-inflammasome-structure/</link>
                    <comments>https://nshpodcasts.podbean.com/e/awardscast-visualizing-inflammasome-structure/#comments</comments>        <pubDate>Mon, 26 Apr 2021 09:08:00 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/f1db6842-e629-37b4-a5ea-4e76f2c44a50</guid>
                                    <description><![CDATA[<p>In this episode of AwardsCast, the 2020 recipient of the Newcomer Helping Hand Award, Dr. Regina Vontell, sits down with Konnie Zeitner, NSH Speaker of the House and fellow past award recipient, to discuss Dr. Vontell’s work with visualizing inflammasome structure in the brain. Applications for the 2021 Newcomer Helping Hand Award, sponsored by Newcomer Supply, are open until June 4th. <a href='https://www.nsh.org/learn/scholarships/newcomer-scholarship'>Apply today! </a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode of AwardsCast, the 2020 recipient of the Newcomer Helping Hand Award, Dr. Regina Vontell, sits down with Konnie Zeitner, NSH Speaker of the House and fellow past award recipient, to discuss Dr. Vontell’s work with visualizing inflammasome structure in the brain. Applications for the 2021 Newcomer Helping Hand Award, sponsored by Newcomer Supply, are open until June 4th. <a href='https://www.nsh.org/learn/scholarships/newcomer-scholarship'>Apply today! </a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/j848id/Newcomer_Helping_Hand9c6yw.mp3" length="12135480" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode of AwardsCast, the 2020 recipient of the Newcomer Helping Hand Award, Dr. Regina Vontell, sits down with Konnie Zeitner, NSH Speaker of the House and fellow past award recipient, to discuss Dr. Vontell’s work with visualizing inflammasome structure in the brain. Applications for the 2021 Newcomer Helping Hand Award, sponsored by Newcomer Supply, are open until June 4th. Apply today! 
 ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1314</itunes:duration>
                <itunes:episode>119</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/awardscast_efyrbc.png" medium="image">
                            <media:title type="html">AwardsCast: Visualizing Inflammasome Structure</media:title></media:content>    </item>
    <item>
        <title>AwardsCast: Histotech of the Year</title>
        <itunes:title>AwardsCast: Histotech of the Year</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/awardscast-histotech-of-the-year/</link>
                    <comments>https://nshpodcasts.podbean.com/e/awardscast-histotech-of-the-year/#comments</comments>        <pubDate>Mon, 26 Apr 2021 09:04:00 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/1abbe89a-be7f-3636-9d51-267891658d35</guid>
                                    <description><![CDATA[<p>In this episode of AwardsCast, LaVinia Ray, the 2020 recipient of the Histotech of the Year Award, talks about how she has grown in her career at Southern Research, where she is currently working on COVID-19 studies. She describes the benefits of NSH volunteerism, working 20 years for one institution, and how she feels about being one of the great histotechs honored with this most prestigious NSH award. Applications are now open for the 2021 Histotech of the Year Award, sponsored by Epredia. <a href='https://www.nsh.org/membership/awards/histotechnologist-award'>Nominate today!</a> </p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode of AwardsCast, LaVinia Ray, the 2020 recipient of the Histotech of the Year Award, talks about how she has grown in her career at Southern Research, where she is currently working on COVID-19 studies. She describes the benefits of NSH volunteerism, working 20 years for one institution, and how she feels about being one of the great histotechs honored with this most prestigious NSH award. Applications are now open for the 2021 Histotech of the Year Award, sponsored by Epredia. <a href='https://www.nsh.org/membership/awards/histotechnologist-award'>Nominate today!</a> </p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7a6d6n/Histotech_of_the_Yearb7pz2.mp3" length="9908651" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode of AwardsCast, LaVinia Ray, the 2020 recipient of the Histotech of the Year Award, talks about how she has grown in her career at Southern Research, where she is currently working on COVID-19 studies. She describes the benefits of NSH volunteerism, working 20 years for one institution, and how she feels about being one of the great histotechs honored with this most prestigious NSH award. Applications are now open for the 2021 Histotech of the Year Award, sponsored by Epredia. Nominate today! 
 ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1088</itunes:duration>
                <itunes:episode>118</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/awardscast_spbtz8.png" medium="image">
                            <media:title type="html">AwardsCast: Histotech of the Year</media:title></media:content>    </item>
    <item>
        <title>AwardsCast: The Philippines</title>
        <itunes:title>AwardsCast: The Philippines</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/awardscast-the-philippines/</link>
                    <comments>https://nshpodcasts.podbean.com/e/awardscast-the-philippines/#comments</comments>        <pubDate>Mon, 26 Apr 2021 08:59:00 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/d78dad0e-c7a0-3d01-bce1-54b2cfcba983</guid>
                                    <description><![CDATA[<p>In this episode of AwardsCast, Evelyn Diaz, the 2020 recipient of the Lee Luna Foreign Travel Scholarship, and Jomar Klee Custodio, the President of the Philippine Society for Histotechnology, discuss Evelyn’s plans to use her scholarship to return to her country of origin, the Philippines, to assist the PSH in their mission of raising the bar for histotechnology. Applications for the 2021 Lee Luna Foreign Travel Scholarship, sponsored by Sakura Fintek, USA, are open through June 4th. <a href='https://www.nsh.org/learn/scholarships/foreign-travel-scholarship'>Apply today! </a></p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode of AwardsCast, Evelyn Diaz, the 2020 recipient of the Lee Luna Foreign Travel Scholarship, and Jomar Klee Custodio, the President of the Philippine Society for Histotechnology, discuss Evelyn’s plans to use her scholarship to return to her country of origin, the Philippines, to assist the PSH in their mission of raising the bar for histotechnology. Applications for the 2021 Lee Luna Foreign Travel Scholarship, sponsored by Sakura Fintek, USA, are open through June 4th. <a href='https://www.nsh.org/learn/scholarships/foreign-travel-scholarship'>Apply today! </a></p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/b3mnix/Lee_Luna960q6.mp3" length="8077237" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode of AwardsCast, Evelyn Diaz, the 2020 recipient of the Lee Luna Foreign Travel Scholarship, and Jomar Klee Custodio, the President of the Philippine Society for Histotechnology, discuss Evelyn’s plans to use her scholarship to return to her country of origin, the Philippines, to assist the PSH in their mission of raising the bar for histotechnology. Applications for the 2021 Lee Luna Foreign Travel Scholarship, sponsored by Sakura Fintek, USA, are open through June 4th. Apply today! 
 ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>803</itunes:duration>
                <itunes:episode>117</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/awardscast_k3m8yf.png" medium="image">
                            <media:title type="html">AwardsCast: The Philippines</media:title></media:content>    </item>
    <item>
        <title>AwardsCast: Reproducibility in Scientific Research</title>
        <itunes:title>AwardsCast: Reproducibility in Scientific Research</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/awardscast-reproducibility-in-scientific-research/</link>
                    <comments>https://nshpodcasts.podbean.com/e/awardscast-reproducibility-in-scientific-research/#comments</comments>        <pubDate>Mon, 26 Apr 2021 08:58:00 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/85cc7a14-2c6c-314e-852f-6fa1c6453ba5</guid>
                                    <description><![CDATA[<p>In this episode of AwardsCast, Gayle Callis, Editor in Chief of the Journal of Histotechnology, meets with Luis Chiriboga, Region I Director, and the 2020 recipient of the Editor’s Award, a unique NSH award given by the Journal Editor for outstanding accomplishments in the realm of publications. They talk about the importance of reproducibility in scientific research and the steps JOH has taken to improve its standing in the scientific research community.</p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode of AwardsCast, Gayle Callis, Editor in Chief of the Journal of Histotechnology, meets with Luis Chiriboga, Region I Director, and the 2020 recipient of the Editor’s Award, a unique NSH award given by the Journal Editor for outstanding accomplishments in the realm of publications. They talk about the importance of reproducibility in scientific research and the steps JOH has taken to improve its standing in the scientific research community.</p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/u5buex/Editors_Award74pb5.mp3" length="5183032" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode of AwardsCast, Gayle Callis, Editor in Chief of the Journal of Histotechnology, meets with Luis Chiriboga, Region I Director, and the 2020 recipient of the Editor’s Award, a unique NSH award given by the Journal Editor for outstanding accomplishments in the realm of publications. They talk about the importance of reproducibility in scientific research and the steps JOH has taken to improve its standing in the scientific research community.
 ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>563</itunes:duration>
                <itunes:episode>116</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/awardscast_swrnz7.png" medium="image">
                            <media:title type="html">AwardsCast: Reproducibility in Scientific Research</media:title></media:content>    </item>
    <item>
        <title>HistoHelp Podcast: AI in the Lab - Part 2</title>
        <itunes:title>HistoHelp Podcast: AI in the Lab - Part 2</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/histohelp-podcast-ai-in-the-lab-part-2/</link>
                    <comments>https://nshpodcasts.podbean.com/e/histohelp-podcast-ai-in-the-lab-part-2/#comments</comments>        <pubDate>Wed, 17 Mar 2021 01:43:00 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/4a13bdc6-9267-33ed-a605-cd60df0ee535</guid>
                                    <description><![CDATA[<p>Welcome to HistoHelp, the podcast series filled with tips and tricks for the lab.  The great advice in this series is provided by NSH members who are here to help you with your common...and not so common problems! In Part 2 of this episode NSH member David Krull and Adam Smith, Indica Labs continue their discussion about AI in the lab and dive deeper into multiplexing and challenges with implementation. ,</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Welcome to HistoHelp, the podcast series filled with tips and tricks for the lab.  The great advice in this series is provided by NSH members who are here to help you with your common...and not so common problems! In Part 2 of this episode NSH member David Krull and Adam Smith, Indica Labs continue their discussion about AI in the lab and dive deeper into multiplexing and challenges with implementation. ,</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/wgw8pj/AI_Part_2_Finalbggpv.mp3" length="51396485" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Welcome to HistoHelp, the podcast series filled with tips and tricks for the lab.  The great advice in this series is provided by NSH members who are here to help you with your common...and not so common problems! In Part 2 of this episode NSH member David Krull and Adam Smith, Indica Labs continue their discussion about AI in the lab and dive deeper into multiplexing and challenges with implementation. ,]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1284</itunes:duration>
                <itunes:episode>115</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/podbeanlogo.png" medium="image">
                            <media:title type="html">HistoHelp Podcast: AI in the Lab - Part 2</media:title></media:content>    </item>
    <item>
        <title>HistoHelp Podcast: AI in the Lab - Part 1</title>
        <itunes:title>HistoHelp Podcast: AI in the Lab - Part 1</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/histohelp-podcast-ai-in-the-lab-part-1/</link>
                    <comments>https://nshpodcasts.podbean.com/e/histohelp-podcast-ai-in-the-lab-part-1/#comments</comments>        <pubDate>Wed, 17 Mar 2021 01:39:00 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/39323c21-b085-3ad8-819e-803ba62eaaa8</guid>
                                    <description><![CDATA[<p>Welcome to HistoHelp, the podcast series filled with tips and tricks for the lab.  The great advice in this series is provided by NSH members who are here to help you with your common...and not so common problems! In Part 1 of this episode NSH member David Krull invites Adam Smith, Indica Labs to talk about AI in the lab, discuss validation, understanding data, and ways you can implement AI/digital in the lab. </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Welcome to HistoHelp, the podcast series filled with tips and tricks for the lab.  The great advice in this series is provided by NSH members who are here to help you with your common...and not so common problems! In Part 1 of this episode NSH member David Krull invites Adam Smith, Indica Labs to talk about AI in the lab, discuss validation, understanding data, and ways you can implement AI/digital in the lab. </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/9n64jv/AI_Part_1_Final7e9j4.mp3" length="21295073" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Welcome to HistoHelp, the podcast series filled with tips and tricks for the lab.  The great advice in this series is provided by NSH members who are here to help you with your common...and not so common problems! In Part 1 of this episode NSH member David Krull invites Adam Smith, Indica Labs to talk about AI in the lab, discuss validation, understanding data, and ways you can implement AI/digital in the lab. ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1488</itunes:duration>
                <itunes:episode>114</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/podbeanlogo.png" medium="image">
                            <media:title type="html">HistoHelp Podcast: AI in the Lab - Part 1</media:title></media:content>    </item>
    <item>
        <title>HistoHelp Podcast: Bielschowsky Stain</title>
        <itunes:title>HistoHelp Podcast: Bielschowsky Stain</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/histohelp-podcast-bielschowsky-stain/</link>
                    <comments>https://nshpodcasts.podbean.com/e/histohelp-podcast-bielschowsky-stain/#comments</comments>        <pubDate>Wed, 17 Mar 2021 01:31:00 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/486442d0-4339-3f26-ad77-e525b66d0026</guid>
                                    <description><![CDATA[<p>Welcome to HistoHelp, the podcast series filled with tips and tricks for the lab.  The great advice in this series is provided by NSH members who are here to help you with your common...and not so common problems! In this episode, NSH member Eric Peterson really does come across a not so common problem involving polar bear tissue.  </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Welcome to HistoHelp, the podcast series filled with tips and tricks for the lab.  The great advice in this series is provided by NSH members who are here to help you with your common...and not so common problems! In this episode, NSH member Eric Peterson really does come across a not so common problem involving polar bear tissue.  </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/xy9wq9/Peterson_Polar_Bear_Final8cdx9.mp3" length="14661007" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Welcome to HistoHelp, the podcast series filled with tips and tricks for the lab.  The great advice in this series is provided by NSH members who are here to help you with your common...and not so common problems! In this episode, NSH member Eric Peterson really does come across a not so common problem involving polar bear tissue.  ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>366</itunes:duration>
                <itunes:episode>113</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/podbeanlogo.png" medium="image">
                            <media:title type="html">HistoHelp Podcast: Bielschowsky Stain</media:title></media:content>    </item>
    <item>
        <title>HistoHelp Podcast: Carrots for Decal End Point Training</title>
        <itunes:title>HistoHelp Podcast: Carrots for Decal End Point Training</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/histohelp-podcast-carrots-for-decal-end-point-training/</link>
                    <comments>https://nshpodcasts.podbean.com/e/histohelp-podcast-carrots-for-decal-end-point-training/#comments</comments>        <pubDate>Wed, 17 Mar 2021 01:12:00 -0400</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/05f4da86-3723-39af-bf5d-7f0c4f94308c</guid>
                                    <description><![CDATA[<p>Welcome to HistoHelp, the podcast series filled with tips and tricks for the lab.  The great advice in this series is provided by NSH members who are here to help you with your common...and not-so-common problems! In this episode, NSH member Linda Culpepper shares a great training strategy using carrots.   </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Welcome to HistoHelp, the podcast series filled with tips and tricks for the lab.  The great advice in this series is provided by NSH members who are here to help you with your common...and not-so-common problems! In this episode, NSH member Linda Culpepper shares a great training strategy using carrots.   </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/kkzcmy/Culpepper_Final.mp3" length="7880438" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Welcome to HistoHelp, the podcast series filled with tips and tricks for the lab.  The great advice in this series is provided by NSH members who are here to help you with your common...and not-so-common problems! In this episode, NSH member Linda Culpepper shares a great training strategy using carrots.   ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>596</itunes:duration>
                <itunes:episode>112</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
        <media:content url="https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog1355248/podbeanlogo.png" medium="image">
                            <media:title type="html">HistoHelp Podcast: Carrots for Decal End Point Training</media:title></media:content>    </item>
    <item>
        <title>Histology Abroad: The Netherlands</title>
        <itunes:title>Histology Abroad: The Netherlands</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/histology-abroad-the-netherlands/</link>
                    <comments>https://nshpodcasts.podbean.com/e/histology-abroad-the-netherlands/#comments</comments>        <pubDate>Mon, 08 Feb 2021 10:03:20 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/f50c043b-80e3-3170-92fe-2453373f5560</guid>
                                    <description><![CDATA[<p>In this episode, Luc Nelemans, Senior Application Specialist with Sakura Finetek Europe, shares his experiences visiting labs across Europe, Russia, India, and the Middle East, providing training on histology equipment, and how COVID has forced them to innovate, providing digital opportunities for virtual equipment training.</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, Luc Nelemans, Senior Application Specialist with Sakura Finetek Europe, shares his experiences visiting labs across Europe, Russia, India, and the Middle East, providing training on histology equipment, and how COVID has forced them to innovate, providing digital opportunities for virtual equipment training.</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/8y45gi/Histology_Abroad_Netherlands.mp3" length="12189175" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, Luc Nelemans, Senior Application Specialist with Sakura Finetek Europe, shares his experiences visiting labs across Europe, Russia, India, and the Middle East, providing training on histology equipment, and how COVID has forced them to innovate, providing digital opportunities for virtual equipment training.]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1143</itunes:duration>
                <itunes:episode>111</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Histology Abroad: Qatar</title>
        <itunes:title>Histology Abroad: Qatar</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/histology-abroad-qatar/</link>
                    <comments>https://nshpodcasts.podbean.com/e/histology-abroad-qatar/#comments</comments>        <pubDate>Mon, 08 Feb 2021 10:01:44 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/68ccc36e-5b05-3bdf-bfe0-b9772e0c6bc2</guid>
                                    <description><![CDATA[<p>In this episode, Arfilson Mars Tansio discusses his previous work in the Philippines, as well as the rise of automation at his current lab, one of the largest histology providers in Qatar. He shares the similarities between Qatar’s continuing education requirements, and those of the United States, as well as how being an NSH member has helped him in his career.</p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, Arfilson Mars Tansio discusses his previous work in the Philippines, as well as the rise of automation at his current lab, one of the largest histology providers in Qatar. He shares the similarities between Qatar’s continuing education requirements, and those of the United States, as well as how being an NSH member has helped him in his career.</p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/faxs23/Histology_Abroad_Qatar.mp3" length="8798221" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, Arfilson Mars Tansio discusses his previous work in the Philippines, as well as the rise of automation at his current lab, one of the largest histology providers in Qatar. He shares the similarities between Qatar’s continuing education requirements, and those of the United States, as well as how being an NSH member has helped him in his career.
 ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>925</itunes:duration>
                <itunes:episode>110</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Histology Abroad: Italy</title>
        <itunes:title>Histology Abroad: Italy</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/histology-abroad-italy/</link>
                    <comments>https://nshpodcasts.podbean.com/e/histology-abroad-italy/#comments</comments>        <pubDate>Mon, 08 Feb 2021 09:55:50 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/caa91a08-386b-3970-ac3f-ff3c5d0e7311</guid>
                                    <description><![CDATA[<p>In this episode, Clara Pecorella and Cristina D’Amico, Product Specialists from Diapath, compare and contrast their experiences working in Italy vs the UK, and share their vision for a safer histology laboratory.  </p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, Clara Pecorella and Cristina D’Amico, Product Specialists from Diapath, compare and contrast their experiences working in Italy vs the UK, and share their vision for a safer histology laboratory.  </p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/mvqunq/Histology_Abroad_Italy.mp3" length="9845353" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, Clara Pecorella and Cristina D’Amico, Product Specialists from Diapath, compare and contrast their experiences working in Italy vs the UK, and share their vision for a safer histology laboratory.  
 ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1022</itunes:duration>
                <itunes:episode>109</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Histology Abroad: Liberia</title>
        <itunes:title>Histology Abroad: Liberia</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/histology-abroad-liberia/</link>
                    <comments>https://nshpodcasts.podbean.com/e/histology-abroad-liberia/#comments</comments>        <pubDate>Mon, 08 Feb 2021 09:47:13 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/c204f344-19bd-307c-8210-9228d169d6c1</guid>
                                    <description><![CDATA[<p>In this special two-part episode, we hear from both Ruth Kerkula, one of only 4 histotechs in the country of Liberia, and Dave Davis, one of the NSH members who helped open JFK Memorial Hospital’s first histology lab, where Ruth works.</p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this special two-part episode, we hear from both Ruth Kerkula, one of only 4 histotechs in the country of Liberia, and Dave Davis, one of the NSH members who helped open JFK Memorial Hospital’s first histology lab, where Ruth works.</p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vkgkv9/Histology_Abroad_Liberia.mp3" length="9534891" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this special two-part episode, we hear from both Ruth Kerkula, one of only 4 histotechs in the country of Liberia, and Dave Davis, one of the NSH members who helped open JFK Memorial Hospital’s first histology lab, where Ruth works.
 ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1200</itunes:duration>
                <itunes:episode>108</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Histology Abroad: Canada</title>
        <itunes:title>Histology Abroad: Canada</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/histology-abroad-canada/</link>
                    <comments>https://nshpodcasts.podbean.com/e/histology-abroad-canada/#comments</comments>        <pubDate>Mon, 08 Feb 2021 09:45:13 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/86ee66f0-1661-3748-9f82-f6d2451f18eb</guid>
                                    <description><![CDATA[<p>In this episode, Heidi Maxwell, Medical Laboratory Technologist and Pathology Assistant at Grey Bruce Health Services in Ontario, Canada, shares how she came to be an MLT specializing in histology and grossing, the requirements for Canadian recertification, and how she is working towards her accreditation to be an inspector for the Institute for Quality Management in Healthcare, the Canadian equivalent of a CAP inspector accreditation.</p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, Heidi Maxwell, Medical Laboratory Technologist and Pathology Assistant at Grey Bruce Health Services in Ontario, Canada, shares how she came to be an MLT specializing in histology and grossing, the requirements for Canadian recertification, and how she is working towards her accreditation to be an inspector for the Institute for Quality Management in Healthcare, the Canadian equivalent of a CAP inspector accreditation.</p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/k8bnjn/Histology_Abroad_Canada.mp3" length="10737830" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, Heidi Maxwell, Medical Laboratory Technologist and Pathology Assistant at Grey Bruce Health Services in Ontario, Canada, shares how she came to be an MLT specializing in histology and grossing, the requirements for Canadian recertification, and how she is working towards her accreditation to be an inspector for the Institute for Quality Management in Healthcare, the Canadian equivalent of a CAP inspector accreditation.
 ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1140</itunes:duration>
                <itunes:episode>107</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Histology Abroad: Rwanda and Nigeria</title>
        <itunes:title>Histology Abroad: Rwanda and Nigeria</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/histology-abroad-rwanda-and-nigeria/</link>
                    <comments>https://nshpodcasts.podbean.com/e/histology-abroad-rwanda-and-nigeria/#comments</comments>        <pubDate>Mon, 08 Feb 2021 09:34:55 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/6b0d286d-682d-32ab-aad7-c5fadcf0b195</guid>
                                    <description><![CDATA[<p>In this episode, Emmanuel Hakizimana from Rwanda, and Daniel Osiagwu from Nigeria, compare their experiences working in different countries within Africa, and share some of the challenges they have experienced, including difficulty obtaining reagents and equipment.</p>
<p> </p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, Emmanuel Hakizimana from Rwanda, and Daniel Osiagwu from Nigeria, compare their experiences working in different countries within Africa, and share some of the challenges they have experienced, including difficulty obtaining reagents and equipment.</p>
<p> </p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/udrgip/Histology_Abroad_Rwanda_Nigeria.mp3" length="13220398" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, Emmanuel Hakizimana from Rwanda, and Daniel Osiagwu from Nigeria, compare their experiences working in different countries within Africa, and share some of the challenges they have experienced, including difficulty obtaining reagents and equipment.
 
 ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1391</itunes:duration>
                <itunes:episode>106</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Histology Abroad: United Kingdom</title>
        <itunes:title>Histology Abroad: United Kingdom</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/histology-abroad-united-kingdom/</link>
                    <comments>https://nshpodcasts.podbean.com/e/histology-abroad-united-kingdom/#comments</comments>        <pubDate>Mon, 08 Feb 2021 09:31:00 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/e0cf56ca-6164-3830-bc5b-719db31919f3</guid>
                                    <description><![CDATA[<p>In this episode, Dr. Guy Orchard from St. John's Institute of Dermatology in the United Kingdom talks about the process of becoming a biomedical scientist in England, opportunities for specialization through diplomas of expert practice, and the unique challenges presented by Victorian-era hospital architecture.</p>
<p> </p>
]]></description>
                                                            <content:encoded><![CDATA[<p>In this episode, Dr. Guy Orchard from St. John's Institute of Dermatology in the United Kingdom talks about the process of becoming a biomedical scientist in England, opportunities for specialization through diplomas of expert practice, and the unique challenges presented by Victorian-era hospital architecture.</p>
<p> </p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/jji46p/Histology_Abroad_UK.mp3" length="22377034" type="audio/mpeg"/>
        <itunes:summary><![CDATA[In this episode, Dr. Guy Orchard from St. John's Institute of Dermatology in the United Kingdom talks about the process of becoming a biomedical scientist in England, opportunities for specialization through diplomas of expert practice, and the unique challenges presented by Victorian-era hospital architecture.
 ]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2108</itunes:duration>
                <itunes:episode>105</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>2020 Poster Podcast Interviews: P10- High-resolution histological preparation of Araneomorphae and Mygalomorphae chelicerae using a modified petrographic technique</title>
        <itunes:title>2020 Poster Podcast Interviews: P10- High-resolution histological preparation of Araneomorphae and Mygalomorphae chelicerae using a modified petrographic technique</itunes:title>
        <link>https://nshpodcasts.podbean.com/e/2020poster-podcastinterviewsp10high-resolution-histologicalpreparation-ofaraneomorphaeand-mygalomorphae-chelicerae-usinga-modifiedpetrographic-techni/</link>
                    <comments>https://nshpodcasts.podbean.com/e/2020poster-podcastinterviewsp10high-resolution-histologicalpreparation-ofaraneomorphaeand-mygalomorphae-chelicerae-usinga-modifiedpetrographic-techni/#comments</comments>        <pubDate>Mon, 21 Dec 2020 13:50:39 -0500</pubDate>
        <guid isPermaLink="false">nshpodcasts.podbean.com/2abb689b-4815-355d-b6df-850cfbb24bfc</guid>
                                    <description><![CDATA[<p>This podcast is part of the 2020 NSH Symposium/Convention Poster Podcast Series. </p>
<p>Authors: Damien Laudier, Laudier Histology</p>
]]></description>
                                                            <content:encoded><![CDATA[<p>This podcast is part of the 2020 NSH Symposium/Convention Poster Podcast Series. </p>
<p>Authors: Damien Laudier, Laudier Histology</p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/prjvxv/Laudier_Final.mp3" length="9218166" type="audio/mpeg"/>
        <itunes:summary><![CDATA[This podcast is part of the 2020 NSH Symposium/Convention Poster Podcast Series. 
Authors: Damien Laudier, Laudier Histology]]></itunes:summary>
        <itunes:author>National Society for Histotechnology</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>930</itunes:duration>
                <itunes:episode>104</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
</channel>
</rss>
